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Abstract 
Alzheimer’s disease (AD) is characterised by cerebellar accumulation and 
aggregation of amyloid beta (Aβ), a cleavage product of the transmembrane 
amyloid precursor protein (APP). APP contains a range of functional domains in its 
large extracellular portion, among which are two copper-binding motifs and one 
zinc-binding motif. The copper-binding motifs are present in the amino-terminal 
region of APP and within the Aβ region of the protein and readily reduce Cu(II) to 
Cu(I), thus APP and its cleavage products are linked to copper metabolism and have 
been hypothesised to participate in cellular copper homeostasis. 
In this project human neuroblastoma cell lines SH-SY5Y were utilised to determine 
the effect of expressing a familial AD mutation on intracellular copper 
concentrations and possible functional alterations or deficits of enzymes that require 
copper as a co-factor. The familial AD mutation first found in a Swedish population 
was previously shown to increase the total amount of released Aβ. Direct 
phenotypic comparison between SH-SY5Y APPWT cell lines expressing endogenous 
levels of APP and APPswe
Coupling native two dimensional liquid chromatography with metal analysis, SDS-
PAGE and Principal Component Analysis identified one major copper and zinc 
containing pool as copper-zinc superoxide dismutase (SOD1) in soluble whole cell 
protein extracts. Comparative analysis of metal content between APP
 cell lines overexpressing APP carrying the Swedish 
mutation was performed in standard culture and manipulated copper concentrations. 
WT and APPswe 
cultures indicated a difference in metallation of SOD1 with copper. APPswe cultures 
displayed reduced metallation of SOD1, whereas SOD1 metallation with zinc 
remained unaltered. Functional analysis of copper-binding enzymes, such as SOD1 
and cytochrome c oxidase (CCO), using standard biochemical approaches, 
identified lower activities for both enzymes during standard cell culture in APPswe 
cells. Upon treatment of cultures with increasing concentrations of exogenous 
copper APPWT enzyme activities remained unaltered but enzyme activities in 
APPswe cultures increased in direct correlation with increasing copper 
concentrations. Combined with phenotypic analysis of growth, survival and 
intracellular metal content it appears that APPswe cultures are copper deficient, but 
 vi 
this can be overcome by copper supplementation. Lower copper accumulation also 
enables greater survival of APPswe
Overall, these data suggest that APP
 cells in elevated copper. 
swe overexpression in SH-SY5Y cells results in 
functional copper deficiency which can be rescued by supplementation of cultures 
with exogenous copper. APPswe
 
 further confers resistance to copper toxicity not 
only via increased Aβ release, but also via increased copper delivery to enzymatic 
target proteins improving cellular antioxidant response and energy metabolism. 
These data are consistent with a function of APP in copper efflux either in a 
regulatory capacity or directly contributing to copper egress. 
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1.1 Brain anatomy 
Chapter 1 – Introduction 
The brain weighs approximately 1.5 kg in adults and is roughly subdivided into 
three areas. The cerebral hemispheres, collectively called cerebrum, account for 
most of the brain’s size and are covered in a highly convoluted cortical layer. The 
cortex is the center for higher-order thinking, learning and memory, thus also 
represents the area most affected in neurodegenerative diseases. Beneath lays the 
brain stem which controls breathing, heart rate, body temperate and other autonomic 
functions. The cerebellum is located beneath the brain stem and is involved in motor 
control and cognitive functions such as language, attention and possibly emotions 
(Strange, 1996). Due to constant functional demands, the brain is the greatest 
consumer among the organs of the body of oxygen and glucose to fuel its oxidative 
metabolism. There is extensive blood supply to the cerebral cortex delivered by a 
large network of blood vessels and capillaries, which are thought to be within a 40-
50μm vicinity to each individual nerve cell. Nerve cell function and synaptic 
transmission depend on specific ionic concentrations in the extracellular space, thus 
fluctuations in blood composition could easily disrupt this sensitive environment. 
To avoid this scenario, the brain is surrounded by a compartment containing 
cerebrospinal fluid (CSF), which links the extracellular nerve cell space with the 
blood supply, but prevents direct contact (Strange, 1996). 
The CSF occupies the space around and between cerebral ventricles and the central 
canal of the spinal cord. It is produced at a rate of 500ml per day with an 
approximate turn over of 3 times per day and is in constant motion, thus providing 
nutrient supply to all areas of the brain and a clearance mechanism for metabolic 
waste. The CSF is formed from blood mainly by a network of ventricular 
capillaries, the choroid plexus, but also from capillaries around the brain and 
represents a low protein ultra-filtrate of blood plasma. Spatial and chemical 
separation of CSF from blood is achieved by a physical barrier called the blood-
brain-barrier (BBB), a layer of specialized epithelial cells lining cerebral capillaries 
(Saunders et al., 1999). Chemical gradients between blood and CSF are established 
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by selective active transport of nutrients such as glucose, trace metals, proteins and 
L-DOPA, a neurotransmitter precursor produced outside the brain. CSF has four 
major functions. It provides buoyancy for the brain to reduce weight associated 
pressure and resulting blockage of blood supply. Further it acts as a buffer, 
preventing physical injury to the brain when hit and facilitates blood reperfusion of 
swollen brains after head injury by decreasing its volume (Saladin, 2007). However, 
providing chemical stability by homeostatic regulation of biological molecules is 
one of the most important functions of CSF. 
1.2 Alzheimer’s disease 
1.2.1 Hallmarks of Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common form of dementia in humans 
accounting for 50-80% of dementia cases. Late-onset AD is typically diagnosed 
from the age of 65 and a rough estimate determined the risk of developing AD to 
double every five years thereafter. In 2006, there were 26.6 million sufferers 
worldwide and it is predicted that by 2050 1 in 85 people globally will be directly 
affected by the disease (Brookmeyer et al., 2007). 
Attention was first brought to this disorder in 1906 by the psychiatrist Alois 
Alzheimer, who detected abnormal deposits in the cortex of the post-mortem brain 
of one of his patients. What Alzheimer described about 100 years ago is now seen 
as the hallmark structures in the identification of Alzheimer’s disease (AD), 
however, it has not yet been determined whether these characteristic deposits are 
causative or an effect of pathological events in the brain. 
The pathological hallmarks developed by AD patients comprise of extracellular 
amyloid deposits referred to as plaques and intracellular neurofibrillary tangles 
(NFT) in brain regions involved in learning and long-term memory. Considerable 
progress has been made in the identification of proteins involved in the disease and 
their potential physiological and pathological functions. Amyloid plaques are 
composed of a hydrophobic fragment derived from a protein known as the amyloid 
precursor protein (APP). APP has a multitude of proposed functions which are 
discussed in later sections. NFT are composed of the hyperphosphorylated species 
of tau, a protein involved in micro-tubule directed neuronal trafficking. Both APP 
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and tau are at the center of multiple metabolic pathways, thus determining the cause 
of AD is not a straightforward task. Mis-regulation of vesicular trafficking, 
metabolic changes in neuronal metal and neurotransmitter homeostasis and 
oxidative stress resulting in energy loss due to mitochondrial disintegration have all 
been implicated in the progression of the disease. One common factor, however, is 
the proteolytic processing of APP to synaptotoxic Aβ, giving rise to the Aβ 
hypothesis (see section 1.4.1). 
AD is a form of progressive neurodegeneration in which first physiological changes 
occur up to 20 years before the first symptoms become apparent. First symptoms at 
the stage of mild cognitive impairment include short-term memory loss, mood 
changes, loss of numerical skills and poor judgement. Patients with moderate AD 
usually display symptoms like confusion, restlessness, difficulties in person and 
face recognition, whereas patients in the later stages of AD may suffer from 
seizures, severe weight loss and a complete loss of awareness (Förstl and Kurz, 
1999). Comparison of brain volumes of hippocampal and endorhinal cortex in 
patients with mild cognitive impairment and AD with a control group show a 
significant reduction in volume of these two regions with AD patients being 
affected more than patients with cognitive impairment. Reduction in cortex volume 
starts in the endorhinal region and proceeds to the hippocampal cortex with 
symptoms closely correlating with the affected brain region (Pennanen et al., 2004). 
AD is clinically diagnosed through a series of behavorial and cognitive tests and the 
diagnosis is supported by medical imaging techniques such as computed 
tomography, magnetic resonance imaging, single photon emission computed 
tomography or positron emission tomography. However, diagnosis of AD can only 
be confirmed post-mortem through the identification of extracellular amyloid 
deposits and intracellular NFT. AD is a terminal illness and patients usually die 
within seven years of diagnosis, not through AD itself, but the cause of death is 
typically a secondary infection such as pneumonia. 
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1.2.2 Genetic determinants of Alzheimer’s disease 
1.2.2.1 Sporadic Alzheimer’s disease 
A variety of factors influence the development and occurrence of sporadic AD or 
late-onset AD, which accounts for 90% of all AD cases. The greatest risk factor is 
age and the likelihood of developing AD increases drastically past the age of 65. 
Age-dependent changes in membrane composition in conjunction with 
hypercholesterolaemia are thought to be involved in the formation of amyloid 
plaques. Cholesterol is concentrated in membrane lipid rafts and it has been shown 
that enzymes involved in the processing of APP, such as β and γ-secretase, localise 
in those rafts, whereas α-secretase localizes outside lipid rafts (Ehehalt et al., 2003). 
There is also a correlation between sex and AD. It was demonstrated that 
testosterone reduces neuronal secretion of amyloid peptides (Gouras et al., 2000b), 
whereas female transgenic mice displayed increased plaque load due to increased β-
secretase activity (Schäfer et al., 2007). Refer to section 1.3.3 for more detail. 
Stroke and brain injury greatly contribute to AD development. Ischaemia is 
characterized by a reduction in cerebral oxygen levels due to restrictions in blood 
flow. Intracellular energy stores are rapidly depleted of ATP and absence of aerobic 
metabolism results in changes in metal ion homeostasis. Particularly potassium and 
calcium transport is interrupted thus increasing the possibility of synaptotoxicity by 
changes in neurotransmitter release, generation of reactive oxygen species (ROS) 
and induction of the mitochondrial apoptotic cascade. Reperfusion of the brain can 
cause additional generation of ROS once the fine chemical balance of the cell is 
altered. Cerebral reperfusion after brain injury is not a localized event, thus toxic 
effects are displayed globally and may pre-condition the brain to be more 
susceptible to AD (Raichle, 1982). It was also shown that under hypoxic conditions 
gene transcription and expression of β-secretase, an enzyme central to amyloid 
generation, were elevated thus possibly inducing the production of the first amyloid 
species which could initiate the amyloid cascade as described section 1.4.1 (Sun et 
al., 2006). 
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Among others Apolipoprotein E (APOE) is the major risk gene associated with AD. 
There are three isoforms of APOE: APOE-ε2, APOE-ε3 and APOE-ε4. It was 
recently shown that APOE promotes the proteolytic degradation of amyloid thus 
facilitating its clearance from the brain. The reduction in plaque burden was isoform 
specific with the greatest plaque reduction observed for mice homozygous for the 
APOE-ε2 allele. APOE-ε4, the isoform predominantly involved in the 
predisposition for development of AD, exhibited impaired ability to facilitate Aβ 
clearance. APOE enhances the break-down of amyloid indirectly by engaging with 
and altering the activity of neprilysin and insulin-degrading enzyme, major players 
involved in amyloid reduction as detailed in section 1.3.6 (Jiang et al., 2008). 
Heterozygous and homozygous allelic variation involving all three isoforms 
determines the risk of possible AD development. Although individuals homozygous 
for APOE-ε4 carry the highest risk of AD predisposition, some never develop AD, 
whereas 40-65% of AD cases are APOE-ε4 negative. This indicates that 
environmental factors such as diet, exercise regime, cognitive training and social 
interaction play a large role and if adjusted appropriately could potentially delay 
late-onset of AD. 
1.2.2.2 Familial Alzheimer’s disease 
Patients displaying genotypes of inherited or familial AD (FAD) account for less 
than 5% of all AD cases. Often multiple generations in one family display signs of 
dementia since patients develop symptoms from the age of 50. Three genes are 
involved in the autosomal dominant inheritance of early-onset AD and comprise of 
APP (chromosome 21), Presenilin1 (chromosome 14) and Presenilin2 (chromosome 
1). There are at least 38 mutations in the APP, 94 in the Presenilin1 and 12 in the 
Presenilin2 genes (http://www.alzforum.org) most of which lead to increased 
production of Aβ, specifically Aβ1-42, the major component of amyloid plaques 
(Scheuner et al., 1996). The increase in Aβ release is achieved in multiple ways. 
The London mutation in APP decreases the ratio of Aβ1-40 to Aβ1-42 (Suzuki et al., 
1994) thus increasing amyloid deposition, whereas the Swedish mutation in APP 
(hereafter referred to as APPswe) enhances overall amyloidogenic APP processing 
(Citron et al., 1992).  
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Of particular interest for this thesis is the double point mutation at positions 670 and 
671 (as shown in figure 1.1) in the 770 amino acid transcript of APP first discovered 
by Mullan et. al. (Mullan et al., 1992) in a Swedish family. This mutation just N-
terminal of the APP Aβ sequence enhances APP processing thus increasing amyloid 
concentrations and its neurodegenerative effects. It is hypothesized that Aβ 
influences a variety of physiological pathways causing disruption to synaptic 
plasticity and function, refer to section 1.4. To study the effects of the Swedish 
mutation many animal and cell culture models have been created. The most 
prominent mouse model is Tg2576 containing the human APPswe protein. 
Expression testing of the human APPswe variant in a rat model demonstrated high 
expression patterns in the cortex, hippocampus and cerebellum, brain regions most 
affected in AD (Folkesson et al., 2007). Comparison studies of fibroblasts obtained 
from symptomatic and pre-symptomatic carriers of the APPswe variant detected 
elevated Aβ levels in both groups suggesting that increased Aβ production is not a 
secondary event, but likely the cause in the development of AD (Citron et al., 1994). 
Thus a model organism containing the APPswe variant and displaying an increased 
APP metabolism is advantageous in studying possible roles of APP, in particular its 
role in cellular metal homeostasis. The human neuroblastoma cell line SH-SY5Y 
stably transfected with human APPswe
1.3 The amyloid precursor protein and its enzymatic processing to form beta-
amyloid 
 is used in this study in order to achieve the 
aims outlined in section 1.8.2. 
1.3.1 The amyloid precursor protein 
The amyloid precursor protein (APP) is ubiquitously expressed in human neuronal 
as well as non-neuronal tissues (Selkoe et al., 1988, Bush et al., 1990, Weidemann 
et al., 1989) and constitutes a type 1 membrane glycoprotein suggested to resemble 
a cell-surface receptor (Kang et al., 1987). It is localized to intracellular membranes 
such as the endoplasmic reticulum and the Golgi as well as to plasma membranes. 
The secretory trafficking processes involved in APP maturation will be described in 
detail in section 1.3.2. APP belongs to an evolutionarily conserved protein family 
(Coulson et al., 2000), which displays high amino acid and domain homology and 
contains the NPXY – clathrin internalization signal. Individual knock out mutations 
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of all three members in mice suggest a function to promote neurite outgrowth, 
neural cell migration and a role in copper homeostasis (Heber et al., 2000, Zheng et 
al., 1995, Müller et al., 1994, White et al., 1999b, Young-Pearse et al., 2007), 
whereas mice with the genotype for a triple knock out die in utero with symptoms 
of cranial defects (Herms et al., 2004).  Cleav ag e o f APP by the α-secretase 
complex, comprising of proteases ADAM10 and ADAM17, results in the release of 
soluble APPα (sAPPα) which is implicated in the regulation of neurite outgrowth 
and cell survival in developing hippocampal neurons (Milward et al., 1992, Mattson 
et al., 1993, Mattson, 1994) and adult synaptic plasticity, a term describing the 
reconnection and reorganization of neurons upon a variation of stimuli. Furthermore 
APP interacts with several trans-membrane and cytosolic proteins involved in 
axonal transport and receptor signaling. These interactions and their respective 
function will be discussed in section 1.3.4. 
The gene for APP is located on the human chromosome 21 (Goldgaber et al., 1987). 
Transcriptional products of the gene are alternatively spliced into three variants with 
corresponding proteins of 695, 751 and 770 amino acid residues (Kitaguchi et al., 
1988) with APP695 being the prevalent isoform in the human brain (Tanaka et al., 
1989, Kang and Müller-Hill, 1990, Rockenstein et al., 1995). This APP695 isoform 
was used in the transfection of SH-SY5Y neuroblastoma cells in the scope of this 
project due to its relevance to AD. The general protein structure of all three 
isoforms comprises of a short intracellular portion, a 23 amino acid transmembrane 
domain and a large extracellular N-terminal tail comprising structural and functional 
domains. As demonstrated in figure 1.1 the most N-terminal domain is a cysteine-
rich heparin binding domain (growth factor domain), which is thought to be the 
main contributor to the biological functions of APP specified above (Rossjohn et al., 
1999). A copper binding site and a zinc binding site are followed by an aspartic and 
glutamic acid rich part of the protein sequence. The Kunitz-type protease inhibitor 
domain (KPI) is present in the splice forms APP770 and APP751 at residue 365, but 
is absent from the APP695 isoform, which attributes to the difference in protein 
length. The Ox2 domain is followed by a second heparin binding domain, a region 
of random coil and a second copper binding site within the Aβ peptide sequence 
(Botelho et al., 2003). The difference in length between the APP770 and APP751 
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isoforms results from splicing of the Ox2 containing exon from the APP751
It has been demonstrated that APP is involved in homodimerisation facilitated by 
two independent sites in its extracellular portion. It was further shown that 
mutational modulation of distinctive sites leads to increased dimerisation and Aβ 
peptide formation, suggesting that this interaction contributes to the regulation of its 
proposed signal activity (Scheuermann et al., 2001). Further evidence exists that 
heparin might be involved in the dimerisation process (Gralle et al., 2006) and that 
in vivo APP forms homo- as well as heterodimer complexes with other APP family 
members, promoting cell-cell adhesion (Soba et al., 2005). 
 mRNA 
transcript. 
1.3.2. Expression, translation and maturation of the amyloid precursor protein 
during progression through the secretory pathway 
APP gene expression can be influenced by a variety of factors. It was shown by 
Bellingham et. al. (Bellingham et al., 2004b) that APP protein levels and gene 
expression are decreased in copper deplete human fibroblasts overexpressing the 
Menkes protein (MNK), a major mammalian copper efflux protein. Furthermore 
Hung et. al. (Hung et al., 1992) demonstrated increased gene expression and levels 
of protein for APP695 in vivo during neuronal differentiation in P19 murine 
embryonal carcinoma cells and increased protein levels of APP695 in primary 
hippocampal neurons during in vitro differentiation. Research suggests that the APP 
cleavage product APP intracellular domain (AICD – as described in more detail in 
section 1.3.3) indirectly regulates the gene expression of APP, BACE and Tip60 
(Cao and Sudhof, 2001). AICD is either restricted to cytosolic membranes by the 
adaptor protein X11α or interacts with the adaptor protein Jip1b which aids AICD 
transport into the nucleus and subsequent interaction with the nuclear histone 
acetylase Tip60 (von Rotz et al., 2004). In accordance with the hypothesis of APP 
involvement in neuronal metal homeostasis, Rogers et. al. (Rogers et al., 2002) 
identified a novel type-II iron responsive element (IRE) in the 5’-untranslated 
region (5’-UTR) of the APP transcript. Selective down-regulation of APP mRNA 
translation in SH-SY5Y neuroblastoma cells in response to intracellular iron 
chelation was reversed by iron influx. The variation of stimulatory and inhibitory 
stimuli and multi-factorial influence on both expression and translation of APP 
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indicates the complexity of APP based disorders and the difficulties of identifying 
the exact functions of this multi-facetted protein. 
Figure 1.1: Schematic representation of APP domains and sequential 
differences between SH-SY5Y APPWT and APPswe
a) APP is an integral membrane protein ubiquitously expressed in a variety of 
tissues. Several splice variants of the protein are known ranging from 695 (APP
 cell lines 
695) 
to 751 (APP751) and 770 (APP770) amino acid residues. In the brain APP695 is the 
most common form, whereas APP751 and APP770 are expressed in other tissues. The 
difference in length is dependent on the presence (APP751 and APP770) or absence 
(APP695) of the Kunitz protease inhibitor domain (KPI). Beginning from the N-
terminus other domains include a heparin-binding/growth-factor-like domain 
(HBD1) and a copper binding domain (CuBD1) followed by a zinc binding domain 
(ZnBD). An aspartic and glutamic acid rich part of the sequence (DE) is followed 
by a Kunitz protease inhibitor domain (KPI) for isoforms APP751 and APP770
b) The Aβ region (shown in red) of the APP protein is shown in more detail. The 
difference in peptide sequence between APP
 and a 
second heparin-binding domain (HBD2). A region of random coil (RC) precedes the 
Aβ peptide sequence (shown in red) which contains a second copper-binding site 
(CuBD2) (Botelho et al., 2003). 
WT and APPswe is represented by a two 
amino acid residue change just N-terminal of the Aβ sequence. Lysine (K) and 
methionine (M) at positions 595/596 have been mutated to asparagine (N) and 
leucine (L). Cleavage sites are indicated by arrows and the appropriate secretase 
responsible for proteolytic processing at any particular site. The β-secretase 
cleavage site is located most N-terminal of the peptide at amino acid residue 596, 
followed by the α-secretase cleavage site at amino acid residue 612. The two most 
common γ-secretase cleavage sites just C-terminal of the Aβ peptide sequence at 
residues 636 and 638 result in Aβ isoforms 40 and 42. Designated amino acid 
residues are derived from the APP695
 
 isoform, which is predominant in the brain. 
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Figure 1.2: Metabolic derivatives of APP in non-amyloidogenic and 
amyloidogenic proteolysis 
The membrane bound APP protein can be processed in two ways leading to a 
pathogenic and non-pathogenic phenotype. APP is proteolytically processed by a 
complex of α-secretases mainly comprising of ADAM10 within the Aβ peptide 
releasing a soluble ectodomain (designated sAPPα), and membrane bound fragment 
C83, which is subsequently cleaved by γ-secretase to generate the p3 fragment and 
the intracellular domain (AICD). 
The amyloidogenic processing of APP is initiated by β-secretase (BACE1) cleavage 
of APP just N-terminal of the Aβ peptide sequence resulting in the extracellular 
release of a peptide fragment designated sAPPβ. Subsequent heterogeneous 
cleavage of the membrane bound fragment C99 just C-terminal of the Aβ sequence 
by γ-secretase results in extracellular Aβ peptide and intracellular AICD generation. 
The most commonly generated forms of the Aβ peptide vary in length from 40-42 
amino acid residues with the majority being of the more soluble 40 amino acid 
residue nature. 
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Translation of APP mRNA occurs simultaneously to insertion of the newly 
synthesised polypeptide chain into the rough endoplasmic reticulum (ER). A 17-
amino acid signal recognition particle at the N-terminus of the APP nascent chain 
directs trafficking into the ER via the Sec61 translocon, mediating APP integration 
into the lipid bilayer via interactions with Sec61α and Sec61β subunits (Alder and 
Johnson, 2004). Following translocation a number of assessory components such as 
the signal peptidase (SPC) complex and the oligosaccharyltransferase (OST) 
complex facilitate processing of the unfolded protein (Alder and Johnson, 2004) and 
initiate O-linked N-glycosylation (Griffith et al., 1995). Experiments in Cos-7 cells 
further identified facilitation of APP transfer from the translocon into the membrane 
bilayer by interaction with Ribophorin 1, a translocon associated subunit of the 
OST, and SPC25 (Wilson et al., 2005). Ribophorin is implicated in co-localisation 
of the N-glycosylating subunit STT3 of the OST with APP (Wilson and High, 
2007). APP is subsequently transported to the trans-Golgi network (TGN) via Sec23 
and Sec24 in a COPII dependent manner (Huttunen et al., 2007). Phosphorylation of 
the APP ectodomain occurs at two distinct cellular locations. Regardless of familial 
mutations APP undergoes phosphorylation in a post-TGN compartment and also at 
the cell surface mediated by an ectoprotein kinase (Walter et al., 1997). Furthermore 
phosphorylation of APP at a site different to usual phosphorylation sites (namely at 
S655) increases the vesicular exit from the TGN and secretory cleavage of APP to 
produce the non-amyloidogenic sAPPα fragment, which is described in detail in 
section 1.3.3 (Vieira et al., 2009). Thus posttranslational modifications are 
imperative for APP processing and secretion (Caporaso et al., 1992). 
Global cellular studies of APP localization patterns reveal a dynamic process of 
APP secretion and internalization. Apart from being localized to intracellular 
membrane such as ER and the TGN it is also observed at the plasma membrane 
(Caporaso et al., 1994, Tomimoto et al., 1995). Evidence exists that APP is re-
internalised and processed in lysosomes (Haass et al., 1992a). However, proteolytic 
processing of APP mainly occurs in the ER, TGN and in endosomes (Grbovic et al., 
2003, Yan et al., 2001). Using immunofluorescent antibodies Yamazaki et al 
(Yamazaki et al., 1996) showed rapid internalization of APP via coated pits into 
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endosomes, prelysosomes and lysosomes contributing to the constitutive processing 
of this protein. In the brain APP has been detected in the membranes of synaptic 
extracts (Kirazov et al., 2001) and has been localized to postsynaptic moieties, 
axons and dendrites (Schubert et al., 1991, Shigematsu et al., 1992) as well as 
cholesterol enriched membranes (Hayashi et al., 2000) and cell adhesion patches 
(Storey et al., 1996). There is evidence that APP might be involved in axonal 
transport acting as kinesin-1 receptor, thus facilitating vesicular trafficking and APP 
fragment secretion. Deletion of the kinesin-binding region in the APP C-terminal 
disrupted vesicular trafficking along the axon (Gunawardena and Goldstein, 2001) 
and in vitro studies detected direct interactions of APP with the TPR domain of the 
kinesin light chain (Kamal et al., 2000). Recent research identifies a novel 
interaction of the APP cytosolic tail sequence YKFFE with the adaptor protein AP-
4, which is thought to reduce the amyloidogenic processing of APP by redirection 
of membrane vesicles from TGN to endosomes, thus eliminating the post-TGN 
cleavage of APP by γ-secretase (Burgos et al., 2010). 
1.3.3 Cleavage and processing pathways of the amyloid precursor protein 
Upon maturation APP undergoes processing by three individual proteases at two 
extracellular and one transmembrane site. Figure 1.1 shows a schematic 
representation of the APP protein and its cleavage sites termed α, β and γ according 
to their respective protease. APP processing at α- and β- cleavage sites is a mutually 
exclusive event and results in the release of large extracellular domains sAPPα 
(Esch et al., 1990) and sAPPβ of the protein. Membrane tethered C-terminal 
fragments, C83 for α- and C99 for β-secretase generated products, are further 
processed by the transmembrane γ-secretase complex, which generates the p3 and 
Aβ1-40/Aβ1-42 
The α-secretase complex has not been characterised in very much detail. The 
complex has both constitutive and inducible components with the inducible activity 
being controlled by protein kinase C (PKC) (Nitsch et al., 1997), which in turn is 
stimulated by glutamate signaling (Lee et al., 1995). The constitutive activity, 
however, has not yet been identified. The complex mainly consists of two 
fragments, respectively. The APP intracellular domain (AICD) is 
released into the cytosol after γ-secretase cleavage of both fragments (see figure 
1.2). 
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disintegrin metalloproteinases ADAM 10 and ADAM17 or TACE. It was shown 
that mice lacking TACE show decreased levels of sAPPα and die in utero indicating 
a vital role for sAPPα in embryonic development (Buxbaum et al., 1998a, Peschon 
et al., 1998). Overexpression of ADAM10 increased α-secretase activity, whereas a 
point mutation in its zinc-binding site inhibited enzyme activity, but did not abolish 
all sAPPα production (Lammich et al., 1999) indicating that α-secretase activity 
might be governed by more than two proteinases. Further ADAM10 activity has 
been demonstrated in vitro using the Aβ peptide 11-28 fragment as substrate 
(Lammich et al., 1999). Both ADAM10 and ADAM17 are synthesised as 
proproteins and require prodomain cleavage by proprotein convertases (PCC) to be 
activated (Anders et al., 2001), a process which readily occurs in the late TGN 
(Schlondorff et al., 2000). 
BACE1 (beta-site amyloid precursor protein cleaving enzyme 1) was first identified 
in 1999 as a membrane-anchored aspartyl protease with homology to the pepsin 
family (Vassar et al., 1999, Hussain et al., 1999, Yan et al., 1999). It cleaves APP 
after residue 596 (APP695 isoform) releasing the sAPPβ and C99 fragments. BACE1 
contains a single membrane-spanning region near its carboxy-terminus, a signal 
sequence and a propeptide sequence close to its amino-terminal and two aspartate 
residues at positions 93 and 289, which are vital for enzyme activity (reviewed in 
(Suh and Checler, 2002). Upon BACE maturation by propeptide cleavage and N-
glycosylation of its ectodomain in the ER, it is relocated to the TGN and 
endosomes, a process catalysed by the phosphorylation of serine 498 in the 
cytosolic tail of the protein (Walter et al., 2001). BACE1 is highly expressed in 
neuronal tissues with a particularly high distribution to cholesterol-specific lipid 
rafts (Marlow et al., 2003), but is also detected in a variety of other human tissues 
(Vassar et al., 1999, Yan et al., 1999). Knock out mice lacking both alleles for the 
enzyme are phenotypically normal and show reduced secretion of Aβ, indicating 
that inhibition of BACE1 might be a potent therapeutic for AD (Luo et al., 2001, 
Cai et al., 2001). Further it has been reported that APPswe (as depicted in figure 1.1) 
is cleaved more readily to produce larger quantities of the potentially neurotoxic Aβ 
peptide (Yan et al., 1999, Perez et al., 1996, Cai et al., 1993). The reasons for 
increased processing of APPswe need to be established. One cause may be increased 
approximation of APP and BACE1 through interactions facilitated by the mutation 
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or possible increased enzyme activity. Angeletti et. al. (Angeletti et al., 2005) 
discovered that BACE1 contains a 24 residue cytosolic domain with high affinity 
for Cu(I). Intricate studies showed that BACE1 interacts with the copper chaperone 
for superoxide dismutase (CCS) (see section 1.8.1) thus potentially redirecting 
copper away from the cellular antioxidant defence system and ultimately linking 
superoxide dismutase activity, cytosolic copper and ectodomain cleavage 
(Dingwall, 2007).  
A second aspartyl protease, BACE2, was also identified in the brain (Farzan et al., 
2000). However, it is expressed at much lower levels than BACE1 (Bennett et al., 
2000a) and thought to be of more importance in vascular tissues such as placenta, 
heart and kidney (Farzan et al., 2000). 
The γ-secretase is a multi-subunit complex that cleaves the transmembrane APP 
fragments C83 and C99 into p3 and Aβ1-40/1-42 at the carboxy-terminus of the Aβ 
sequence, respectively, releasing AICD into the cytosol. It was reported that 
GXXXG motifs within the transmembrane region determine the etiology of Aβ 
depending on the dimerisation strength of the motif. Mutations in GXXXG cause a 
shift to the generation of shorter Aβ species (Munter et al., 2007). There are 
opposing views with regards to the main components of this complex. Presenilin 1 
(PS1) and presenilin 2 (PS2) are thought to be the major catalytic enzymes in the 
secondary APP cleavage step. Both are integral membrane proteins containing eight 
transmembrane domains. Inactive full-length proteins undergo cleavage between 
domains 6 and 7 to produce two fragments which associate in a hetero-dimer 
complex (Capell et al., 1998). Evidence in support of the theory that presenilins are 
the catalytic cleavage subunits of the γ-secretase complex, includes reduced γ-
secretase activity in PS1 knockout mice resulting in reduced secretion of the Aβ and 
p3 fragments and cellular accumulation of the C83 and C99 fragments (De Strooper 
et al., 1998).  However, another line of evidence demonstrating no changes in Aβ 
production in fibroblasts derived from presenilin knockout mice (Armogida et al., 
2001) suggests that presenilins may act as mediators facilitating the trafficking of 
APP C-terminal fragments to their cleavage specific site (Sisodia et al., 2001, Xia et 
al., 2000, Cai et al., 2003). Ponting et. al. (Ponting et al., 2002) discovered an 
evolutionarily conserved presenilin homologue gene family coding for proteins with 
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multiple transmembrane domains and two predicted catalytic aspartyl residues, as 
were previously detected in presenilins and thought to mediate endoproteolysis and 
γ-secretase activity (Wolfe et al., 1999). These other family members might account 
for the compensatory catalytic cleavage in fibroblasts from PS1 knockout mice. A 
second component of the γ-secretase complex is nicastrin, a transmembrane protein, 
which interacts with the C-terminal fragments of APP and presenilins (Esler et al., 
2002). It was shown by Yu et. al. (Yu et al., 2000) that mutational modifications in 
conserved regions of the protein resulted in increased Aβ production, whereas 
deletion of the same region resulted in complete abrogation of Aβ secretion. Post-
translational modifications such as glycosylation and nicastrin trafficking were 
abolished in presenilin double knockout mice strengthening the arguments of a 
potential role for presenilins in the assembly and maturation of the γ-secretase 
complex rather than enzyme activity itself (Leem et al., 2002). 
Similarities between APP cleavage and Notch cleavage have been detected. Notch 
is a type-I transmembrane receptor that is catalytically processed by TACE (Brou et 
al., 2000) or ADAM10 (Hartmann et al., 2002) upon ligand binding and thought to 
be involved in fate decisions during embryonal development. Subsequent 
intramembrane cleavage (De Strooper et al., 1999) is reminiscent of APP C-
terminal cleavage by γ-secretase with the resulting cytosolic fragment engaging in 
transcriptional activation. Both proteins interact with presenilins during γ-secretase 
cleavage, indicating that due to binding competition this might be the rate limiting 
step in Aβ production. 
Not only post-translational modifications and exogenous stimuli determine the fate 
of APP cleavage. One important factor is the putative localization of its processing 
enzymes. After translation in the rough ER, APP is transported through the TGN to 
the plasma membrane, where partial re-internalisation of full-length and 
transmembrane carboxy-terminal fragments via endosomes occurs (Yamazaki et al., 
1996). Endosomal vesicles are either redirected to the TGN for recycling or to the 
lysosomal compartment for degradation. α-secretase activity is found in 
compartments of the anterograde transport system, namely the ER, the TGN and 
secretory vesicles, whereas β- and γ-secretases act on APP and its proteolytic 
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products in all anterograde and retrograde compartments, ie. the ER, the TGN, 
secretory vesicles, endosomes and lysosomes. 
 
1.3.4 Protein interactions with the amyloid precursor protein 
Continuous production of APP during embryogenesis and adulthood suggests a 
permanent role for the protein in neuronal development and implications in synaptic 
plasticity implying effects on memory and cognition. In addition to its involvement 
in neurite growth and neuronal maintenance via sAPPα it was suggested that APP 
may play a part in G-protein coupled signaling in the brain. APP displays a 
structural configuration reminiscent of a membrane anchored receptor. In fact, it 
was shown that APP is coupled to trimeric G0
APP has also been implicated in cell adhesion and motility due to its ability to bind 
specific proteins involved in these processes. The large extracellular portion of APP 
contains several domains that provide binding motifs for heparin (Mok et al., 1997), 
collagen (Beher et al., 1996), laminin (Kibbey et al., 1993), beta-1-integrin 
(Yamazaki et al., 1997) and telencephalin. It was observed that PS1 binds both APP 
and telencephalin providing a possible spatial link between the two proteins 
(Annaert et al., 2001). 
 proteins via its intracellular tail 
(Nishimoto et al., 1993). Downstream signaling cascades may include adenylyl 
cyclase, phospholipase C, voltage-dependent calcium channels and pathways for 
apoptosis (Nishimoto et al., 1993). However, the downstream effects of APP 
mediated G-protein signaling are not known. 
APP is also involved in the formation of actin filaments. The adaptor protein Fe65 
binds to the intracelullar domain of APP and interacts with mammalian homologue 
of drosophila enabled (MENA), which binds to profilin and enhances actin filament 
formation. This interaction provides a link between a potential receptor protein and 
the cytoskeleton other than APP binding to micro-tubules via JIP1. Overexpression 
of APP and Fe65 demonstrated increased cell motility and growth cone dynamics 
(Sabo et al., 2001). 
The same binding motif responsible for interactions of Fe65 and JIP1 with APP 
(YENPTY), which is conserved in cytoplasmic domains of several tyrosine kinase 
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receptors, also facilitates the interaction of APP with the adaptor protein family X11 
(Borg et al., 1998). X11α and X11β are the two neuronal isoforms, however, most 
research to date was performed to elucidate the function of X11α. X11α binds to 
APP via its phospho-tyrosine-binding (PTB) domain preventing APP processing 
and production of amyloidogenic as well as non-amyloidogenic soluble fragments 
(Borg et al., 1998) and a decrease in amyloid plaque deposition was detected in vivo 
in APPswe
1.3.5 Aggregation of the amyloid beta peptide and formation of plaques 
 transgenic mice (Lee et al., 2003). The inhibition of Aβ production is 
thought to be due to attenuated γ-secretase processing of APP upon interaction with 
X11α (Xie et al., 2005). It was further demonstrated that X11α binds to PS1, thus 
direct competition between APP and X11α for PS1 binding might account for 
decreased APP processing. Direct inhibition of APP and PS1 interaction was 
demonstrated for X11β bound to caldein resulting in the retardation of intracellular 
protein maturation (Araki et al., 2003). The X11 protein family might also have a 
role in the regulation of protein trafficking since they are localized throughout the 
neuron and co-purification of caldein and X11β with the kinesin heavy chain was 
demonstrated (Araki et al., 2003). It was shown by Vassar et. al. (Vassar, 2005) that 
the optimal pH for BACE activity is slightly acidic, conditions attributed to the late 
Golgi, endosomes and lysosomes. Thus enzyme activity is prominent in those 
compartments. Due to X11 interactions with the transport system and reduced 
processing of APP, it was suggested that X11 proteins retain APP or direct APP 
trafficking to compartments unsuitable for α, β, or γ-secretase activity. A further 
function attributed to X11 proteins is involvement in cellular copper homeostasis by 
providing a connective link between APP and the copper chaperone for superoxide 
dismutase (CCS) (McLoughlin et al., 2001), which in turn interacts with the 
cytosolic domain of BACE (Angeletti et al., 2005). There is a large body of 
evidence that AD can be correlated with copper imbalance and that APP is one of 
the major players in this metabolic disruption (reviewed in (Bush, 2003). Since the 
involvement of copper in the pathology of AD is the major focus of this thesis, 
detailed analysis of copper transport, metabolism and its role in neurodegeneration 
will be provided in sections 1.5 and 1.6.  
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Aβ is produced in small amounts by a variety of cell types and under physiological 
conditions in the CSF of AD and non-AD patients suggesting physiological 
relevance for the peptide and its participation in neurotoxic events as an effect of 
misregulation (Busciglio et al., 1993, Shoji et al., 1992, Haass et al., 1992b). It was 
suggested that Aβ might have a physiological role as neuronal modulator of A-type 
K+ currents (Plant et al., 2006). BACE1 processes approximately 10% of all APP 
protein with the resulting species of Aβ peptides varying in length from 39-42 
amino acids. The major two species are Aβ1-40 (90%) and Aβ1-42 (10%) and 
represent an indicative means of measuring the advance of AD as their relative ratio 
decreases with disease progression. Studies suggest that most Aβ species are 
produced in the late secretory and endocytic compartments (Buxbaum et al., 1998b, 
Wirths et al., 2004), however, an extensive line of research suggests that the more 
hydrophobic form Aβ1-42 is mainly produced in the ER, whereas Aβ1-40
1.3.6 Degradation of amyloid aggregates 
 is produced 
in the TGN (Cook et al., 1997, Greenfield et al., 1999, Hartmann et al., 1997, Haass 
et al., 1993, Wilson et al., 2002). Studies in canine kidney epithelial (MDCK) cells 
determine the main cleavage event of APP to occur intracellularly rather than on the 
cell surface (Haass et al., 1995).  The Aβ peptide exists as monomer, dimer and in 
oligomeric form, before it forms protofibrils and ultimately fibrils, which aggregate 
to plaques characteristic for AD (Bitan et al., 2003). Although large β-sheet 
aggregates of amyloid remain mainly extracellular, pools of intracellular small, 
soluble, non-fibrillar oligomers known as Aβ-derived diffusible ligands (ADDLs) 
(Lambert et al., 1998) have been determined. The discovery of intracellular Aβ 
suggests either the re-internalisation of soluble oligomers or the formation of 
oligomers in vesicular compartments, and identify the intracellular soluble pool of 
Aβ as causative for the extracellular plaque formation (Oddo et al., 2006). In vitro 
experiments demonstrate a dependence of fibril aggregation on time and 
concentration, characteristics of two major risk factors determined for FAD-linked 
AD patients, age and the shift of soluble to insoluble amyloid species production in 
mutations linked to APP, PS1 and PS2 (as explained in section 1.2.2.2). 
The steady state levels of Aβ in the brain are finely controlled by maintaining a 
balance between anabolism and catabolism of the peptide (Saido, 1998). 
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Accumulation of Aβ and subsequent aggregation into fibrils and plaques in sporadic 
cases of AD can mainly be accounted for due to a reduction in catabolism. No 
single protease has been identified as potential Aβ degrading enzyme. However, 
candidate enzymes include cathepsin D and E, gelatinase A and B, trypsin or 
chymotrypsin-like endopeptidases, aminopeptidase, neprilysin (NEP), serine 
protease complexed with α-2 macroglobulin and insulin degrading enzyme (IDE) 
(Saido and Iwata, 2006). During aggregation Aβ undergoes structural changes from 
an α-helical to a β-sheet conformation which reduces the accessibility for proteases 
at particular cleavage sites and renders the peptide more resistant for cerebral 
clearance via the CSF. Thus a range of proteases might be involved in distinct Aβ 
clearance depending on its aggregation state. 
Special focus has so far been placed on IDE, NEP and matrix metalloproteinase 2 
(MMP2) as potential Aβ proteases. IDE exists in soluble form in the cytoplasm and 
extracellularly in the CSF of the nervous system. In vivo and in vitro studies 
demonstrate that the motif recognized by IDE is not the β-sheet, but conformations 
of the monomeric form in a pre-amyloid state (Bennett et al., 2000b, Qiu et al., 
1998). Recent studies on PS1 V97L mutant cell cultures revealed an increased level 
of Aβ1-42 accompanied by the decrease of expression and activity of IDE (Qin and 
Jia, 2008) indicating that the severity of disease progression due to reduced Aβ 
clearance not only exists in sporadic AD cases, but potentially has a major influence 
on FAD patients. NEP was detected in the brain almost exclusively in form of a 
membrane-bound protein. Using inhibitors to IDE and NEP it was shown that IDE 
preferably degrades soluble forms of Aβ, whereas NEP degrades membrane bound 
forms of the peptide. Further NEP knockout mice showed distinct Aβ deposition in 
the order of hippocampus, cortex, thalamus/striatum and cerebellum, areas 
especially affected by Aβ deposition in AD patients (Iwata et al., 2001) and a 
reduction in neprilysin levels with increasing age in human brains is thought to 
contribute to higher amyloid levels (Hersh and Rodgers, 2008). It was reported that 
Angiotensin-converting enzyme (ACE) is involved in the regulation of the ratio of 
hydrophobic and more hydrophilic amyloid species in Tg2576 mice. Reduction of 
Aβ1-42 concentrations and increases Aβ1-40 was observed, an effect which was 
blocked by ACE inhibitor captopril suggesting ACE involvement in the promotion 
of soluble Aβ (Zou et al., 2007). Gelatinase A, or MMP2, was also found to play a 
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role in Aβ degradation (Roher et al., 1994). It was shown that increased Aβ 
hydrophibicity, interactions with zinc or copper resulting in increased aggregation 
and specific FAD mutations prevented MMP2 activity dependent clearance of 
amyloid (Crouch et al., 2009). However, this effect was reversed by addition of zinc 
and copper together with the chelating agent clioquinol (White et al., 2006, Crouch 
et al., 2009) indicating that metal induced aggregation of Aβ is one of the major 
challenges in finding a cure to AD. However, before therapeutic agents can be 
developed it is important to determine the severity of neurotoxocity of monomeric, 
oligomeric and fibrillar species of Aβ. For a comprehensive review of APP 
processing and Aβ clearance refer to Makarova et. al. (Makarova et al., 2004). 
1.4 Beta-amyloid mediated mechanisms of neurotoxicity 
1.4.1 The amyloid cascade hypothesis 
The amyloid hypothesis is based on the theory that gradually changing steady-state 
levels of Aβ initiate a pathological cascade that ultimately results in the formation 
of amyloid plaques and neurodegeneration in the brain (Hardy and Higgins, 1992). 
A quick overview of various stages of the process is shown in figure 1.3. However, 
this hypothesis is somewhat controversial as several groups discovered a 
discrepancy between disease severity and plaque burden. It has been shown that the 
soluble pool of Aβ oligomers is characteristic for disease severity (McLean et al., 
1999) and that fibrillar aggregates are less toxic than their soluble counterpart 
(Hartley et al., 1999, Lambert et al., 2001, Gong et al., 2003, Lacor et al., 2007, 
Crouch et al., 2005). ADDLs, as mentioned before, have been implicated in the 
inhibition of hippocampal long-term potentiation (LTP) in rats in vivo when present 
at concentrations comparable to those in human AD brain and CSF (Walsh et al., 
2002) and were found to be 70 fold more concentrated in AD patients compared to 
non-AD patients (Gong et al., 2003). Further studies of cerebral distributions of 
soluble and fibrillar amyloid (Kayed et al., 2003) imply a close correlation between 
distribution and concentration of ADDLs with AD toxicity. An alternative to the 
traditional amyloid hypothesis discusses the possible interaction of Aβ oligomers 
with the PrP protein, which resembles an Aβ receptor in neuronal membranes and 
might be facilitating the induction of down-stream neurodegenerative processes 
(Lauren et al., 2009). 
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Behavorial studies in rat implicate Aβ oligomers in cognitive dysfunction (Cleary et 
al., 2005), however, the exact biochemical interactions are not yet fully understood. 
Lacor et. al. (Lacor et al., 2007) recently demonstrated that ADDLs alter dendritic 
spine composition, morphology and density by binding specifically to excitatory 
pyramidal neurons and reducing the expression of NMDA and EphB2 receptors. 
Both receptors are functionally related to synaptic plasticity with the NMDA 
receptor playing a central role in LTP and EphB2 exerting control over NMDA-
dependent LTP (Lacor et al., 2007). Although, recent developments attribute toxic 
characteristics to soluble oligomeric forms of Aβ, an insoluble pool of intraneuronal 
Aβ was detected in NT2N cultures, which accumulated in a time dependent manner 
in the ER and intermediate compartment (Skovronsky et al., 1998). This 
accumulation of Aβ1-42
No single major function or target of the amyloid peptide has been determined, 
which leaves room for speculation about the physiological significance of naturally 
produced base levels of Aβ. As alteration or addition to the traditional amyloid 
hypothesis, Haass et. al. (Haass and Selkoe, 2007) suggest a role for large insoluble 
Aβ deposits as a source for oligomeric and monomeric species, thus implying a 
constant equilibrium between the two aggregation forms. 
 preceeds the formation of NFT and plaque deposition 
suggesting that intracellular aggregation occurs in the early stages of AD (Gouras et 
al., 2000a, Wirths et al., 2004). 
1.4.2 Oxidative stress 
Oxidative stress has been identified as a major contributor to neuronal impairment 
in a number of degenerative diseases such as AD, Amyloid Lateral Sclerosis (ALS) 
and Parkinson’s disease (PD). 
In the resting state the brain consumes around 20% of total systemic oxygen 
indicating the need for a tight control of oxidative balance and regulation of 
antioxidant status (Smith et al., 2007). Apart from being produced via the oxidative 
phosphorylation pathway, highly reactive oxygen species (ROS) such as hydrogen 
peroxide, hydroxyl radicals, superoxides and nitric oxide (NO) are generated 
through interactions of molecular oxygen with biological compounds. This can be in 
the form of metal-catalysed Haber-Weiss or Fenton reactions or by calcium 
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mediated phospholipase activation, xanthine oxidase (XO) and nitric oxidase 
synthase (NOS) activity (Lewen et al., 2000). Aβ has been implicated in stimulating 
the influx of excess synaptic Ca2+, thus causing the synthesis of nitric oxide by NOS 
upon glutamate release from NMDA receptors (Parks et al., 2001). Aβ generated 
ROS was also shown to cause cell death in AD brains by increasing intracellular 
Ca2+
A variety of biomarkers has been determined to measure the degree of oxidative 
damage with respect to DNA damage (Dizdaroglu, 1992) including mitochondrial 
DNA (Mecocci et al., 1994), peroxidation of lipids and altered gene expression as a 
result of ROS generation (Allen and Tresini, 2000). Increased nuclear DNA damage 
in AD brain has been reported (Gabbita et al., 1998) as well as extensive protein 
carbonylation (Vitek et al., 1994). A high correlation between fibrillar Aβ and 
protein and lipid peroxidation stress markers (3-nitro-tyrosine and 4-hydroxy-2-
nonenal – HNE, respectively) has been observed (Matsuoka et al., 2001) indicating 
that, although ROS is produced intra and extracellularly (Schippling et al., 2000), 
the species responsible for oxidative damage is the aggregated form of Aβ. 
 levels (Mattson and Goodman, 1995, Yamamoto et al., 1998). Further it was 
demonstrated that Aβ increases ROS concentrations (Hensley et al., 1994, Harris et 
al., 1995), which lead to apoptotic cell death in differentiated neuronal cell culture 
(Tamagno et al., 2003). However, the apoptotic cascade was inhibited upon cell 
exposure to antioxidants (Keller et al., 1997a).  
Removal of extracellular synaptic glutamate by high-affinity glutamate receptors is 
crucial in the prevention of neuronal excitotoxicity. HNE, an aldehydic product of 
membrane lipid peroxidation, mediates oxidation-induced impairment of glutamate 
(Keller et al., 1997b) and glucose transporters (Mark et al., 1997) leading to a 
decrease in cellular ATP levels, synaptic degeneration and cell death. HNE further 
inhibits Na+/K+
As a metallo-protein Aβ is directly involved in the generation of ROS by Fenton-
type reactions. Details about metal-binding specificity of amyloid and APP will be 
discussed in section 1.6.1. Upon metal binding Aβ aggregates and in a mode of 
catalytic recycling reduces bound Cu(II) and Fe(III) to Cu(I) and Fe(II) releasing 
H
 ATPases (Mark et al., 1995) and promotes protofibril formation of 
Aβ via covalent modifications (Siegel et al., 2007). 
2O2 and hydroxyl radicals (Huang et al., 1999). Synaptically released zinc is also 
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involved in Aβ aggregation supporting the oxidative properties and plaque 
formation of amyloid. Peptide aggregation was reversed in vitro upon treatment of 
brain slices with metal chelators and production of H2O2
Figure 1.3: Amyloid cascade hypothesis 
 was only detectable in  
The schematic describing the amyloid hypothesis has been directly taken from 
Haass et. al. (Haass and Selkoe, 2007) and explains the biological steps for 
accumulative Aβ toxicity. Gradual changes in Aβ metabolism leads to increased 
levels of the peptide and its oligomerisation into higher aggregation states. 
Oligomeric toxicity results in inflammatory responses, synaptic disruption and 
changes in metal ion homeostasis. Finally oligomers aggregate to form plaques 
characteristic for AD. 
A recent alternative hypothesis is based on Aβ binding to PrP which presents a 
receptor-like structure in neuronal membranes potentially leading to down-stream 
neurodegenerative processes (Lauren et al., 2009). 
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aggregated species of Aβ (Curtain et al., 2001). Barnham et. al. (Barnham et al., 
2003a) reported that spontaneous oxidation of methionine 35 in the Aβ peptide 
inhibits membrane penetrating abilities, thus increasing extracellular amyloid 
burden. Further it was observed that this oxidation facilitated the binding of redox 
active Cu(II) and its reduction to produce H2O2
1.4.3 Axonal transport inhibition 
. 
Fast anterograde axonal transport of APP has been reported (Koo et al., 1990). This 
active transport is facilitated by kinesin motor proteins, which interact with micro-
tubule associated tau protein. Pathologic hyperphosphorylated tau aggregates to 
form NFT, thus compromising anterograde and retrograde kinesin-dependent 
transport of Golgi-derived vesicles, neurofilaments and peroxisomes, a process 
which enhances ROS production and neurotoxocity (Stamer et al., 2002). It was 
thought that APP binds to kinesin via the kinesin light chain-1 (KLC) subunit 
(Kamal et al., 2000), however, it now emerged that APP indirectly interacts with 
kinesin via c-Jun N-terminal kinase-interacting protein 1 (JIP1) (Sisodia, 2002). 
Hyperphosphorylated tau also binds JIP1, thus directly competing for physiological 
binding of JIP1 to KLC (Ittner et al., 2009). Mice carrying a double delete mutation 
for the KLC1 subunit displayed cytoskeletal disorganization, abnormal cargo 
accumulation, axonal and dendritic swelling and axonopathies (Falzone et al., 
2009), symptoms which were also detected in AD transgenic mice with an increased 
amyloid deposit burden (Stokin et al., 2005). The direct link, if one exists, between 
amyloid burden and the hyperphosphorylation of tau needs to be established. 
1.4.4 Other potential causes of Aβ mediated neurodegeneration 
There is a variety of mechanisms by which Aβ exerts toxicity such as protein 
aggregation, oxidative stress, biometal dyshomeostasis and mitochondrial failure 
(Crouch et al., 2008). A recent and comprehensive review discussed these major 
neurodegenerative pathways. 
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The promotion of increased synaptic Ca2+ influx and cellular Ca2+ imbalance, which 
causes consistent synaptic neurotransmitter release, is facilitated by amyloid 
penetration into the membrane bilayer forming an ion channel pore which supports 
the selective current of cations additional to Ca2+ across the membrane (Arispe, 
2004). Increased cellular Ca2+
Amyloid aggregates have also been detected in mitochrondria and are implicated in 
the reduction of mitochondrial respiration by impairing cytochrome oxidase, α-
ketoglutarate dehydrogenase and pyruvate dehydrogenase enzyme activity. 
Increased levels in NO, as detected in post-mortem AD brains, exacerbated enzyme 
impairment resulting in major loss of energy production (Casley et al., 2002). 
Neuronal mitochondrial alcohol dehydrogenase readily binds Aβ (ABAD), which 
results in distortion of enzyme structure, loss of function and promotes the 
generation of free radicals. Double transgenic mice displayed increased ABAD 
concentrations in Aβ-rich environments and an accelerated decline in spatial 
learning ability and memory (Lustbader et al., 2004). 
 levels have been associated with the release of 
mitochondrial cytochrome c culminating in the initiation of the apoptotic cascade 
and neuropathology. 
Recently extracellular metallated amyloid plaques have been described as exhibiting 
type-3 copper oxidase activity by catalyzing the oxidation of dopamine, 
catecholamine and indoleamine, thus interfering with the re-uptake of 
neurotransmitters and directly contributing to a decrease in excitatory potential (da 
Silva and Ming, 2007). 
Additional effects of Aβ accumulation are the increased endocytosis of NMDA 
receptors thus decreasing the potential for neurotransmission (Snyder et al., 2005), 
stimulation of actin polymerisation and interference with neuronal transport 
(Mendoza-Naranjo et al., 2007), downregulation of IDE (Qin and Jia, 2008) and 
initiation of immune responses. 
1.5 Copper in biology 
1.5.1 An introduction to metals in biology 
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Metals are essential for the survival of all organisms. Current estimates suggest that 
around 50% of all enzymes require metals as a co-factor (Andreini et al., 2008) 
either to maintain structural integrity or as catalytic facilitator. However, these 
essential metals can have toxic effects when accumulated in excess or bound by the 
wrong protein species. Some metals are redox-active, thus can participate in Fenton 
or Haber-Weiss type reactions and generate ROS. Metals involved in Fenton 
reactions are mainly Cu(I) and Fe(II) which, upon oxidation with biologically 
produced hydrogen peroxide, generate hydroxyl radicals. Haber-Weiss reactions 
contribute to oxidative stress burden by iron catalysed generation of hydroxyl 
radicals from hydrogen peroxide. 
[Equ. 1]  Cu(I) + H2O2 → Cu(II) + OH· + OH
[Equ. 2]  Fe(III) + H
− 
2O2 → Fe(II) + OOH· + H
Freely available and excess metal could potentially prevent the binding of metals to 
their respective binding-site, thus interfering with the biological function of 
particular metalloproteins. 
+ 
To avoid these detrimental effects metal ion availability needs to be tightly 
controlled. An intricate cellular system comprised of regulatory and sensory 
elements has evolved to ensure the adaption of the cell’s metabolism to 
environmental stimuli. Intracellular metal homeostasis is maintained by active 
influx, efflux and storage of ions depending on their cellular concentration 
(Rutherford and Bird, 2004), thus preventing excess cellular metal and cellular 
deficiency. Metal-regulated changes in metallothionein storage, importers or 
exporters are mainly attained by metal-activated transcription factors or repressors, 
thus adjusting the homeostatic properties of the cell to systemic fluctuations in 
metal concentrations (O'Halloran, 1993). Additionally, upon sensing excess metal, 
cells may also switch their metabolism to a set of proteins which binds the particular 
excess metal, thus providing alternative ligands. 
1.5.1.1 Metal selectivity and biochemical properties of copper 
It is traditionally assumed that upon folding in the ER or as apo-protein in the 
cytosol, proteins acquire their metal co-factor(s) from a readily available pool of 
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metals simply by distinction of the ion’s thermodynamic properties. Such properties 
are fairly unique to each metal ion. Ligands chemically distinguish between 
different metals by size, charge, hydration status and the metal’s affinity for 
different binding-sites and ligands. It is not unusual that, upon metal binding, the 
structure of both the protein ligand and the metal ion are slightly altered to 
accommodate a change in bond angles and lengths (Frausto da Silva and Williams, 
2001). The coordination geometry of a metal is also a discerning factor in metal-
binding specificity. Each metal ion has preferential coordination geometries within 
a biological molecule. Cu(II) can be coordinated in a tetragonal or tetrahedral 
geometry, whereas Cu(I) prefers trigonal, linear or tetrahedral coordination 
(Crichton and Pierre, 2001). Enzymes binding more than one metal ion species 
developed different metal sites that are specific for a certain coordination geometry. 
Copper-zinc containing superoxide dismutase binds zinc in a conformation close to 
tetrahedral, whereas copper is bound in a distorted tetragonal way. The provision of 
different binding pockets for different metals ensures the correct insertion of the 
correct metal. Metal ion specificity can further be established by selective control of 
oxidation state (ie, the reduction of Cu(II) to Cu(I) by importer associated reductase 
FRE1 in yeast) and by adjustment of cellular concentrations and availability of both 
metals and ligands (Frausto da Silva and Williams, 2001). 
However, in the past decade it was observed that some proteins have a higher 
affinity for metal ions other than their proposed biological binding-partner. A model 
has been established, which describes the order of affinity of organic ligands for 
divalent cations and the stability of metal-ligand complexes.  
Mg(II), Ca(II) < Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II), Cu(I) > Zn(II) 
The Irving-Williams stability order (as shown above) implies that organic ligands 
bind to monovalent and divalent copper ions with a higher affinity than to any of the 
other divalent transition metals in the series (Frausto da Silva and Williams, 2001). 
Thus it is vital for the assembly of metalloproteins other than copper-binding 
proteins, that copper is maintained in a protein-bound state at all times to avoid 
binding and replacement of metal ions essential for particular enzyme function. 
Elaborate cellular mechanisms have evolved that ensure that copper and other metal 
ions remain in a protein-bound or ligand-bound state. Trafficking of copper ions is 
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monitored and facilitated by metal-specific importers that transfer the copper ion to 
metallochaperones via direct protein-protein interaction. Metallochaperones in turn 
deliver and at times insert copper directly into target protein again via direct 
interaction, thus eliminating the possibility of free copper existing anywhere in the 
cell (Rae et al., 1999). For detailed analysis of cellular copper transport refer to 
section 1.5.4. The direct protein-protein interaction during metal ion transfer allows 
for additional specificity, not only governed by chemical properties of the metal ion, 
but also through physical inhibition or mediation of protein binding and interaction. 
Copper is an essential trace element and plays a role in a number of metabolic 
reactions. A list of copper-dependent enzymes and their functions is outlined in 
table 1.1 together with a list of copper handling proteins. Copper exists in two 
oxidation states as mentioned above, thus represent a valuable element in biological 
reduction and oxidation reactions. However, the cycling between oxidised and 
reduced state may also contribute to the generation of ROS, leading to chemical 
alterations of lipid membranes, proteins and DNA molecules as described in section 
1.4.2.  
1.5.2 Zinc in synaptic transmission 
Zinc is a ubiquitous element in all tissues of the human body and it is estimated that 
as much as 10% of all human genes encode zinc-binding proteins (Andreini et al., 
2006). Zinc is used mainly as a structural co-factor (eg. In zinc-fingers) by all 
groups of enzymes namely hydrolases, ligases, transferases, oxidoreductases, lyases 
and isomerases, but also as redox-active agent when bound to thiolate ligands 
(Maret and Vallee, 1998), indicating the importance of maintaining systemic zinc 
levels. 
Zinc involvement in neuronal signaling was first described in 1984 (Howell et al., 
1984) with an estimation that 10% of all cerebral zinc is found in pre-synaptic 
vesicles (Howell and Frederickson, 1990). Pre-synaptic vesicular zinc 
concentrations were found to be 300-350μM (Frederickson et al., 1983), whereas 
the average zinc concentration across the brain is 100-150μM. Further it was 
demonstrated that in neuronal cells intracellular amounts of zinc are in the pM 
range, whereas zinc levels in the extracellular fluid of the synaptic cleft can reach 
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μM concentrations (Bozym et al., 2006), indicating tight active control and transport 
of the ion. The divalent zinc transporter ZnT-3 is highly expressed in brain regions 
that contain zinc-containing glutamatergic neurons, where it serves to transport 
cytosolic zinc into vesicles (Palmiter et al., 1996) and in the clearance of synaptic 
zinc (zinc transport is reviewed in (Sekler et al., 2007). Increased calcium-
dependent vesicular zinc release was demonstrated following electrical stimulation 
of hippocampal brain slices (Crichton and Pierre, 2001) or stimulation with high 
concentrations of K+
Zinc is co-released with the neurotransmitters glutamate and GABA and acts as a 
neuromodulator of inhibitory and excitatory amino acid receptor ion channels 
(Smart et al., 1994). It was hypothesized that another form of zinc signaling is 
intracellular zinc signaling analogous but distinct in response to that of calcium 
(Rink and Haase, 2009). Calcium is stored in the sarcoplasmic or smooth 
endoplasmic reticulum, however no cellular storage for pools of intracellular zinc or 
mechanism of zinc release have been identified, apart from metallothioneins and 
possibly synaptic vesicles. A neurotransmitter like signaling process via the 
synaptic cleft has been observed in which zinc enters postsynaptic dendrites and 
somata through gated, zinc-permeable channels (Li et al., 2001). Recent studies 
identified a selective postsynaptic Zn(II)-sensing receptor in the hippocampus, 
which upon activation, stimulated intracellular calcium release, thus actively 
participating in transduction of neuronal signaling (Besser et al., 2009). 
 (Assaf and Chung, 1984). 
1.5.3 Copper homeostasis within the body 
Copper is used as enzymatic co-factor in a number of biological reactions and 
pathways. The major mammalian copper-binding proteins are summarized in table 
1.1. Absorption of dietary copper mainly occurs in the lumen of the small intestine 
and is to some extend regulated by systemic copper demands. Most of the absorbed 
copper is directed towards the liver via portal circulation where it is either 
incorporated into cytosolic proteins, ceruloplasmin for further transport via the 
circulatory system or to the bile for excretion. 
Two genes involved in systemic and cellular copper transport are the Menkes 
(Vulpe et al., 1993) and Wilson (Bull et al., 1993) disease genes. Both were first 
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identified due to abnormal copper phenotypes of either severe copper deficiency or 
copper overload. Both ATP7A and ATP7B (Menkes and Wilsons disease proteins, 
respectively) are copper efflux pumps of the P-type ATPase family of cation 
transporters (Vulpe et al., 1993) and display 70% homology. ATP7A and ATP7B 
contain eight transmembrane domains and six copper-binding domains with a 
canonical sequence of GMXCXXC in their intracellular N-terminal domain. These 
six domains are thought to be involved in receiving copper from cytosolic 
trafficking molecules and regulating the transport of the ion out of the cell or into 
organelles such as the TGN, where copper is inserted into secreted proteins. Since 
both proteins perform the same function yet mutations in either contribute to vastly 
different systemic copper status, it has been hypothesized that there is a distinct 
pattern of tissue expression facilitating the secretion from or uptake of copper into 
the body. Indeed, it was demonstrated by Mercer et. al. (Mercer et al., 2003) that 
ATP7A is expressed in most tissues with minimal expression in the liver, whereas 
ATP7B is expressed in small amounts in mammary glands, placenta, ovaries and 
mainly in the liver (Llanos and Mercer, 2002), thus promoting excretion of excess 
copper into bile. A schematic representation of systemic copper transport is shown 
in figure 1.4. It was first reported by Petris et. al. (Petris et al., 1996) and 
subsequently confirmed by Strausak et. al. (Strausak et al., 1999) that ATP7A and 
ATP7B undergo copper-induced trafficking to maintain stable cellular copper 
levels. Deletions or mutations in the metal binding sites closer to the membrane 
(binding site 5 or 6) result in ATP7A retention in the TGN rather than trafficking to 
the plasma membrane upon copper supplementation (Strausak et al., 1999). Thus 
ATP7A is not simply a copper exporter, but also provides some sort of copper 
sensing mechanism. 
1.5.4 Copper homeostasis within the cell 
Regulation of cellular copper homeostasis is as important as controlling systemic 
copper levels. Copper is in a protein-bound or ligand-bound state at all times when 
trafficked or transferred from one ligand to another to prevent its participation in the 
generation of ROS or occupation of metal sites intended for other metal ions. To 
achieve constant copper binding it was shown that copper transfer can occur 
through sequential creation and elimination of intermolecular bonds between copper 
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provider and recipient and/or conformational rearrangement of both (Lamb et al., 
2001). 
 
 
Table 1.1: Examples of copper binding and copper homeostasis proteins 
 
 
Protein Function 
APP Protein involved in neuronal development and 
potentially Cu metabolism; cleavage leads to 
the generation of Aβ peptide that aggregates 
in senile plaques associated with AD 
ATOX1 Metallochaperone that delivers Cu to ATP7A 
and ATP7B Cu(I) transporters 
ATP7A Cu(I)-transporting P-type ATPase expressed 
in all tissues except the liver 
ATP7B Cu(I)-transporting P-type ATPase expressed 
primarily in the liver 
CCS Metallochaperone that delivers Cu to Cu/Zn 
SOD 
Ceruloplasmin Serum ferroxidase that functions in Fe(III) 
loading onto transferring 
COMMD1 Copper metabolism MURR domain1 involved 
in hepatic copper efflux 
COX11 Involved in copper transfer from COX17 to 
COX1 
COX17 Metallochaperone that transfers Cu to Sco1 
and Cox11 for cytochrome oxidase Cu 
loading in mitochondria 
CTR1 High-affinity Cu(I) transporter involved in 
cellular Cu uptake 
CTR2 High-affinityCu(I) transporter involved in 
endosomal copper transport 
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Cytochrome c oxidase 
(CCO) 
Terminal enzyme in the mitochondrial 
respiratory chain; catalyses the reduction of 
dioxygen to water 
DMT1 Divalent metal transporter involved in Cu(II) 
and Cu(I) import 
Dopamine β-hydroxylase 
(DBH) 
Oxygenase; converts dopamine to 
noradrenaline 
Hephaestin Transmembrane multi-Cu ferroxidase; 
involved in iron efflux from enterocytes and 
macrophages 
Laccase Phenol oxidase involved in melanin 
production 
Lysyl oxidase Catalyses the formation of aldehydes from 
lysine in collagen and elastin precursors for 
connective tissue maturation 
Metallothionein Cysteine-rich small-molecular-weight metal-
binding and detoxification protein 
Peptidylglycine-α-amidating 
mono-oxygenase (PAM) 
Catalyses the conversion of peptidylglycine 
substrates into α-amidated products; involved 
in neuropeptide maturation 
Prion protein (Prp) Protein whose function is unclear, but binds 
Cu via N-terminal octapeptide repeats 
SCO1/2 Involved in copper transfer from COX17 to 
COX2 
SOD1 Antioxidant enzyme; catalyses the 
disproportionation of superoxide to hydrogen 
peroxide and dioxygen 
Tyrosinase Mono-phenol mono-oxygenase; involved in 
melanin synthesis 
XIAP X-linked inhibitor of apoptosis involved in 
hepatic efflux 
 
Adapted from Kim et. al. (Kim et al., 2008) and Prohaska (Prohaska, 2008). 
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Figure 1.4: Model of systemic copper homeostasis 
Copper is absorbed in the small intestine via ATP7A and transported to the liver 
where it is incorporated into cytosolic enzymes, incorporated into ceruloplasmin 
(CP) for systemic transport or excreted into bile via ATP7B. Copper is delivered to 
most tissues and the fetus via ATP7A, whereas copper destined for the placenta and 
mammary glands is delivered via ATP7B. 
Directly taken from Mercer and Llanos (Mercer and Llanos, 2003). 
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During vascular transport copper is bound to ceruloplasmin, a multi-copper plasma 
ferroxidase which is essential for mammalian iron homeostasis. The enzyme 
contains six copper ions in three distinct copper-binding sites, however in the 
absence or impaired function of ATP7B, holoprotein is released into the blood 
stream resulting in increased and toxic levels of iron in the brain (Hellman et al., 
2002). Copper transfer mechanisms between ceruloplasmin and cellular copper 
importers have not yet been established. 
CTR1 is a highly conserved high-affinity Cu(I) importer containing three 
transmembrane domains, a methionine-rich N-terminal, a cysteine-histidine cluster 
in its C-terminal and an MXXXM motif in its second transmembrane domain (Kim 
et al., 2008). Recent studies provide evidence that CTR1 is present as a homotrimer 
possibly forming a pore-like structure for copper import between the subunit 
interfaces (Aller and Unger, 2006). It is not yet known what drives the import of 
Cu(I) via CTR1 or whether CTR1 is associated to metalloreductases to maintain 
copper in its reduced state for uptake. However, it has been established that CTR1 
expression is not dependent on cellular copper status and experimental evidence 
suggests that upon elevated levels of copper the importer is trafficked to endosomal 
compartments in HEK293 cells (Petris et al., 2003). It is suggested by Kim et. al. 
(Kim et al., 2008) that high and low affinity copper binding sites in the CTR1 
transporter or a CTR1 interacting molecule might be directly involved in sensing of 
extracellular or organellar copper concentrations. A role for CTR1 in copper 
transport from endosomal compartments to cytosolic copper chaperones was 
proposed after experiments in CTR1 knockout mice showed elevated levels of 
copper chaperones and reduced levels in copper-binding enzymes although 
intracellular copper was hyperaccumulated, thus depleted CTR1 is thought to 
prevent endosomal copper pools from becoming bioavailable (Nose et al., 2006). 
Recently a second mechanism of copper sensing by CTR1 via its cytosolic C-
terminus was suggested. Wu et. al. (Wu et al., 2009) observed that yeast lacking the 
entire C-terminus of CTR1 were still functional in high-affinity copper uptake, but 
also displayed extreme sensitivity to elevated extracellular copper concentrations. 
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Expression levels or changes in subcellular localization were not observed in the 
mutant indicating that the C-terminal domain of CTR1 might be involved in 
trafficking of CTR1 in excess copper and copper sensing. 
A copper sensing mechanism for depleted copper levels in yeast includes MAC1, a 
transcriptional regulator of ctr1 and fre1 genes. Fre1 encodes a plasma membrane 
reductase which provides reduced Cu(I) ions for uptake via Ctr1. Both molecules 
are co-expressed and display the same palindromic sequence in the 5’-flanking 
region of their individual promoters. Copper deprivation is transduced via the 
MAC1 cysteine-rich domains causing direct and specific binding of MAC1 to ctr1 
and fre1 promoters resulting in upregulation of gene expression (Yamaguchi-Iwai et 
al., 1997), whereas elevated copper levels lead to intramolecular interactions in 
Mac1 preventing transcription activation (Jensen and Winge, 1998). Excessive 
accumulation of copper in yeast is prevented by ACE1, a transcriptional activator of 
cup1 and crs5 genes, which encode copper metallothioneins and sequester surplus 
copper from the cytoplasm (Thiele, 1988). A third gene activated by ACE1 is that of 
Cu/Zn superoxide dismutase (Gralla et al., 1991) which is suggested to play a role 
in the metal ion buffering capacity of yeast and simultaneously decreases the 
copper-induced production of ROS (Culotta et al., 1995). Copper-dependent 
activation is achieved through the formation of a tetracopper-thiolate cluster in the 
copper regulatory domain of ACE1 (Dameron et al., 1991). Both activation of Ace1 
and inactivation of MAC1 by copper is executed in the nucleus, however, transport 
routes for copper to signal copper excess or deficiency have not yet been 
established. To date no equivalent copper sensing system has been identified in 
humans.  
Excess neuronal copper is sequestered by metallothionein 3 (MT-3) or GIF for 
growth inhibitory factor, a mammalian brain specific member of the metallothionein 
family (Palmiter et al., 1992) which is synthesized in axons and dendrites of zinc-
containing neurons of the cortex and hippocampus (Masters et al., 1994). MT-3 is a 
cysteine-rich 68 amino acid residue peptide with a metal-binding cluster of 
cysteines at the N- and C-terminal which can accommodate monovalent and 
divalent metal ions and are linked via a flexible region. MT-3 isolation from human 
brain revealed a mixture of Cu(I) and Zn(II) (Uchida et al., 1991) bound in 
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homometallic clusters with a predominant metal ion occupation of 
M(II)(3)(CysS)(9) and a M(II)(4)(CysS)(11) (Meloni et al., 2009). However, due to 
detection of MT-3 foremost in zinc-containing neurons it was hypothesised that 
copper-binding represents displacement of zinc from the clusters (Masters et al., 
1994), a theory that could be explained with a higher affinity of ligands for copper 
than any other metal as stated in the Irving-Williams stability order. MT-3 has also 
been implicated in clearance of zinc from the synaptic cleft due to its extracellular 
presence and storage of zinc for transfer into synaptic vesicles intracellularly. 
After transfer of Cu(I) into the cell it is directed towards three possible targets by a 
group of proteins that are evolutionarily conserved and act as copper chaperones 
(see figure 1.5). First identified in Saccharomyces cerevisiae as an antioxidant in the 
prevention of oxidative stress (Hung et al., 1998), ATX1 was shown to bind Cu(I) 
with high affinity via two conserved cysteine residues (Pufahl et al., 1997). It is 
trafficked to the TGN where it supplies proteins destined for excretion with copper 
by interaction with the transmembrane copper transporter CCC2. The human 
equivalent to ATX1, human ATX1 homologue 1 (HAH1) or ATOX1 (Klomp et al., 
1997), which contains the same conserved cysteine residues (Hung et al., 1998), 
was observed to interact with the N-terminus of the human equivalent for CCC2, the 
copper transporting ATPases ATP7A and ATP7B (Larin et al., 1999) (see section 
1.5.3). 
A second target for cellular copper transport is Cu/Zn superoxide dismutase 
(SOD1), a soluble enzyme involved in the disproportionation of hydroxyl radicals, 
thus preventing oxidative damage to the cell. Part of the cellular SOD1 and its 
chaperone have been localized to the mitochondrial inner membrane space (Sturtz et 
al., 2001), however the highest concentrations of SOD1 and its chaperone can be 
found in the cytoplasm. SOD1 receives copper from, and is activated by, its copper 
chaperone for SOD1 (CCS), a process which is eliminated in lys7 null mutants of 
yeast (lys7 being the gene for yeast CCS) and results in an immature version of 
SOD1 due to the failure of CCS to incorporate copper into the SOD1 active site 
(Culotta et al., 1997). Provision of CCS restored SOD1 maturation to form an active 
holoprotein in vivo. CCS consists of three functional domains that are structurally 
distinct. Domain I is the most N-terminal domain and contains the metal-binding 
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motif MHCXXC resembling that of the Atx1 metallochaperone. Domain II is highly 
homologous in amino acid sequence and structural folding to SOD1 and involved in 
heterodimer formation with its target protein (Casareno et al., 1998), however, it 
does not contain the functional sites present in SOD1, while domain III, the most  
 
 
 
Figure 1.5: Model of cellular copper homeostasis 
Copper is imported into the cell via Ctr1 and trafficked towards three cuproenzyme 
targets (rectangles). Copper chaperones (circles) CCS, ATOX1 and COX17 deliver 
copper to cytosolic SOD1, TGN ATP7A (neuronal) or TGN ATP7B (hepatic) and 
CCO, respectively. Excess copper is directed towards metallothionein (MT) for 
cellular storage. Hepatic TGN copper is inserted into ceruloplasmin or excreted via 
exocytosis into the bile canaliculus, a process facilitated by COMMD1 (MURR1), 
whereas neuronal TGN copper is inserted into cupro-enzymes for secretion. 
Directly taken from Prohaska and Gybina (Prohaska and Gybina, 2004). 
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C-terminal of the three domains, contains the metal-binding motif CXC and is vital 
for CCS function. Upon heterodimer formation structural rearrangement of both 
proteins is observed with domain III being linked to SOD1 via an intermolecular 
disulfide bond and in a proximate position to the SOD1 active site to participate in 
metal ion transfer (Schmidt et al., 1999, Lamb et al., 2001, Rae et al., 2001). It was 
observed that a pre-existing pool of apo-SOD1 serves as a substrate for CCS in 
yeast without the need for SOD1 synthesis or protein unfolding (Schmidt et al., 
2000). 
Although previous experiments demonstrated CCS as a vital factor for SOD1 
maturation through copper insertion (Bartnikas and Gitlin, 2003) a second role has 
been suggested in which CCS deploys an oxygen and disulfide-dependent 
mechanism of copper transfer. SOD1 contains two cysteine residues on its globular 
surface, which are not involved in metal-binding in the active site of the enzyme. 
These cysteine residues are in a reduced state due to SOD1 localisation in the 
cytosol, which is known for its reducing properties. It is suggested that the copper-
loaded form of CCS catalyses SOD1 maturation in four distinct steps. Firstly, the 
copper-binding motif of CCS domain III interacts with Cys-146 of SOD1 in an 
oxygen-dependent manner to form a disulfide bridge. This dimerisation process 
leads to copper transfer from CCS to the active site of SOD1 and the exchange of 
the intermolecular disulfide to form an intra-molecular disulfide bridge with SOD1 
Cys-56 resulting in the release of CCS (Furukawa et al., 2004). It is not clear in 
which order these two steps occur. Upon intra-molecular disulfide formation SOD1 
is more likely to form homodimers which are thought to be the enzymatically active 
species, whereas reduced and de-metallated SOD1 favors the monomeric state 
(Arnesano et al., 2004). Thus oxygen-responsive CCS induction of SOD1 
maturation might imply a role for CCS in sensing of intracellular oxygen 
concentrations (Brown et al., 2004). 
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Contrary to previous findings of CCS being vital for SOD1 maturation, Carroll et. 
al. (Carroll et al., 2004) have demonstrated CCS-independent partial activation and 
enzymatic function of human SOD1, but not the yeast protein. Glutathione 
activation of human SOD1 was observed in yeast cells or immortalized fibroblasts 
indicating differences between the yeast and human enzyme. The dependence of 
yeast SOD1 for CCS is due to two proline residues near its C-terminal which are 
missing in the human protein and introduction of which into the human protein 
renders its activation dependent on CCS. Reconstitution of human SOD1 was 
observed by Cu(I)-GSH complexes using EPR and optical spectroscopy as well as 
NMR spectroscopy (Ciriolo et al., 1990). 
The third target for copper in the eukaryotic cell is the mitochondrial enzyme 
cytochrome c oxidase (CCO). The enzyme is located in the inner membrane and 
functions in the final step of the respiratory electron transfer chain. Copper is 
required as a co-factor for two individual copper-binding sites. The CuA site in 
subunit COX2 binds three copper ions, whereas the CuB site in subunit COX1 binds 
one. CCO contains thirteen subunits ten of which are encoded by the nuclear 
genome. The copper-binding subunits however are encoded by the mitochondrial 
genome indicating copper insertion into CCO within the mitochondrion (Carr and 
Winge, 2003). The maturation of CCO is complex for three reasons. Firstly for 
availability of all required subunits, subunit synthesis in two different compartments 
needs to be synchronized. Secondly the ten nuclear encoded subunits have to be 
imported into the mitochondrion, a process which involves a multitude of assessory 
proteins and transporters and needs to bridge two layers of membrane.  Finally the 
assembly of CCO is dependent on a variety of metal co-factors which need to be 
imported into the mitochondrion. The focus for a role in intracellular copper 
transport as a metallochaperone to the mitochondrion has been on COX17, since its 
presence was demonstrated in both the cytosol and the inner-membrane space 
(Beers et al., 1997). COX17 is a small cysteine-rich protein which binds three Cu(I) 
ions (Heaton et al., 2000) and when knocked out prevents the formation of a 
functional CCO complex, a phenotype that is rescued by additions of copper to the 
growth medium (Glerum et al., 1996a). However, this proposed role was not 
supported by data showing formation of a functional CCO complex upon tethering 
of COX17 to the mitochondrial inner membrane (Maxfield et al., 2004). Thus other 
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mechanisms must exist for the transfer of copper to the mitochondrion. Several 
assessory proteins have been identified that aid the transfer of copper from COX17 
to CCO subunits COX1 and COX2. SCO1 (Nittis et al., 2001) and COX11 (Carr et 
al., 2002) are Cu(I)-binding membrane-bound proteins and thought to be copper 
donors to COX2 and COX1, respectively. In vitro studies demonstrated COX17 
requirement in the metallation of both SCO1 and COX11 (Horng et al., 2004) and 
the ability of SCO1 overexpression to compensate for COX17 null mutant 
phenotypes (Glerum et al., 1996b) emphasizes the intricate interplay of these 
assessory proteins in the metallation of CCO. The discovery of a large non-
proteinaceous low molecular weight copper pool within yeast mitochondrial matrix 
(Cobine et al., 2004) presents another possible way of metallation of CCO and 
SOD1 located in the inter-membrane space (Cobine et al., 2006) explaining 
functional CCO upon COX17 tethering to the mitochondrial inner membrane. In a 
separate experiment the expression of yeast metallothionein in the mitochondrial 
matrix attenuated enzyme activities of SOD1 and CCO without decreasing overall 
mitochondrial copper levels, and possibly resulting in the demetallation of the small 
matrix ligand, suggesting that the result is demetallation of the small matrix ligand 
and that copper binding to the low molecular weight ligand is essential for COX17- 
and CCS-mediated copper transfer within the mitochondria. The factor or chaperone 
contributing to the mitochondrial copper pool has not yet been identified.  
1.5.5 Copper dependent proteins in the brain 
1.5.5.1 Superoxide dismutase 
SOD1 is localized to the cytoplasm and the mitochondrial intermembrane space 
(Sturtz et al., 2001) in yeast and mitochondrial matrix in human brain (Vijayvergiya 
et al., 2005) and is activated by its copper chaperone CCS. Entry to the 
mitochondria occurs prior to disulfide formation or metallation with zinc and copper 
(Field et al., 2003). Expression of SOD1 is relatively stable and enzyme activity is 
considered to be an internal control of SOD1 gene expression (Zelko et al., 2002). 
SOD1 expression has been shown to be activated by ACE1 in yeast (Gralla et al., 
1991) following exposure of cells to copper suggesting a potential role for SOD1 in 
copper buffering or functional storage. Multiple mutations in SOD1 are associated 
with forms of familial ALS (Rosen et al., 1993) and aggregation of the protein. 
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Dysfunction results in increased oxidative damage and accelerated neuronal 
damage. 
 
 
1.5.5.2 Cytochrome c oxidase  
The multi-component assembly of CCO has been described in section 1.5.4. Since 
AD is characterised by neurodegeneration likely caused in part by mitochondrial-
induced apoptosis attention has been focussed on the mitochondrial respiratory 
complexes and their potential contribution to neuronal death. Through comparison 
of CCO activity tested in normal and AD brains a decrease in CCO activity was 
observed in the latter group. The altered enzyme activity was caused by decreased 
levels of mRNA of CCO specific subunits 1 and 3 (Chandrasekaran et al., 1994) 
with subunit 1 representing one of the copper binding sites in the enzyme and 
altered kinetic properties due to structural changes of the protein (Parker and Parks, 
1995). However, there are many more factors that could influence CCO activity, 
such as alteration in activity or expression of any one of the 13 subunits and 
numerous assessory proteins that contribute to copper supply and incorporation. 
1.5.5.3 Dopamine β-hydroxylase and peptidylglycine α-amidating 
monooxygenase 
Dopamine β-hydroxylase (DBH) is a soluble and membrane-anchored cuproenzyme 
present in catecholamine releasing vesicles in sympathetic nerves and catalyses the 
conversion of the neurotransmitter dopamine to noradrenaline. Structural analysis of 
DBH confirms the presence of two Cu(II) binding sites involved in redox-cycling, 
thus catalysing the conversion of neurotransmitters (Friedman and Kaufman, 1965). 
Decreases in enzyme activity, mRNA levels and protein levels were observed in rats 
deficient in dietary copper (Nelson and Prohaska, 2008) and also in patients with 
Menkes disease (Kaler et al., 2008). 
Peptidylglycine α-amidating monooxygenase (PAM) is an oxidoreductase localised 
in the secretory pathway which catalyses the α-amidation of glycine extended 
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peptide precursors, a process essential for the bioactivation of several hormones and 
neuropeptides (Kulathila et al., 1999). Amidation is a two step reaction performed 
by the two separate catalytic subunits peptidylglycine alpha-hydroxylating 
monooxygenase (PHM) and peptidyl-alpha-hydroxyglycine alpha-amidating lyase 
(PAL). The PHM subunit is a copper-binding domain containing two distinct copper 
binding sites both of which are essential for enzyme activity (Kolhekar et al., 1997) 
and requires molecular oxygen and ascorbate as co-factors. As with DBH, dietary or 
hereditary copper deficiency could potentially result in decreased enzyme activity. 
1.5.6 Disorders of copper imbalance 
1.5.6.1 Menkes disease 
Menkes disease is an X-linked genetic condition caused by mutations in a gene, 
encoding a highly conserved copper-transporting ATPase (ATP7A). The protein 
functions in intestinal copper import as well as systemic and cellular distribution of 
the metal (Danks et al., 1972), a function, which has partly been established due to 
low serum copper and ceruloplasmin levels in patients carrying mutations. The 
incidence of Menkes disease is 1 per 298,000 live-born babies (Tønnesen et al., 
1991) and development of symptoms occurs within the first few months of life often 
resulting in death at the age of three. Clinical symptoms include characteristic white 
kinky hair, hypothermia, seizures, hypo-pigmented skin and focal cerebral and 
cerebellar degeneration (Danks et al., 1972). Some of the symptoms are indicative 
for copper deficiency in essential copper-binding enzymes such as PAM, DBH, 
CCO or tyrosinase. Treatments include copper injections to bypass unresponsive 
intestinal uptake, however although low hepatic copper stores are replenished 
quickly, brain copper levels only gradually recover (Danks et al., 1972). 
1.5.6.2 Wilson’s disease 
Wilsons disease is a rare autosomal recessive genetic disorder and characterized by 
excess hepatic copper accumulation. The mutated gene encodes the highly 
conserved copper-transporting ATPase (ATP7B), which functions in copper 
excretion into bile and copper loading into ceruloplasmin with localisation in the 
liver, placenta and kidneys. Clinical symptoms usually develop between the ages of 
6 and 20 years and include chronic hepatitis, tremor, seizures, insomnia, 
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parkinsonism and signs of depression and psychosis. The disease affects 1 in 
100,000 individuals and if detected early can be treated with chelating agents such 
as dimercaprol or penicillamine and zinc salts to prevent intestinal copper uptake. 
However, damages incurred to liver and brain are not reversible, thus early 
detection is essential to prevent liver cirrhosis and mental retardation. In extreme 
cases treatment includes liver transplants (Aftab et al., 2007). 
1.5.6.3 Neurological disorders 
Neurological disorders that have been implicated in perturbed metal homeostasis 
include Parkinson’s disease (Wang et al., 2010), Prion disease or Creutzfeldt Jakob 
disease (Thompsett et al., 2005, Jobling et al., 2001), familial amyotrophic lateral 
sclerosis (FALS) (Furukawa and O'Halloran, 2005) and AD. All of these disorders 
display abnormal levels of protein unfolding and/or aggregation in response to 
increased or decreased metal availability leading to intracellular or extracellular 
deposits. The metals involved, the toxic protein species and aggregation form are 
summarized in table 1.2. 
1.6 Metals and APP 
AD has been described as a disease of perturbed metal regulation and homeostasis. 
In particular copper, iron and zinc have been implicated in the disease progression 
and development of detectable symptoms. In the scope of this project special 
attention is paid to changes in copper homeostasis due to a familial mutation in the 
APP protein and downstream effects on cellular characteristics and phenotypes. In 
the following sections the biological link of APP and its cleavage product with 
copper and potential consequences for copper misregulation with regards to 
neurodegenerative desieases will be discussed. 
1.6.1 Metal-binding properties of amyloid precursor protein and amyloid beta 
APP has a zinc-binding and two copper-binding domains, one of which is located 
next to the N-terminal growth factor like domain; the second one is located within 
the amyloid beta sequence (see figure 1.1). Processing of APP is positively 
influenced by dimerisation and increases Aβ production 6-8 fold (Scheuermann et 
al., 2001). However, Cu(II) binding to the N-terminal domain is readily reduced to 
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Cu(I) (White et al., 1999a) and has been proven to reduce Aβ levels probably due to 
copper-mediated disruption of APP dimerisation (Kong et al., 2008). No significant 
conformational changes in APP have been observed upon Cu(II)-binding (Kong et 
al., 2008), thus this copper-binding site might have a lower affinity for copper than 
the copper-binding site found within the Aβ sequence and potentially present a 
candidate binding-site involved in protein-protein copper transfer. Structural 
homology of APP to copper chaperones and the location of the copper-binding site 
on the protein surface support this hypothesis (Barnham et al., 2003b). 
Recent research demonstrates a new possible role for APP as iron export 
ferroxidase. It has been shown by Duce et. al. (Duce et al., 2010) that this activity 
lies within a conserved H-ferritin-like active site, which leaves APP to catalytically 
oxidize Fe(II) and is inhibited by Zn(II). Upon APP ablation in primary neurons and 
HEK293T cell lines iron retention was observed and mice carrying the APP null 
mutation showed increased sensitivity to dietary iron. Further analysis of the 
expression levels of APP and the iron-storage protein ferritin in high cellular copper 
levels support a possible role for APP as an iron exporter. 
Aβ is a peptide with high affinity for Cu(II), Fe(III) and Zn(II). The Cu(II) binding 
site displays attomolar affinity and was found to be stronger in Aβ1-42 than Aβ1-40 
(Atwood et al., 2000). Coordination of metallated Aβ into fibrils and plaques is 
induced by synaptically available Zn(II) at concentrations of 300nM, which are 
exceeded upon release of synaptic vesicles by 1000 fold (Bush et al., 1994). Lovell 
et. al. (Lovell et al., 1999) demonstrated neuroprotective properties of zinc-mediated 
amyloid aggregation that were mainly due to enhancement of Na+/K+ ATPase 
activity which prevents the disruption of calcium homeostasis and cell death in 
cultured, primary hippocampal neurons. However, excess zinc and copper 
concentrations facilitate plaque formation conferring a metalloenzyme-like activity 
to Aβ (Opazo et al., 2002) and increasing catalytic oxidation of cholesterol and 
lipids to form H2O2. Concentrated ROS production might overwhelm the local 
antioxidant defence system and enhance neurodegenerative pathology. Amyloid 
formation can be reversed by application of chelators to the brains of post-mortem 
patients (Cherny et al., 1999) and amyloid accumulation is markedly inhibited by 
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treatment with copper and zinc chelators in AD transgenic mice (Cherny et al., 
2001). 
 
 
 
 
 
 
 
Table 1.2: Neurodegenerative diseases and the respective metals involved in 
protein aggregation  
 
 
 
Disease Protein deposit Toxic protein Metal 
Alzheimer’s 
disease 
Extracellular Aβ 
plaques and 
intracellular 
neurofibrillary tangles 
Aβ/ 
Hyper-
phosphorylated 
tau, possibly 
Prp
Cu, Zn, Fe 
c 
Creutzfeldt-
Jakob 
disease/Prion 
disease 
Prion plaques Prp Mn c 
Familial ALS Bunina bodies SOD1 Cu, loss of Zn 
Parkinson’s 
disease 
Lewy bodies Α-synuclein Cu, Fe 
 
 
Adapted from Bush (Bush, 2003). 
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1.6.2 The proposed role for APP in copper homeostasis 
A role for APP in neuronal copper homeostasis either as a regulator or efflux 
protein or mediator of such has been suggested (Maynard et al., 2002, Bush et al., 
2003). Both Aβ and APP have high-affinity Cu(II) binding sites which readily 
promote the reduction to Cu(I) (Multhaup et al., 1996). It has been suggested that 
Aβ might be involved in extracellular copper scavenging activities and clearance of 
excess metal during normal physiology thus reducing the risk of copper-related 
neurotoxicity and that AD is an apparent phenotype of clearance corruption (Bush, 
2003). Analysis of human CSF demonstrated promotion of soluble Aβ degradation 
under physiological copper and zinc concentrations, whereas excess zinc and copper 
induce Aβ precipitation (Strozyk et al., 2009) contributing to amyloidosis and 
increased oxidative neurotoxocity. 
Overexpression of APP opposes the age-dependent elevation in brain copper thus 
AD might develop due to increased clearance of copper from brains containing 
versions of APP FAD mutations promoting functional defects in mitochondrial 
CCO and antioxidant enzymes due to a functional copper deficiency. The role as a 
possible efflux mechanism for copper is supported by findings that copper levels are 
increased in the cerebral cortex and liver of APP and APLP2 knockout mice (White 
et al., 1999b) and embryonic fibroblasts (Bellingham et al., 2004a). It was also 
shown that expression of an APP mutation that abolishes copper binding increased 
intracellular copper concentrations several fold supporting the role of APP as a 
potential copper exporter (Treiber et al., 2004) especially since the APP copper 
binding site shows structural homology to copper chaperones and is located at the 
surface of the protein (Barnham et al., 2003b). Borchardt et. al. (Borchardt et al., 
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1999) discovered a dose-dependent window of opportunity in which particular 
copper concentrations promote non-amyloidogenic processing of APP, whereas 
higher concentrations, as are detected in the ageing brain, promote Aβ production. 
However, opposing analyses of APP function in copper homeostasis identified 
d ecreased  levels o f Aβ in  th e CSF o f AD-patients (Van Nostrand et al., 1992), 
increased concentrations of copper, zinc and iron in AD brain (Lovell et al., 1998) 
and elevated copper content in APP overexpressing HEK293 cells indicating that a 
possible mechanism of increased APP cleavage might restore intracellular copper 
levels and reverse functional copper deficiency of CCO, antioxidants and other 
copper-binding enzymes (Suazo et al., 2009). This finding was supported by 
observations that intracellular copper deficiency increases Aβ secretion (Cater et al., 
2008) and the occurrence of increased Aβ and copper complexation with lipid rafts 
upon cellular copper deficiency (Hung et al., 2009), a mechanism which opposed 
the suggested role of APP in facilitating efflux of excess copper. 
Due to conflicting results of APP overexpressing models with regards to copper 
distribution and the lack of understanding concerning whether a lack of functional 
copper or excess copper induces neurotoxicity and pathological phenotypes, no 
definite statement can be made about the exact role of APP in copper homeostasis. 
APP clearly is involved in copper metabolism, however whether it plays a 
regulatory role or functions as a transporter or chaperone remains to be determined. 
1.7 Experimental design and challenges for the study of metalloproteins 
1.7.1 Metalloproteomics 
Bioinformatic approaches to determine metal-binding sites in proteins based on 
amino acid sequence and folding predictions present a challenge since metal-
coordination is not only governed by the individual amino acid residues that 
coordinate the metal ion (first coordination sphere), but also, among others, by 
residues adjacent to ligand amino acids which contribute to specific binding 
geometries (so called second coordination spheres), extra ligands such as water, and 
post-translational modifications of the protein. Metal-occupancy can only be 
established with confidence experimentally. 
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A variety of experiments have been designed to identify metalloproteins and to 
determine the specificity of the metal bound by proteins. Experiments differ in their 
approach by focussing on the protein or the metal during purification. 
 Attempts have been made to identify metalloproteins in Pyrococcus furiosus using 
two levels of chromatography with subsequent analysis of the fractions for metal 
content by ICP-MS and protein content by high-throughput tandem mass 
spectrometry. Data obtained was analysed using bioinformatics databases to assign 
metalloproteins to peptide fragments (Cvetkovic et al., 2010). Remarkably more 
than half of the identified proteins were not predicted through bioinformatics 
emphasizing the view that metalloproteomes are largely uncharacterised. 
Another study focused on metal-based determination of metalloproteins by targeted 
labeling of particular trace elements with suitable radioisotopes and native 
separation of holoproteins by isoelectric focusing combined with blue native 
acrylamide gel electrophoresis during which the G250 stain binds to and visualizes 
proteins without denaturation and demetallation. Radiolabelled isotopes in the gel 
were subsequently visualized using autoradiography and proteins identified by 
tandem mass spectrometry (Sevcenco et al., 2009). 
Ferrer et. al. (Ferrer et al., 2007) performed two-dimensional non-denaturing PAGE 
followed by visualization of metalloproteins in the gel by treatment with the 
chemiluminescent substrate luminal. Candidate proteins were subjected to 
sequential quadrupole TOF-MS and high resolution ICP-MS with a result of over 
85% of all identified metalloproteins binding iron in Ferroplasma acidiphilum. In 
contrast to the method described previously this experimental design allows for 
quantification of the total metalloprotein content of the proteome. 
A fourth approach was tested by members of this research group (Kevin Waldron 
unpublished data) and comprised of comparative diagonal two-dimensional native 
gel electrophoresis. Proteins were separated by native PAGE in two dimensions in 
duplicate resulting in diagonal alignment with one set of proteins being subjected to 
a native gel containing a metal-specific chelator. Direct comparison of both gels 
allowed detection of demetallated proteins due to differences in separation and 
resolution away from the diagonal. Proteins of interest were analysed by MALDI-
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TOF-mass spectrometry. The reverse experiment in which metal is added to the 
PAGE gel before second dimension separation is performed. 
1.7.2 Limitations of various biochemical approaches 
One constant risk during metalloprotein-based experiments is exposure to reducing 
agents such as DTT or SDS and sample exposure to oxygen. Contact can result in 
metal dissociation from the protein due to disulfide formation of cysteine ligands or 
metal oxidation. Thus it is useful to limit purification and analysis steps to a 
minimum. 
A further obstacle is the ubiquitous presence of trace metals in experimental 
solutions and disposables, which could potentially result in flawed data and 
misinterpretation of metals and their concentrations actually present in a sample. 
This is particularly true for metal analysis in PAGE samples, with regards to 
polyacrylamide itself containing a variety of metals which could potentially displace 
the original metal in a sample protein or bind to a non-metal-binding protein 
containing suitable ligands. 
To identify proteins by mass spectrometry it is often necessary to purify the 
particular protein through many handling steps, which could potentially result in 
metal oxidation and altered migratory properties of the protein. 
Immobilised metal affinity chromatography (IMAC), usually used for the 
purification of His-tagged proteins, is occasionally used to purify metal-binding 
proteins, which bind to the column and can be eluted with high concentrations of 
histidine. However this approach has the potential to bind all sample proteins that 
contain a gratuitous metal-binding site. 
1.7.3 A low resolution native 2D-LC approach coupled to denaturing 
separation of proteins and Principal Component Analysis 
A metal-based approach for routine identification of metal binding proteins has 
been established within this research group 
(http://www.natureprotocols.com/2008/11/12/metalloprotein.php). Low resolution 
of metalloproteins in soluble protein extracts is achieved by native 2D-LC using 
anion exchange as first and size exclusion as second dimension and subsequent 
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analysis of the obtained samples for metal content by ICP-MS to identify the major 
metalloprotein pools. Fractions containing large amounts of metal are resolved by 
SDS-PAGE and amounts of protein measured by densitometric analysis. Principal 
component analysis, PCA, (as described in section 2.4.10.2) is employed to 
compare the change of abundance of each individual protein with the change in 
abundance of metal and allows for the selection of a candidate protein which is 
identified by MALDI-TOF-MS. This method is specifically developed to identify 
major metalloproteins and their abundance or metal-binding properties in response 
to environmental stimuli and genetic manipulation. The protocol can be refined by 
altering anion exchange and size exclusion chromatographic conditions to adjust 
protein separation and aid PCA analysis, but crucially enables protein identification 
without the need for vigorous purification through many steps. 
1.8 This study 
1.8.1 Hypothesis 
1. It is hypothesized that APP or its cleavage products make an unspecified 
contribution to copper homeostasis. 
2. Interactions of human CCS with the neuronal adaptor protein X11α via domain 
III (McLoughlin et al., 2001) and with BACE1 via domain I (Angeletti et al., 2005) 
have been demonstrated as well as interactions of X11α with APP (McLoughlin and 
Miller, 1996). Together with the findings that BACE1 contains a high affinity Cu(I) 
binding site in its cytosolic domain (Angeletti et al., 2005) these observations open 
up the possibility of physiological or pathological copper supply via CCS to 
proteins other than SOD1. Alternatively CCS could mediate physiological or 
abberant BACE1 interactions. Although, direct copper transfer from CCS has only 
been demonstrated for SOD1 (Rae et al., 2001), the co-localisation of CCS, BACE1 
and APP by X11α may play a significant role in a potentially copper-regulated way 
of determining APP processing fate and the development of AD. This model would, 
in addition to possible copper transfer from CCS to APP or BACE1, involve the 
redirection of copper from the original target protein SOD1 potentially contributing 
to AD pathology by decreasing the levels of enzymatically active antioxidant. This 
could potentially result in more pronounced phenotypes related to oxidative stress in 
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APPswe
1.8.2 Aims 
 carriers with a predicted 6-8 fold increase in APP cleavage and Aβ 
production (Citron et al., 1992). The hypothesis is outlined in a simplified way in 
figure 1.6.  
The aims of this project were three-fold: 
1. Identification of major metal-binding pools (especially for copper) in whole cell 
protein extracts by low resolution chromatography as described in section 1.7.3 in 
conjunction with statistical analysis by principal component analysis has only been 
performed in prokaryotic organisms. The method was tested on a variety of 
eukaryotic organisms. 
2. Attempts were made to determine and identify major metal pools (especially for 
copper) in the SH-SY5Y neuroblastoma wild type (APPWT) cell line and a SH-SY5Y 
cell line overexpressing the Swedish mutation in APP (APPswe
3. Any contribution of APP to neuronal copper homeostasis was explored by 
assaying a range of copper-related phenotypes in neuronal cells overexpressing 
APP
). 
swe and subsequent comparison with the control APPWT
 
 cell line. 
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Figure 1.6: Hypothesis of alteration in copper homeostasis by the Swedish 
mutation and its implication in APP processing and antioxidants status in SH-
SY5Y cells 
Copper is imported into the cell by CTR1 and distributed to three distinct pathways. 
Copper is bound by the copper chaperone for superoxide dismutase (CCS) for metal 
delivery to SOD1, to COX17 for insertion into mitochondrial cytochrome c oxidase 
and to HAH1 for incorporation into proteins in the Golgi and exocytosis. Upon 
trafficking to the cell surface APP is cleaved either by α-secretase (APPWT) or β-
secretase (APPswe). It was shown by McLoughlin et. al. (McLoughlin et al., 2001) 
that CCS binds BACE1 through the adapter protein X11-α. Citron et. al. (Citron et 
al., 1992) demonstrated that the Swedish mutation causes a 6-8 fold increase in APP 
cleavage by BACE1. It is thus hypothesised that the ability of CCS to deliver 
copper to SOD1 and BACE1, or at least interact with both proteins might lead to 
aberrant copper homeostasis in cells containing the Swedish mutation. This could 
impact not only on plaque formation and oxidative stress, but also cause an 
intracellular copper deficit which might manifest itself in the decline of copper 
specific metalloenzymes such as SOD1, cytochrome oxidase and dopamine-beta-
hydroxylase, important for neuronal conductivity. It is noted that there is a 
continuous base level of α-secretase cleavage in the APPswe cell line and a low level 
cleavage by β-secretase in APPWT
 
. 
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2.1 Equipment, chemicals and reagents 
Chapter 2 - Materials and methods 
All chemicals were purchased from Sigma (Haverhill, UK) unless otherwise stated. 
All enzymes used for nucleic acid manipulation were purchased from Promega 
(Southhampton, UK) unless otherwise stated. 
For trace metal work, all glassware was washed in 4% (v/v) HNO3
Cell culture solutions were purchased from PAA (DMEM, D-PBS, Somerset, UK), 
Invitrogen (Glutamine, Penicillin/Streptomycin, foetal calf serum, TrypLE Express, 
Glasgow, UK) and Autogene Bioclear (foetal calf serum, Nottingham, UK). 
 over night to 
remove traces of residual metal. Glassware was then rinsed with nano-pure water 
(Millipore Simplicity 185 Filtration System) and used immediately.  
All plastic consumables were purchased sterile, flasks from TPP (Helena 
Biosciences, Sunderland, UK) and centrifuge tubes and pipettes from Starlab 
(Milton Keynes, UK). Non sterile equipment and solutions were autoclaved at 
121ºC for 20 minutes. 
2.2 Strains, cell lines and plasmids used 
2.2.1 Saccharomyces cerevisiae strain and maintenance 
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The haploid budding yeast strain Saccharomyces cerevisiae W 303 1a was grown in 
liquid Yeast Peptone Dextrose (YPD) medium (10g/L yeast extract, 20g/L peptone, 
20g/L glucose). Cultures were grown at 30°C while agitated. Culture medium was 
sterilized by autoclaving at 121°C for 20 minutes before inoculation. 
2.2.2 SH-SY5Y APPWT and APPswe
The original neuroblastoma cell line SK-N-SH was created by bone marrow biopsy 
of a female patient in 1975 (Helson et al., 1975), however, the genetically female 
and thrice sub-cloned neuroblastoma cell line SH-SY5Y was chosen as model cell 
line for my studies. The wild type SH-SY5Y cell line expressing endogenous levels 
of APP (designated APP
 mutation 
WT) and the APP Swedish mutation (APP 695aa) 
overexpressing SH-SY5Y cell line (designated APPswe
2.2.3 Cell culture of SH-SY5Y 
) were used for experiments 
(see table 2.1). Mutant cell lines were previously produced by transfection of the 
high-expression mammalian transfection vector pcDNA3.1 carrying the Swedish 
APP mutation gene. The structure of the vector is shown in figure 2.1. 
2.2.3.1 Maintenance 
SH-SY5Y cells were cultured as monolayers in Dulbecco’s Modified Eagle Medium 
(DMEM) containing 1.5g/L sodium bicarbonate, 1 mM sodium pyruvate, 0.1 mM 
nonessential amino acids and supplemented with 10% (v/v) foetal calf serum (FCS), 
2mM L-glutamine, 100units/ml Penicillin and 100µg/ml Streptomycin. The cultures 
were incubated at 37°C in a humidified 5% (v/v) CO2
2.2.3.2 Harvest 
 atmosphere. Cryo-stocks 
were produced by resuspension of confluent cells in FCS containing 10% (v/v) 
DMSO and gradual freezing of 1ml aliquots for cryo-storage in isopropanol. 
Culture medium was aspirated and the monolayer thoroughly washed with D-PBS 
(without Ca, Mg) before being dissociated from the cell culture flask using the 
trypsin equivalent TrypLE Express. The flask was then rocked to ensure the 
coverage of the whole monolayer with TrypLE Express and incubated at 37°C for 2 
minutes. Subsequently cells were resuspended in D-PBS and pelleted at 800 rpm for 
5 minutes. The pellet was aspirated and either used immediately or stored at -20°C. 
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The maximum dilution rate used for passaging cells was 1:7. Cells were not used 
beyond their 30th
2.2.4 Cell culture of HepG2 
 passage. 
2.2.4.1 Maintenance 
HepG2 cells were cultured as monolayers in Roswell Park Memorial Institute 
medium (RPMI 1640) supplemented with 10% (v/v) foetal calf serum (FCS), 2mM 
L-glutamine, 100units/ml Penicillin and 100µg/ml Streptomycin. The cultures were 
incubated at 37°C in a humidified 5% (v/v) CO2
 
 atmosphere. Cryo-stocks were 
produced by resuspension of confluent cells in FCS containing 10% (v/v) DMSO 
and gradual freezing of 1ml aliquots for cryo-storage in isopropanol. 
 
 
 
Strain Description Expression Source 
SH-SY5Y 
APP
Subclone of SK-N-SH cell line and 
can be obtained from the 
ATCC/DSMZ 
WT 
N/A David Howlett 
at GSK 
SH-SY5Y 
APP
Cell line transfected with 695 aa 
APPswe swe
stable 
 gene using the pcDNA3.1 
mammalian transfection vector 
David Howlett 
at GSK 
 
Table 2.1: SH-SY5Y cell lines used in experiments 
Both cell lines were obtained from GSK. SH-SY5Y APPWT represents the 
experimental control with base level expression of endogenous APP. The SH-SY5Y 
APPswe cell line was established by lipofection of the APP gene carrying the 
Swedish mutation linked to familial AD into the control cell line using the high-
expression mammalian transfection vector pcDNA3.1 (figure 2.1). For future 
analysis of experimental data it should be noted that the APPswe cell line represents 
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phenotypes as a function of overexpressing the Swedish mutation in SH-SY5Y, not 
as a function of the Swedish mutation per se. 
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Figure 2.1: Schematic representation of the mammalian transfection vector 
pcDNA3.1 
The high-expression plasmid was utilised as an expression vector for the APPswe
Directly taken from the Invitrogen vector catalogue 
(http://www.liv.ac.uk/physiology/ncs/catalogue/Cloning/pcDNA3.1(-).htm). 
 
mutation gene. The plasmid contains the neomycin resistance gene for mammalian 
cell selection using geneticin (G418) and the ampicillin resistance gene for selection 
in E.coli. The inserted APP gene is regulated by the CMV promoter giving 
constitutive high expression. 
 
 
 
 
2.2.4.2 Harvest 
Culture medium was aspirated and the monolayer thoroughly washed with D-PBS 
(without Ca, Mg) before being dissociated from the cell culture flask using the 
trypsin equivalent TrypLE Express. The flask was then rocked to ensure the 
coverage of the whole monolayer with TrypLE Express and incubated at 37°C for 2 
minutes. Subsequently cells were resuspended in D-PBS and pelleted at 800 rpm for 
5 minutes. The pellet was aspirated and either used immediately or stored at -20°C. 
The maximum dilution rate used for passaging cells was 1:7. Cells were not used 
beyond their 30th
2.3 Genetic Techniques 
 passage. 
2.3.1 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
2.3.1.1 RNA extraction from whole cells 
All solutions used in this procedure were produced in DEPC-treated water, which 
was prepared by supplementing ddH2O with DEPC (0.1% v/v), incubation at 37°C 
for at least 12 hours and subsequent autoclaving at 121°C for 20 minutes. Gloves, 
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centrifugation tubes, pipettes and benches were treated with RNase AWAY 
(Molecular BioProducts Inc., San Diego, CA, USA). 
Cell pellets were defrosted, resuspended in 10 volumes of pre-warmed RNA lysis 
buffer (50mM Tris-Cl, pH 8.0, 100mM NaCl, 20mM EDTA, pH 8.0, 2% (w/v) 
SDS, 60mM β-mercaptoethanol, 10µg/ml proteinase K) and incubated at 37°C for 
30 minutes. A 5x phenol extraction was performed by adding an equal volume of 
5:1 phenol:lysis buffer to the sample, which was then centrifuged at 4,000rpm for 
10 minutes using a Beckman J6-HC centrifuge. The aqueous top layer was collected 
into a new tube, an equal volume of 1:1:1 phenol:chloroform:lysis buffer added and 
the centrifugation step repeated. The aqueous top layer was collected into corex 
ultracentrifuge tubes and adjusted to 0.5M ammonium acetate using a 10M stock. 
RNA was subsequently precipitated by adding 2.5 volumes of 100% ethanol (-
20°C) and sample incubation at -20°C for 2 hours or at -80°C over night. Following 
the incubation the nucleic acid was pelleted by ultracentrifugation at 12,000 rpm 
(Sorvall RC-5B centrifuge) for 30 minutes at 4°C. The supernatant was discarded, 
the pellet resuspended in a small volume (2ml) of 70% (v/v) ethanol and the 
centrifugation step repeated. The pellet was then allowed to air-dry over night and 
resuspended in 50µl DEPC-treated water. The sample was either used immediately 
or snap-frozen and stored at -20°C. The amount of RNA per sample was estimated 
using a NanoDrop ND-1000 Spectrophotometer (Labtech, East Sussex, UK) 
according to manufacturer’s instructions. 
2.3.1.2 cDNA synthesis 
2.3.1.2.1 DNaseI treatment of RNA 
DNaseI treatment of all RNA samples was performed to prevent genomic DNA 
amplification at later stages of the experiment. Fresh reaction tubes were prepared 
containing 5µg of RNA (or less depending on RNA concentration of each individual 
sample), 10µl of DNaseI reaction buffer and 4µl (8 units) DNaseI. The sample 
volume was adjusted to 100µl using DEPC-treated water and the sample incubated 
at 37°C for 3 hours. The reaction was stopped by adjusting the sample to 5mM 
EDTA using a 50mM EDTA, pH 8.0 stock. The sample was subsequently incubated 
at 70°C for 10 minutes and used immediately or snap-frozen and stored at -20°C. 
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2.3.1.2.2 RNA and primer denaturation 
For further analysis two samples were prepared for each strain and condition 
providing a reaction with and without reverse transcriptase, the latter serving as a 
control. Figures in the appendix section indicate the exact amounts of RNA and 
cDNA used for each experiment as this may vary and adjustments need to be made. 
In general samples are prepared containing 1µg RNA template, 1µl Oligo(dT)15
2.3.1.2.3 Reverse transcription 
 
primers from the Im-PromII reverse transcription kit (Promega) and are made up to 
a total volume of 20 or 30µl depending on RNA concentration. A negative control 
was set up containing no RNA template. Samples were incubated at 70°C for 5 
minutes, cooled on ice for at least 5 minutes and briefly centrifuged before the RT 
reaction. 
For the reverse transcription reaction a master mix of solutions as indicated in table 
2.2 has been prepared before samples were supplemented with 15µl of the 
appropriate mix (with or without RT) to ensure better comparability between the 
samples. Reaction temperatures were as follows: Primer annealing at 25°C for 5 
minutes, primer extension at 42°C for 60 minutes and inactivation at 70°C for 15 
minutes. 
2.3.1.3 Polymerase Chain Reaction (PCR) 
The PCR reactions were produced in a total volume of 100µl per sample. 
Depending on the effectiveness of reverse transcription, cDNA concentration and 
band visibility on a gel, the volume of cDNA is adjusted for each reaction as 
described in the individual figures. In general the volumes of the reaction mix are 
outlined in table 2.3 and the primers used can be found in table 2.4. The protocol for 
the reaction is as follows: sample denaturation at 95°C for 5 minutes, 30 cycles of 
95°C for 1 minute (denature), 65°C for 1 minute (anneal) and 72°C for 20 seconds 
(extend). The reaction was finished by a 5 minute extension at 72°C and a sample 
hold at 4°C. The cycle number and annealing temperature can vary between primers 
and will be specified in each figure legend. 
2.3.1.4 DNA separation by agarose gel electrophoresis 
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A 2% (w/v) gel was produced by microwaving analytical grade agarose (Promega) 
in 60ml 1x TBE buffer (45mM Tris-borate, 2mM EDTA), cooling and addition of 
5µl of 10mg/ml ethidium bromide solution. The gel was cast by pouring the mix 
into a BioRad Mini-Sub Cell GT gel apparatus and left to set. The gel was then 
immersed in 1x TBE buffer and 30µl of sample loaded into each well. Sigma 100kb 
DNA ladder was used as size standards and the gel run at 100V. Gels were 
visualised under UV light and photographed using BioRad Quantity One Software. 
2.4 Molecular biology techniques 
2.4.1 Copper and BCS supplementation 
Cells were grown to near confluence, supplemented with increasing concentrations 
of copper (0µM, 50µM, 150µM, 300µM, 500µM) and incubated for another 24 
hours. Copper stocks were tested for copper concentration every two weeks by ICP-
MS and stock volumes added to the culture media adjusted accordingly. 
Chelator supplemented cells were grown in BCS supplemented DMEM (0µM, 
5µM, 10µM, 20µM, 25µM, 50µM, 100µM) for 3 passages with the fourth 
generation being used for subsequent experiments. All solutions used for passaging 
were supplemented with the appropriate amount of BCS to avoid introduction of 
copper during the cell passaging procedure. 
2.4.1.1 Modified method for copper supplementation 
To have a direct comparison between copper and BCS treated cells (copper treated 
cells did not undergo as many passages), a batch of each SH-SY5Y APPWT and 
APPswe cells was grown as previously described for BCS supplementation. In brief, 
both cell lines were grown in copper containing media, passaged three times and the 
4th generation was then grown to confluence and used for further experiments. In 
contrast to the BCS supplementation procedure, all solutions used to split copper 
treated cells, were not supplemented with the transition metal. It was observed that 
copper in D-PBS and trypsin would pellet upon centrifugation and accumulatively 
throughout three passages would increase the copper concentration in the individual 
samples by three fold. 
 65 
2.4.2 Estimation of protein concentration and standardisation 
2.4.2.1 Membranous protein 
Membrane protein concentrations were estimated using the BCA protein assay 
reagent kit (reagent A and B) provided by Thermo Scientific, Illinois, USA. 
Reagent A was mixed with reagent B in a ratio of 50:1 and 200µl were added to 
20µl sample or standard in a 96-well plate. The plate was incubated at 37°C for 30 
minutes and absorbance was measured on a Thermo Labsystems Multiscan Ascent 
plate reader at a wavelength of 560nm. Standards were prepared from 2mg/ml BSA 
stock solution (Pierce, Illinois, USA) and ranged from 20µg/ml up to 2mg/ml. 
Samples and standards were prepared in triplicate to ensure accuracy in protein 
estimation. 
2.4.2.2 Soluble protein 
Soluble extracts were subjected to protein estimation using Coomassie Plus 
(Thermo Scientific). Standards were ranging from 5µg/ml to 20µg/ml and produced 
using a 20µg/ml stock. Samples were diluted 1:10 several times until within 
standard range. The sample volume of 100µl was made up to 200µl using  
 
 
 
 
 
 For experimental samples 
and negative control 
For experimental samples 
nH2 4.5 µl O 5.5 µl 
5x RTase buffer 4 µl 4 µl 
MgCl2 4 µl  (25mM) 4 µl 
dNTPs (10mM) 1 µl 1 µl 
RNasin 0.5 µl 0.5 µl 
Reverse Transcriptase 1 µl - 
Total Volume 15 µl 15 µl 
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Table 2.2: Reverse transcription master mix 
For reverse transcription a master mix of the above solutions was prepared and then 
aliquoted before supplementation with 1μg of RNA. 
 
 
 
 
 
 
 
 
 
 
 
 
Reactant Experimental volume 
cDNA 1.5µl 
nH2 65.5µl O 
(go)Taq 5x buffer 20µl 
MgCl2 8µl  (25mM) 
dNTPs (10mM) 2µl 
Forward primer 1µl 
Reverse primer 1µl 
Taq polymerase 1µl 
 
Table 2.3: Polymerase chain reaction master mix 
For PCR a master mix of the above solutions was prepared and then aliquoted 
before supplementation with 1.5μl of cDNA. 
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Gene Forward Primer Reverse Primer Length 
hsod1 5’-tggccgatgtgtctattgaa-3’ 5’-gggcctcagactacatccaa-3’ 20/20 
hccs 5’-ccatcagtacggggacctta-3’ 5’-ccaggtcatcttctccctca-3’ 20/20 
hβ-actin 5’-acactgtgcccatctacgagg-3’ 5’-aggggccggactcgtcatact-3’ 21/21 
 
Table 2.4: Primers used for reverse transcription – polymerase chain reaction 
(RT-PCR) 
To analyse the effect of overexpressing APP carrying the Swedish mutation on 
copper homeostasis with regards to metallation of intracellular copper binding 
proteins, expression levels of human SOD1 and CCS were monitored in APPWT and 
APPswe
 
 cell lines under increasing and depleted copper conditions using RT-PCR. 
The house keeping gene human β-actin was chosen as expression control. Expected 
product lengths are 210bp (hsod1), 230bp (hccs), and 612bp (hβ-actin). 
Coomassie in a 96-well plate and absorbance was measured at a wavelength of 
595nm. Samples and standards were produced in triplicate to ensure accuracy. 
2.4.3 Whole cell metal profiling 
2.4.3.1 Preparation of soluble whole cell extracts by freeze-grinding 
Neuroblastoma cultures were harvested as described in section 2.2.3.2. 
Saccharomyces cerevisiae cultures were harvested as described in section 2.2.1. Rat 
liver mitochondria were prepared as described in section 2.4.8.1 and 2.4.8.2. The 
resulting pellet was resuspended in a minimum volume (3ml) of extraction buffer 
(50mM Tris pH 8.8, 1mM PMSF) and added to a liquid nitrogen containing mortar. 
The cells were ground to a fine powder using a chilled pestle. To maintain a 
reducing environment the ground cells were transferred into an anaerobic chamber 
under liquid nitrogen and defrosted before being transferred to an Eppendorf tube 
and centrifuged at 4,000 rpm (Beckman J6-HC centrifuge) for 15 minutes at 4°C to 
remove cell debris. The resulting crude extract was then ultracentrifuged at 
150,000xg (Beckman L8-80 Ultracentrifuge) for 40 minutes at 4°C to remove 
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residual membrane fragments. The amount of protein was estimated as described in 
section 2.4.2.2. 
2.4.3.2 First dimension liquid chromatographic separation by anion exchange 
All subsequent experiments were performed in the anaerobic chamber and all 
solutions were purged with nitrogen for at least 30 minutes depending on volume 
size. The anion exchange column was prepared by three consecutive 10ml washes 
using extraction buffer (50mM Tris, pH 8.8, 1mM PMSF) containing 0mM NaCl, 
1,000mM NaCl, 0mM NaCl. Soluble protein was then loaded onto a 1ml HiTrap Q 
HP column at 0.3ml min-1
2.4.3.3 Second dimension liquid chromatographic separation by size exclusion 
 at a maximum total protein of 70mg. The column was 
washed with extraction buffer and then eluted with 1ml each extraction buffer 
containing 100mM, 200mM, 300mM, 400mM, 500mM and 1,000mM NaCl. A 
sample volume of 0.2ml of each protein fraction was used for subsequent size 
exclusion chromatography, the remaining sample was stored at 4°C. 
Aliquots (0.2ml) of each of the previously eluted anion exchange protein fractions 
were subjected to size exclusion chromatography on a Tosoh TSK SW3000 column 
fitted with a TSKgel SW guard column. The constant flow was provided by a high 
performance liquid chromatography (HPLC) pump system. Samples were eluted in 
10mM Tris, pH 7.5, 50mM NaCl, 1mM PMSF at 0.5ml min-1
2.4.3.4 Metal analysis by inductively coupled plasma-mass spectrometry 
 with fractions being 
collected every minute for 30 minutes. The column was washed before and between 
samples with 0.2ml of buffer containing 10mM Tris pH 7.5, 1M NaCl, 10mM 
EDTA to remove metals bound to the size exclusion matrix. Samples were used 
immediately for analysis by inductively coupled plasma - mass spectrometry (ICP-
MS), and the rest stored at -20°C. 
Metal standard solutions were prepared from stock metal solutions of 10,000ppm 
and 1,000ppm for copper and cobalt, and iron, zinc and manganese (BDH, VWR 
International, Leicestershire, UK), respectively. ICP-MS calibration standards were 
prepared through serial dilution of stock solutions in 2.5% (v/v) HNO3 to 100ppb 
with further dilution to the appropriate metal standard concentration (0ppb, 0.5ppb, 
1ppb, 5ppb, 10ppb and 30ppb). The final dilution produced the standard in a 
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mixture of 2.5% (v/v) HNO3 and size exclusion buffer in a ratio 4:1 to standardize 
for the final sample solution. ICP-MS samples (1.5ml) were prepared by the 
addition of 0.3ml size exclusion sample to 1.2ml 2.5% (v/v) HNO3
 [Equ. 3]  ppb x 5 / MWs = [µM] sample metal 
 and analysed 
using a Thermo X-series ICP-MS. The machine was maintained and auto-tuned 
before each run in accordance with manufacturer’s instructions and operated under 
conditions suitable for multi-elemental analysis. Samples and standards were 
analysed in triplicate and the average used for further data analysis. Results are 
expressed as µM metal present in the sample using the following calculation as 
means of conversion from ppb. 
ppb: being the average of triplicate ICP-MS readings of metal concentration in any 
particular sample 
5: being the dilution factor of ICP-MS samples 
MWs: Molecular weight specific to the analysed metal. 
 
 
2.4.4 Identification of metal-binding proteins 
To identify proteins in the 2D-LC fractions that are possible candidates for metal 
binding, samples containing metal pools as determined by ICP-MS were resolved 
on SDS-PAGE gels and analysed for correlation of metal pools to protein pools. 
2.4.5 SDS-PAGE analysis for protein analysis 
2.4.5.1 Preparation of SDS-PAGE gels 
Discontinuous SDS-PAGE gels were prepared at 15% (v/v) acrylamide for the 
resolving gel and 5% (v/v) for the stacking gel using a 30% acrylamide/bis-
acrylamide stock solution according to Sambrook & Russell (Sambrook and 
Russell, 2001). The resolving gel was further composed of 375mM Tris, pH 8.8 
(1,5M stock) and 0.1% (w/v) electrophoresis grade SDS (10% (w/v) SDS stock), 
whereas the stacking gel contained 250mM Tris, pH 6.8 (1M stock) and 0.1% (w/v) 
SDS. Both gels were polymerized using a 10% (w/v) APS stock (freshly prepared 
weekly to prevent degradation) and TEMED which was added to the gel solutions at 
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a final concentration of 0.1% (v/v) and 0.0005% (v/v), acting as a polymerization 
catalyst. Gels were cast in a BioRad Protean II minigel kit using 15mm glass plates. 
2.4.5.2 Sample analysis using SDS-PAGE gels 
2D-LC samples were prepared as follows. An aliquot (130µl) of sample was mixed 
with 50µl of 6x SDS gel loading buffer (80% (v/v) glycerol, 1% (w/v) SDS, 50mM 
Tris-Cl buffer, pH 6.8, 50mM DTT, 0.05% (w/v) BPB). While the samples were 
denatured by boiling for 10 minutes at 95°C in a PCR thermocycler the gel was 
immersed in 1x SDS running buffer (25mM Tris-Cl, pH 8.3, 250mM Glycine, 0.1% 
(w/v) SDS). Subsequently samples were loaded into the gel wells together with a 
molecular size marker (Sigma Low Range Markers). The high percentage of 
glycerol enabled multiple loading of samples into wells to increase the protein 
signal. Gels were run at 120V for 2 hours and proteins were visualized with 
fluorescent SYPRO Ruby stain (Molecular Probes). The staining process included 
the gel being rinsed in deionised water to remove residual running buffer and 
incubation for up to 1 hour with 50% (v/v) methanol, 7% (v/v) acetic acid until the 
gel decreased in size. The gel was rinsed in deionised water before being placed in 
the stain over night. A solution of 10% (v/v) methanol, 7% (v/v) acetic acid was 
used to destain the gel before it was photographed using BioRad quantity 1 software 
(described in section 2.4.10.1) and analysed by PCA analysis (described in section 
2.4.10.2). 
2.4.5.3 Protein identification by MALDI-TOF-MS peptide mass fingerprinting 
Protein bands identified as possible metal binding proteins were excised from the 
SDS gel with a scalpel. Following zip-tip purification the samples were digested 
with trypsin and analysed by matrix-assisted laser desorption ionization – time of 
flight – mass spectrometry (MALDI-TOF-MS - Applied Biosystems Voyager 
DESTR). The MASCOT search tool was subsequently used to search peptide 
databases for fragment masses comparable to the peptide fragment masses 
generated by mass spectrometry. The MALDI-TOF-MS analysis and MASCOT 
search were performed by the Pinnacle Proteomics and Molecular Biology unit, 
University of Newcastle upon Tyne. 
2.4.6 Phenotype analysis under metal depletion and supplementation 
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2.4.6.1 Growth curves 
SH-SY5Y APPWT and APPswe cell lines were grown to confluence in 2x150cm2 
flasks per line with supplementations made as described previously in section 2.4.1. 
Cells were harvested as described in section 2.2.3.2 and the resulting pellets were 
resuspended in 10ml D-PBS. Aliquots (0.2ml) of the resuspended pellet were used 
for analysis and diluted adequately for the use in a hemocytometer. Cells were 
manually counted taking into account the 4 corner and 1 central square in each of 
the hemocytometer chambers. The cell count was performed in triplicate, the 
average and total cell count ml-1
 [Equ. 4]  A x D x 10,000 = cells/ml 
 sample determined using the following calculation: 
A: being the average of cells counted in 10 squares (counted in triplicate) 
D: being the dilution factor of the original sample into trypan blue solution (usually 
5) 
10,000: hemocytometer specific factor being composed of the volume of each 
square comprising 1x10-3
6x75cm
ml, multiplied by the number of squares counted (10). 
2 flasks each containing 1x106 cells were set up for each cell line and 
growth condition and harvested at appropriate time intervals. Cells were harvested 
as previously described (section 2.2.3.2), resuspended in 0.6ml D-PBS and 
appropriately diluted (1/100 and 1/1000) into filter-sterilised casyton solution 
(isotonic salt solution) to be analysed in a cell counter (Schaerfe Systems, Casy® 
Cell Counter and Analyser System, Model TT, Reutlingen, Germany) using a 
150µm capillary. Final results are expressed as cells ml-1
2.4.6.2 Survival studies using trypan blue exclusion as indication of survival 
 of original sample for each 
of the collection days. 
Cell cultures were set up as for growth curves (section 2.4.6.1), however only 
survival studies for cells supplemented with copper were carried out due to the 
multiple passaging number for BCS supplemented cultures and the resulting loss of 
cells between passages. Cell cultures were exposed to increasing amounts of CuSO4 
(0µM, 50µM, 150µM, 300µM, 500µM) 24 hours prior to harvesting. Pellets were 
prepared as described in section 2.2.3.2 and resuspended in 8ml D-PBS. Aliquots 
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(0.2ml) of the resuspension were mixed with 0.3ml D-PBS and 0.5ml of 0.4% 
trypan blue for analysis of cell survival using the trypan blue exclusion method. 
After 10 minutes of incubation (room temperature) in the stain cells were counted 
manually in triplicate. Cells excluding trypan blue were recorded as live, whereas 
stained cells were recorded as dead. The survival rate is represented as % survival 
and compared to the same cell line without copper supplementation. 
2.4.6.3 Testing for intracellular metal accumulation by whole cell acid digest 
Supplemented cultures were prepared as described previously (section 2.4.6.1) and 
harvested. Cell counts ml-1 of samples were established as described in section 
2.4.6.1. Aliquots of 1.5x106 cells for each cell line and condition were pelleted at 
800xg for 10 minutes and resuspended in 1ml ultrapure 65% (v/v) HNO3. Samples 
were incubated at room temperature for at least 1 week. Independent triplicates for 
all samples were set up. The cell digests were then centrifuged for 30 minutes at 
15,000xg to remove intact cells and debris. The supernatant was transferred to a 
fresh tube and centrifuged under the same conditions to further purify the sample. 
Subsequently the digests were analysed for metal content by ICP-MS. Samples were 
prepared by addition of 0.5ml of acid digest to 2ml of 2.5% (v/v) HNO3. ICP-MS 
metal standards were prepared from 10,000 and 1,000ppm Cu, Zn, and Fe stocks. A 
serial dilution in 2.5% (v/v) HNO3 was performed to create a 1ppm metal standard 
solution mix, which was then used to produce 5ml of various standards (0ppb, 
50ppb, 100ppb, 150ppb, 200ppb, 250ppb, 300ppb, 350ppb, 400ppb, 500ppb) in 
2.5% (v/v) HNO3
2.4.7 Enzyme activity assays 
. Samples were subsequently subjected to ICP-MS analysis as 
described in section 2.4.3.4. 
2.4.7.1 Enzymatic determination of Glutathione content 
The glutathione content of 100mM NaCl samples obtained from yeast whole cell 
extract through first anionic liquid column chromatography and subsequent 
separation by high pressure liquid chromatography (HPLC) was determined using 
the sigma glutathione assay kit according to manufacturer’s instructions. In brief, 
the glutathione content is assayed using a kinetic assay in which catalytic amounts 
of glutathione are cycled between reduced and oxidized form to cause a continuous 
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reduction of 5,5'-dithiobis-(2-nitrobenzoic) acid (DTNB) to TNB. Using NADPH, 
glutathione reductase converts the oxidized form of glutathione into the reduced 
form. The product, TNB, is assayed colorimetrically at 412 nm. A schematic 
representation of the reaction is shown in figure 2.2. 
2.4.7.2 SOD1 activity assay 
2.4.7.2.1 Native polyacrylamide gel electrophoresis to detect SOD1 
To retain SOD1 protein structure and enzymatic activity a native polyacrylamide gel 
is run prior to activity staining. A discontinuous gel comprising a 15% (v/v) 
resolving gel and 5% (v/v) stacking gel was prepared as previously described in 
section 2.4.5.1 according to Sambrook and Russell (Sambrook and Russell, 2001) 
with slight variations. Gels were cast in a BioRad Protean II minigel kit using 
15mm glass plates. Under SDS omission TEMED was used as polymerization 
catalyst and gels were allowed to set over night at 4°C. Unlike described by 
Beauchamp and Fridovich (Beauchamp and Fridovich, 1971) no riboflavin was 
added to the gel mixture. Protein samples obtained through 2D-LC were added to 
 
GSH
GSSG
Glutathione reductase
DTNB
NADP+
NADPH + H+
TNB
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Figure 2.2: Schematic representation of glutathione content assay 
The glutathione content of protein extracts is assayed using a kinetic assay in which 
catalytic amounts of glutathione are cycled between reduced and oxidized form to 
cause a continuous reduction of 5,5'-dithiobis-(2-nitrobenzoic) acid (DTNB) to 
TNB. Using NADPH, glutathione reductase converts the oxidized form of 
glutathione into the reduced form. The product, TNB, is assayed colorimetrically at 
412 nm. 
Chemical structures were directly taken from chemistry and biology databases 
(http://www.chemicalbook.com/CAS%5CGIF%5C70-18-8.gif, 
http://www.bio.davidson.edu/people/kabern/BerndCV/Lab/Website%20(Summer%
202009)/LSHomepage/Glutathione-skeletal.png). 
 
 
 
2x loading buffer (as described in section 2.4.5.2) lacking SDS and DTT in equal 
volumes (50µl for each sample, 20µl for the pure SOD1 control) and transferred 
into the gel wells. The gel was run in 1x native gel buffer (25mM Tris, 200mM 
glycine) at 100V for 2 hours. Commercially available human SOD1 extracted from 
erythrocytes was used as control. 
2.4.7.2.2 In-gel activity assay of SOD1 activity 
The gel was soaked in 2.45mM NBT for 20 minutes before being immersed in a 
solution containing 28mM TEMED, 28µM riboflavin, 36mM potassium phosphate, 
pH 7.8 for 15 minutes. Superoxide dismutase activity was initiated by illumination 
on a Hancock illuminator until the gel changed colour from light yellow to dark 
purple. Enzyme activity was detected as white bands resulting from the chemical 
conversion of O2- radicals generated by photochemically induced riboflavin to 
H2O2, thus preventing the reduction of NBT to formazan and the colour change to 
purple (Beauchamp and Fridovich, 1971). The exact chemical pathway is displayed 
in figure 2.3. 
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2.4.7.2.3 Modified method for soluble whole cell protein extraction 
SH-SY5Y monolayer cultures from 150cm2
 
 flasks/sample were pelleted at 800xg for 
5 minutes and either used immediately or stored at -20ºC. Pellets were resuspended 
in 420µl of 50mM phosphate buffer, pH 7.8 and 120µl of 10% (w/v) SDS. After 
thorough mixing the samples were incubated at 37ºC for 30 minutes with 
subsequent cooling for 5 minutes on ice. A 60µl addition of 3M KCl was made, the 
sample vortexed and incubated on ice for a further 30 minutes. Incubation was 
followed by a 15 minute centrifugation at 13,000xg in a benchtop centrifuge. The 
supernatant was removed for protein estimation as described in section 2.4.2.2 and 
the pellet discarded. The extraction process of whole cell soluble protein in this 
protocol was modified to achieve high protein concentration in a small volume. The 
extraction process described in section 2.4.2.2 results in a large volume suitable for 
metal profiling, but not fluorescent spectrophotometry for activity assays. 
NBT formazan
2 O2- O2, H2O2
riboflavinreduced riboflavin
+
O2, light
SOD
inhibition
O2 + H2O2
 
Figure 2.3: Schematic representation of chemical reactions occurring during 
the in-gel SOD1 activity assay 
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The in-gel SOD activity staining is a two-step chemical reaction. After resolving 
protein samples on a native PAGE gel, the gel is soaked in two reaction substrates, 
which comprise of 2.45mM nitro-tetrazolium blue (NBT) and 28µM riboflavin (as 
described in section 2.4.7.2.2). Subsequently the gel is exposed to O2 and light to 
initiate the oxidation of riboflavin during the conversion of O2 to O2-. This anionic 
superoxide in turn converts NBT into formazan resulting in a gel colour change 
from light yellow to purple. Superoxide dismutase prevents the conversion of NBT 
to formazan by sequestration and dismutation of the O2-
Chemical structures were directly taken from chemistry and biology databases 
(http://www.comberservice.ie/foto/_optional_glovebox_clip_image002.jpg, 
http://www.invitrogen.com/etc/medialib/en/images/ics_organized/brands/molecular-
probes.Par.49619.Image.-1.0.1.gif). 
 radical to hydrogen 
peroxide and oxygen. Enzyme activity can be detected as white bands. 
 
2.4.7.2.4 Spectrophotometric analysis of SOD1 activity 
Cells were harvested as described previously (section 2.2.3.2) and whole cell 
soluble protein extracts obtained using the protocol described in section 2.4.7.2.3. 
Total cellular SOD activity was measured as described by McCord and Fridovich 
(McCord and Fridovich, 1969) by monitoring cytochrome c absorbance intensity 
using the Varian Cary E4 UV-VIS NIR spectrophotometer at a wavelength of 
550nm. 
A 100µM cytochrome c (bovine heart cytochrome c) stock was prepared in 50mM 
KPO4 buffer, pH 7.8 and stored in the dark at 4°C. The working solution for the 
SOD1 activity assay was prepared fresh on the day of use and was composed of 
50µM cytochrome c and 0.1mM EDTA in 50mM KPO4 buffer. A 0.1U addition of 
xanthine oxidase was made prior to each reaction. SOD1 protein standards using 
SOD1 protein purified from human erythrocytes (Sigma-Aldrich, UK) were 
produced by addition of increasing units of active protein to the reaction ranging 
from 0 to 2.5 units in 0.5 unit increments using a 196.5U/ml, 0.064mg/ml protein 
stock. Reaction cuvettes for standards were also supplemented with 100µg BSA 
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(50µl of 2mg/ml stock) and 60µl of the 300mM KCl, 2% (w/v) SDS, 35mM KPO4
 
 
buffer mixture which was used for sample extraction to control for any differences 
in absorbance arising from reaction components other than cytochrome c. Whole 
cell protein extracts were added in equal amounts (100µg/sample) and the reaction 
initiated by the addition of 50µM xanthine (50µl of 10mM stock) and monitored for 
30 minutes. The chemical reaction in shown as a schematic representation in figure 
2.4. 
Uric Acid
2 O2
2 O2.-
SOD
inhibition
O2 + H2O2
Xanthine
Cyt c red
Cyt c ox
Xanthine oxidase
 
 
Figure 2.4: Schematic representation of liquid SOD1 activity assay 
SOD1 activity is measured spectrophotometrically at a wavelength of 550nm. 
Under aerobic conditions xanthine is oxidised to uric acid by xanthine oxidase 
releasing O2-. This anionic superoxide in turn reduces oxidised cytochrome c 
resulting in an increase of absorbance intensity. Superoxide dismutase prevents the 
reduction of cytochrome c by sequestration and dismutation of the superoxide 
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radical to hydrogen peroxide and oxygen. Enzyme activity is measured as a function 
of absorbance intensity quenching. 
Chemical structures were directly taken from chemistry and biology databases 
(http://www.metallo.scripps.edu/promise/COX.html, 
http://www.epa.gov/oppbppd1/biopesticides/ingredients/tech_docs/tech_116900.ht
m). 
Cyt c red
Cyt c ox
Cytochrome c 
oxidase red
O2
Ascorbic acid
H2O
Dehydroascorbic acid
Cytochrome c 
oxidase ox
 
Figure 2.5: Schematic representation of cytochrome c oxidase activity assay 
Cytochrome c oxidase activity is measured spectrophotometrically at a wavelength 
of 550nm. Under aerobic conditions cytochrome c oxidase oxidises the fully 
reduced form of cytochrome c resulting in a decrease of absorbance intensity. 
Cytochrome c was fully reduced using molar excess concentrations of ascorbic acid 
(see section 2.4.7.3.4), which was subsequently removed from the reaction by 
dialysis (see section 2.4.7.3.5) to prevent cyclic reduction of cytochrome c and 
reaction inconsistencies. 
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Chemical structures were directly taken from chemistry and biology databases 
(http://www.metallo.scripps.edu/promise/COX.html, 
http://www.themedicalbiochemistrypage.org/vitamins.html). 
 
 
 
2.4.7.3 Cytochrome c oxidase activity assay 
Cultures (150cm2 flask/sample) of APPWT and APPswe
2.4.7.3.1 Preparation of total cellular membrane fraction 
 neuroblastoma cell lines 
were grown to 80% confluence, supplemented as previously described in section 
2.4.1 and harvested as described in section 2.2.3.2. The assay was performed as 
described by Horecker and Heppel (Horecker and Heppel, 1949). 
Pellets were resuspended in 1ml of 20mM KPO4 buffer (pH 7.8) and lysed by 
sonication in a water bath for 3 x 3 minute intervals with 5 minute intervals on ice. 
To remove undisrupted cells and organelles samples were centrifuged at 800xg 
(Microcentaur benchtop centrifuge) for 10 minutes and the supernatant transferred 
to corex tubes for ultracentrifugation. Samples were centrifuged at 150,000xg 
(Beckman L8-80 ultracentrifuge) to separate the soluble from the membranous 
material. Pellets were resuspended in 12ml of 20mM KPO4 buffer (pH 7.8) and the 
ultracentrifugation step repeated. Pellets were then resuspended in 0.5ml of the 
same buffer and the protein content was determined by the BCA method as 
previously described in section 2.4.2.1. Samples were adjusted to the same protein 
concentration of 120µg/ml in 20mM KPO4
2.4.7.3.2 Reduction of cytochrome c and dialysis 
 buffer to reduce variability between 
different samples during the activity assay with regards to volume and 
concentration. Samples were used on the same day or the day following extraction. 
Since the cytochrome c oxidase assay is measuring the oxidation of reduced 
cytochrome c (see figure 2.5 for schematic representation of cytochrome oxidase 
activity assay) it is important to fully reduce the cytochrome c stock in advance of 
the assay. However, excess reducing agent needs to be removed ahead of the 
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experiment to avoid competition between the oxidation reaction and residual 
reducing agent, in this case ascorbic acid. 
2.4.7.3.3 Demetallation of dialysis tubing 
The dialysis tubing was prepared according to Sambrook & Russell (Sambrook and 
Russell, 2001). Several pieces (20cm in length) of dialysis membrane (Medicell Int. 
Ltd., UK) with a molecular-weight cut-off of 3,500 Daltons were boiled over a 
Bunsen for 10 minutes in 500ml 2% (w/v) sodium bicarbonate (NaHCO3) and 1mM 
EDTA, pH 8.0 while being stirred continuously. Following cooling, the tubing was 
washed repetitively with nH2O before being boiled for another 10 minutes in 500ml 
of 1mM EDTA, pH 8.0. The tubing was left to cool and stored in a screw-top 
Falcon tube at 4°C submerged in nH2
2.4.7.3.4 Ascorbic acid reduction of cytochrome c  
O until further use. 
A 50µM cytochrome c (bovine heart cytochrome c) stock was prepared in 20mM 
KPO4 buffer, pH 7.8 and stored in the dark at 4°C. The working solution for the 
cytochrome c oxidase activity assay was prepared fresh on the day of use and 
consisted of 3µM cytochrome c in 20mM KPO4 buffer. Absorbance scans were 
taken on a Varian Cary E4 UV-VIS NIR spectrophotometer. A quartz cuvette 
containing 0.9ml of working solution was titrated with increasing amounts of 50mM 
ascorbic acid (50µM intervals up to 400µM final concentration) and UV/visible 
spectra obtained after each ascorbic acid addition between wavelengths 200-800nm 
(see appendix 2 figure 5.5). An increase in absorbance (reduction of cytochrome c) 
was observed at A550nm
2.4.7.3.5 Removal of ascorbic acid from the cytochrome c stock using dialysis 
. Saturation of reduction was observed at 350µM ascorbic 
acid addition. It was calculated that 64.8mM ascorbic acid were needed to fully 
reduce the 50µM cytochrome c stock. 10ml of stock were reduced by an addition of 
100mM (400µl of 2.5M stock) ascorbic acid. 
Reduced cytochrome c stock was transferred into the dialysis tubing, which was 
sealed off at both ends. The sample was placed into 2L of 20mM KPO4 buffer and 
stirred at 4°C for 1 hour. Subsequently it was transferred to 5L of KPO4 buffer and 
stirred at 4°C over night to allow osmosis of ascorbic acid to complete. The reduced 
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cytochrome c was removed from the dialysis tubing and stored at 4°C until further 
use. 
2.4.7.3.6 Spectrophotometric analysis of cytochrome c oxidase activity 
Cytochrome c oxidase activity was measured spectrophotometrically. Aliquots 
(0.9ml) of above mentioned working solution containing 3µM of fully reduced 
cytochrome c were transferred into a quartz cuvette and scans comprising 
wavelengths 200-800nm were taken to control for full reduction of cytochrome c at 
550nm. Reactions were initiated by addition of 8µg protein and analysed for 30 
minutes. The rate of cytochrome c oxidation was determined by using ε550nm = 
29,500 M-1 cm-1
2.4.8 Subcellular fractionation of Rat Liver Tissue and SH-SY5Y cell cultures 
. 
2.4.8.1 Extraction of liver tissue from Wistar rats 
Ex-breeder male Wistar rats with a weight of 300g and over were anaesthetised by a 
low dose of CO2 in an airtight chamber and their life terminated either by increasing 
the CO2
2.4.8.2 Cellular fractionation for mitochondrial extract of rat liver  
 to a leathal dose for 5 minutes or by breaking of the neck. The liver was 
then removed and immediately used for mitochondrial extraction. 
The protocol was obtained from Mattiazzi et. al. (Mattiazzi et al., 2002) and slightly 
adjusted. 
Rat liver was cut into fine pieces and major veins and obstructions removed. 
Subsequently the tissue was transferred to an Elvejhem homogenizer and 
submerged in mannitol sucrose EGTA (MSE) buffer (220mM mannitol, 70mM 
sucrose, 10mM Hepes, pH 7.4, 1mM MgCl2, 1mM EGTA) freshly supplemented 
with 1% (w/v) BSA (functions as protease inhibitor and antioxidant). The mixture 
was homogenized using a Bosch drill for 4x15 second intervals. The homogenate 
was transferred into chilled centrifuge tubes and the volume maximised with MSE 
buffer. The samples were subsequently subjected to 2 low intensity centrifugations 
at 400xg and 2 high intensity centrifugations at 8,600xg at 4ºC in a Sorvall RC-5B 
centrifuge for 10 minutes/cycle. Supernatant from the low intensity spins and pellets 
from the high intensity spins were collected and the final pellet resuspended in 4ml 
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MSE buffer without BSA. The suspension was aliquoted into 1.5ml Eppendorf 
tubes and pelleted by centrifugation at 8,600xg for 10 minutes. The supernatant was 
aspirated, the mitochondrial extracts snap-frozen in liquid nitrogen and stored at -
20°C. 
For mitochondrial extracts of SH-SY5Y cells a slight variation in protocol is used. 
30x150cm2
2.4.8.3 Confirmation of rat liver mitochondrial fraction by Western Blot 
 flasks of 80% confluent monolayer culture were harvested as described 
in section 2.2.3.2 and the pellet resuspended in 5ml of MSE buffer supplemented 
with 1% (w/v) BSA. Cells were homogenized with 30 up-and-down strokes of an 
Elvejhem homogenizer and the homogenate centrifuged as described above for rat 
liver tissue. Centrifugation speeds were 800xg for the low intensity spin and 
8,600xg for the high intensity spin. Pelleted mitochondria were resuspended in MSE 
buffer without BSA and centrifuged at 800xg for 10 minutes at 4°C. The sample 
was aspirated and snap-frozen. 
2.4.8.3.1 Sample preparation for Western Blot 
Rat liver mitochondria were prepared as described in section 2.4.8.1 and 2.4.8.2. 
The resulting pellet was resuspended in a minimum volume (3ml) of extraction 
buffer (50mM Tris pH 8.8, 1mM PMSF) ground to a fine powder in liquid nitrogen 
as described in section 2.4.3.1. Upon defrosting an aliquot of the crude extract was 
preserved for later analysis, the remaining sample was centrifuged at 4,000 rpm 
(Beckman J6-HC centrifuge) for 15 minutes at 4°C to remove cell debris. Both 
extracts were diluted 1/5 and 1/10 and subjected to Tris-glycine SDS-PAGE as 
described before (section 2.4.5.1 and 2.4.5.2). Transferable markers were used for 
protein size determination. 
2.4.8.3.2 Transfer of protein onto blotting membrane 
Protein was transferred from the SDS-PAGE to a PVDF membrane (Millipore, 
Bedford, MA) using a half dry blotting machine for 1 hour at 20V. The gel was 
placed onto the membrane and between filter paper soaked in 1x transfer buffer, pH 
8.3 (50mM Tris base, pH 8.3, 40mM glycine, 4% (w/v) SDS, 20% (v/v) methanol). 
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Before the transfer the PVDF membrane was immersed in 100% methanol followed 
by nanopure water and soaked in transfer buffer for at least 2 minutes. 
2.4.8.3.3 Blocking of membrane with antibodies 
The gel was stained with Panceau for a few seconds and rinsed with nanopure 
water. It was subsequently blocked with blocking solution (5% (w/v) non-fat dry 
milk powder, 10% (v/v) of 10x TBS buffer, 0.5% (v/v) Tween) for 1 hour before 
being incubated with a 1/1,000 dilution of primary antibodies in blocking solution 
over night. Rabbit polyclonal primary antibodies specific to human and rat (Abcam, 
Cambridge, UK) were directed against the mitochondrial marker protein prohibitin. 
Following over night incubation, the membrane was washed three times for 5 
minutes with blocking solution and incubated with a 1/2,000 dilution of HRP-
conjugated goat anti-rabbit secondary antibodies (Abcam) for 2 hours. Excess 
antibodies were washed from the membrane as before using 1x TBS buffer (50mM 
NaCl, 20mM Tris, pH 7.5).  
2.4.8.3.4 Protein detection by chemiluminescence 
Chemiluminescence is induced by the addition of 6.4µl H2O2
2.4.9 Metal binding analysis of a low molecular copper binding compound  
 to 10ml of ECL 
solution (1.25mM luminol, 0.2mM coumaric acid, 100mM Tris, pH 8.5, 0.72% 
DMSO). The mix was evenly distributed across the membrane and films were 
developed at various time intervals. 
2.4.9.1 Preparation of copper (I) stock solution 
Due to the rapid disproportionation characteristics of Cu(I) the titration stock 
solution was prepared anaerobically and transferred to the rubber sealed sample 
cuvette using a gas-tight Hamilton syringe. Upon introduction into the anaerobic 
chamber all solutions were purged with nitrogen to remove residual dissolved 
oxygen with the exception of ultrapure 30% (w/v) concentrated HCl. 10ml of final 
working solution (1M NaCl, 0.1M HCl, diluted in nanopure H2O) were  added to 
0.05g of solid cuprous chloride and the mixture shaken until all solid material had 
dissolved. An aliquot (1ml) of this cuprous buffer solution was diluted to the final 
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working concentration of 2mM Cu(I), 40mM NaCl, 4mM HCl in 24ml of 
100mMTris, pH7.5, 150mM NaCl buffer. The quality and accuracy of the Cu(I) 
stock was measured by ICP-MS using control values of 40ppb and 80ppb. A 1/10 
dilution of the 2mM Cu(I) stock was produced in 100mMTris, pH7.5, 150mM NaCl 
buffer. Aliquots of 31.5µl and 62µl of the 0.2mM copper stock were added to 
968.5µl and 937µl of buffer to generate the 400 and 800ppb samples, respectively. 
ICP-MS calibration standards were prepared as previously described in section 
2.4.3.4 using final standard concentrations of 0ppb, 1ppb, 5ppb, 30ppb, 50ppb and 
100ppb. The final dilution produced the standard in a mixture of 2.5% (v/v) HNO3 
and 100mMTris, pH7.5, 150mM NaCl buffer in a ratio 4:1 to standardize for the 
final sample solution. ICP-MS samples (1.5ml) were prepared by the addition of 
0.3ml of the copper stock sample to 1.2ml 2.5% (v/v) HNO3
2.4.9.2 Cu(I) titration to biological 2D-LC extracts 
 and analysed using a 
Thermo X-series ICP-MS. The copper stock concentration was recalculated on the 
basis of ICP-MS results and the µM additions to the titration reaction adjusted. 
A 0.5ml (1.2µM copper) low molecular weight 2D-LC sample, supposedly 
containing the low molecular weight copper complex, was anaerobically transferred 
into an acid-washed 1ml quartz cuvette (Hellma) fitted with a double septum 
anaerobic seal. Flourescence spectra were taken between wavelengths of 800-
200nm on a Cary Eclipse Fluorescence Spectrometer using second dimension 
elution buffer as reference point. A 2mM Cu(I) stock was used for additions of 
molar excess copper increasing in 0.6µM increments using a gas-tight Hamilton 
syringe fitted with an automated dispenser. Spectra were taken after each addition. 
2.4.9.3 Cu(I) binding assay using the Cu(I)-specific chelator BCS 
A 50mM stock solution of BCS was prepared under anaerobic conditions and 
serially diluted. BCS was titrated into the same sample with increasing molar excess 
using a 2mM working solution and increments of 0.6 µM. Spectra were taken after 
each addition. The subsequent standardization of the BCS/Cu spectra to the buffer-
only spectrum revealed BCS-dependent spectral features. 
2.4.9.4 Gel filtration analysis of a low molecular weight metal binding 
compound  
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A 0.5ml aliquot of previously eluted 2D-LC sample displaying a low molecular 
copper peak during ICP-MS analysis was resolved anaerobically on a Sephadex G-
25 size exclusion column (PD-10 desalting column, GE Healthcare) to determine 
the binding of metals to protein. The column was washed with 2ml of second 
dimension elution buffer (10mM Tris pH 7.5, 50mM NaCl, 1mM PMSF) and 
residual metal traces removed by washing with 0.2ml buffer containing 10mM Tris 
pH 7.5, 1M NaCl, 10mM EDTA. Subsequently the column was washed with 3 
column volumes of buffer and samples were eluted in 10mM Tris pH 7.5, 50mM 
NaCl, 1mM PMSF. Eluant fractions (0.5ml) were analysed for protein content by 
Bradford assay as described in section 2.4.2.2 or metal content for zinc, copper and 
manganese as described in section 2.4.3.4. 
2.4.9.5 ICP-MS analysis of samples 
Metal standards for zinc and copper were produced as described in section 2.4.3.4. 
Protein samples were diluted 1:5 and analysed by ICP-MS. Final results are shown 
as µM concentrations. 
2.4.10 Bioinformatics and statistical analysis 
2.4.10.1 Quantity one software 
BioRad Quantity 1 software was used to analyse SDS-PAGE and agarose gels and 
to produce densitometric analyses of individual protein bands for comparison with 
the according 2 dimensional metal pools by Principal Component Analysis. 
2.4.10.2 Matlab for Principal Component Analysis (PCA) 
To process data of great variability the statistical software package Matlab is used as 
basis for Principal Component Analysis. PCA is a mathematical tool to combine 
and correlate metal content data obtained from metal profiling and ICP-MS analysis 
of biological extracts and protein data obtained through SDS-PAGE gels across the 
metal containing fractions of the 2D-LC extract. An example of the use of PCA is 
given in Nature Protocols for identification of proteins associated with specific 
periplasmic metal pools of Synecchocystis PCC 6803 
(http://www.natureprotocols.com/2008/11/12/metalloprotein.php). PCA works on 
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the basis of compressing a set of data with high variability to a set of data with 
lower variability, revealing a way to best indicate variance within the data set. This 
is achieved by converting a number of correlated variables into a smaller number of 
uncorrelated variables, which are referred to as principal components. Each 
principal component removes as much variability as possible, with the most 
emphasis being placed on the first principal component, then the second and so 
forth. 
 
2.4.10.3 Statistical analysis 
Statistical analysis was performed on data sets that were established by triplicate 
measurements. BCS or CuSO4 treated samples were compared to the control using 
the 1-Way ANOVA ( analysis of variance) test provided in Sigma Plot software. 
The null-hypothesis, which states that differences in enzyme activity, cell growth or 
survival between control and BCS or CuSO4
2.4.10.4 General Bio-informatics 
 treated cultures is due to random 
chance, is rejected when the P-value is below the significance level of 5% (p<0.05). 
The majority of experimental data sets displayed a P-value below the significance 
level of 1%. Exact statistical significance is specified in all relevant figures. 
Protein, RNA and DNA sequences were obtained through BLAST searches using 
PubMed. 
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3.1 Low resolution 2D-LC analysis of soluble metal-complexes in eukaryotic 
model species 
Chapter 3 – Results 
Since 47 % (Andreini et al., 2008) of all proteins require metal as a co-factor to 
maintain their enzymatic and structural properties, it is of importance to establish 
methods that enable the study of metalloproteins under physiological conditions. A 
method has recently been developed by Dr. Kevin Waldron and Dr. Steven Tottey, 
which comprises of the liquid separation of protein extracts first by charge using 
anion exchange chromatography followed by size exclusion chromatography under 
native conditions. Through subsequent analysis of each of the fractions obtained for 
metal content by inductively coupled plasma – mass spectrometry (ICP-MS) and 
protein analysis by SDS-PAGE it is possible to establish links between proteins and 
a possible metal co-factor. By using mathematical methods to create the links it is 
possible to avoid elaborate purification of proteins to homogeneity under native 
conditions. This method has been successful in the identification of futA2 as a 
putative iron-binding protein in periplasmic extracts of Synechocystis
Two dimensional liquid chromatography (2D-LC) is not only useful for detecting 
previously unknown interactions of metals and proteins, but also in the investigation 
of changes in metal distribution due to genetic variation and/or environmental 
stimuli. 
 PCC 6803 
(Waldron et al., 2007). More-over, in the course of this work a more elaborate 
methodology was used to identify the maganese and copper proteins MncA and 
CucA, respectively (Tottey et al., 2008). 
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To extend the use of this method with respects to differences between prokaryotic 
systems, eukaryotes and higher mammalian species, a number of model organisms 
were subjected to 2D-LC and subsequent analysis for copper, zinc, iron, manganese 
and cobalt. 
3.1.1 2D-LC analysis of Saccharomyces cerevisiae whole cell soluble protein 
extract 
Saccharomyces cerevisiae is a well understood organism that is often used as the 
simplest possible model organism for eukaryotic systems. The wild type strain 
W303 1a was grown in 1L of standard YPD media to OD600nm=0.4 and subjected to 
successive washes in 100μM EDTA and nH2O to remove residual metal from the 
cell surface before being subjected to 2D-LC. Lysis of cells by freeze grinding in 
liquid nitrogen as described in section 2.4.3.1 and transfer into an anaerobic 
environment was intended to minimise the oxidation of any proteinaceous thiol 
groups, which would otherwise result in metal ions being released from their 
binding partner rendering the two dimensional separation unsuitable for metal 
analysis by ICP-MS. The cell lysate was centrifuged to remove intact cells and cell 
debris as described in section 2.4.3.1 and following estimation of protein content 
was concentrated on a 1ml anion exchange HiTrap Q HP column at pH 8.8 in buffer 
containing 50mM Tris, 1mM PMSF. A maximum of 70mg of total soluble whole 
cell protein extract was loaded onto the column. Protein fractions (1ml) were eluted 
in elution buffer containing increasing concentrations of NaCl (0mM, 100mM, 
200mM, 300mM, 400mM, 500mM, 1,000mM)  and aliquots (0.2ml) were 
transferred to a Tosoh TSK SW3000 size exclusion chromatography column where 
the anion exchange protein fractions were separated according to their molecular 
weight (MW). The size exclusion column was coupled with a high performance 
(HP) peristaltic pump ensuring samples were eluted at a flow rate of 0.5ml min-1 for 
30 minutes in 10mM Tris, pH 7.5, 50mM NaCl, 1mM PMSF. Prior to protein 
loading, the size exclusion column was washed with a solution containing 10mM 
Tris, pH 7.5, 1M NaCl, 10mM EDTA to remove any residual metals bound to the 
matrix from previous samples. Of the 35 size exclusion fractions collected the first 5 
were discarded since they represent the eluant preceding the void volume of the 
column and will not contain any molecules derived from the extract. Multi-
elemental analysis of each HPLC sample for each anion exchange salt fraction was 
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performed by ICP-MS as described in section 2.4.3.4 and the data plotted as 3-
dimensional contour plot in figure 3.1. 
In this analysis the metals, copper (a), zinc (b), manganese (c), and iron (d) but not 
cobalt (e) show pools that are associated with high molecular weight species; cobalt 
displays association with only low molecular weight protein species. Each of the 
divalent metals shows large metal pools in the low molecular weight regions of the 
contour plot, which could result either from metal relocation from larger 
metalloproteins to smaller species including non-proteinaceous small molecules 
during the extraction process or free metal, released during size exclusion 
chromatography. It seems that for all metals there is a trend in which the high 
molecular weight metal-binding species elute at a lower salt concentration (ie. 100, 
200, 300mM for copper, zinc and manganese) whereas the low molecular weight 
species are eluted throughout all salt concentrations. Iron seems to be the only metal 
that is present in all size exclusion fractions in high and low molecular weight 
species. 
Interestingly, a high molecular weight copper pool in the 100mM anion exchange 
fractions is observed which seemingly co-migrates with a zinc pool at 11.5ml size 
exclusion volume. Both graphs for copper and zinc are overlaid in figure 3.1 (f) to 
illustrate co-migration. 
3.1.2 2D-LC analysis of rat liver mitochondria soluble protein extract 
Figure 3.1 suggests that such crude 2D-LC in conjunction with metal analysis by 
ICP-MS could be adequate to identify some of the major metal pools in whole cell 
extracts of simple eukaryotes. Thus the soluble protein extract an organ of a higher 
eukaryotic organism, which is  know for its high metal content (especially iron) was 
used. Rat liver is easily accessible and provides a useful sample for such analysis. 
However, to reduce protein complexity in the sample, fractionation of rat liver for 
the mitochondrial fraction is attempted. This should provide a 3-dimensional metal 
profile that focuses on the major metal pools rather than showing every single pool 
that might be created by binding partners with low abundance, which are anticipated 
to otherwise generate problems for further analysis if individual proteins are below 
detection level of the SYPRO Ruby gel stain.  
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Rat liver was extracted as described in section 2.4.8.1 and the mitochondrial 
fraction purified by differential centrifugation as described in section 2.4.8.2. 
Mitochondrial fractionation was tested using Western Blot analysis (data not 
shown) as described in section 2.4.8.3 using rabbit polyclonal primary antibodies 
specific to human and rat directed against the mitochondrial marker protein 
prohibitin and a HRP-conjugated goat anti-rabbit secondary antibody. 
Mitochondrial soluble extracts were subjected to 2D-LC under anaerobic conditions 
as described previously for  
Figure 3.1: 2D-LC fractionation of metal pools in Saccharomyces cerevisiae 
soluble whole cell protein extract 
Soluble whole cell protein extract was prepared from 1L of culture grown to an 
OD600nm of 0.4. Cells were washed in 100μM EDTA and subsequently deionised 
water to remove residual metal from the culture media and prevent contamination of 
the extract with EDTA before being lysed by freeze grinding as described in section 
2.4.3.1. Subsequent to sequential centrifugation the protein content was estimated 
by BSA-calibrated Coomassie assay and the extract subjected to 2D-LC (see 
sections 2.4.3.2 and 2.4.3.3). First the sample was concentrated on a 1ml HiTrap Q 
HP anion exchange column. Fractions were eluted in extraction buffer (50mM Tris, 
pH 8.8, 1mM PMSF) containing increasing concentrations of NaCl (0mM, 100mM, 
200mM, 300mM, 400mM, 500mM, 1,000mM). Aliquots (0.2ml) of each anion 
exchange fractions was subjected to high performance liquid chromatography on a 
Tosoh TSK SW3000 size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 
1mM PMSF at a flow rate of 0.5ml min-1. Samples were collected every minute for 
30 minutes and analysed for metals by inductively coupled plasma-mass 
spectrometry standardised to standard metal solutions as described in section 
2.4.3.4. Results are shown for (a) copper (contours represent 0.03μM increments), 
(b) zinc (contours represent 0.03μM increments), (c) manganese (contours represent 
0.02μM increments), (d) iron (contours represent 0.03μM increments), (e) cobalt 
(contours represent 0.002μM increments), and (f) copper (blue) and zinc (black) 
(contours represent 0.03μM increments). Fractions containing both copper and zinc 
pools are indicated by the red bar and will subsequently be referred to as p1yeast
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Saccharomyces cerevisiae and subjected to multi-elemental analysis by ICP-MS. 
Figure 3.2 displays contour plots for copper (a), zinc (b), manganese (c), iron (d), 
and cobalt (e). All contour plots show similarity to the equivalent metal plot for 
Saccharomyces cerevisiae. It is apparent that there are fewer metal pools in the rat 
mitochondrial extract reducing the complexity of the plot especially for iron (see 
figure 3.1 (d)). However, those pools are more discernable due to higher micromolar 
concentration of metal being present in fewer fractions with regards to distribution 
across anion exchange salt fractions and also size exclusion fractions. Major metal 
pools are observed in the 200mM and 100mM anion exchange fractions with less 
metal being distributed throughout the whole extract. Several metal pools for copper 
(300mM fraction) and zinc (200mM, 300mM fractions) are more resolved in the rat 
liver mitochondrial extract, which aids the further analysis of distinct metal pools to 
determine the binding partner for any particular metal pool. Furthermore, the 
manganese contour plot shows a major manganese pool in the 200mM salt fraction 
at a size exclusion volume of 9ml. 
Co-migrating zinc and copper pools putatively similar to those previously identified 
in Saccharomyces cerevisiae are shown for rat liver mitochondria in figure 3.2 (f). 
Both metals were eluted in the 100mM anion exchange fraction and migrate at a 
similar apparent molecular weight eluting at 10.5ml size exclusion volume. The size 
exclusion volumes at which copper and zinc co-migrate for this particular metal 
pool vary by 2 fractions (equivalent to 1ml of size exclusion eluant) between 
Saccharomyces cereviasiae and rat liver mitochondrial extracts, it remains possible 
that the same protein is responsible for copper and zinc binding in both extracts. To 
assess which protein might be the binding partner to copper and zinc the respective 
2D-LC fractions were resolved on a SDS-PAGE gel as described at a later stage in 
section 3.3. 
3.1.3 2D-LC analysis of HepG2 whole cell soluble protein extract 
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Advancing to even higher eukaryotes, a human liver carcinoma cell line - HepG2 – 
was grown in RPMI media as monolayer cultures to 80% confluency, harvested as 
described in section 2.2.4.2 and washed with D-PBS several times to remove 
residual metal contained in the medium. Cell pellets were subjected to lysis and 
centrifugation as described previously (section 2.4.3.1). Soluble whole cell extracts 
were subjected to 2D-LC as described for rat liver mitochondria and fractions 
analysed for metal content by ICP-MS. Figure 3.3 displays 2-dimensional contour 
plots for copper (a), zinc (b), manganese (c), iron (d), and cobalt (e). In comparison 
to rat liver mitochondrial metal contour plots, HepG2 extracts show a significantly 
different distribution of copper according to charge and size. The copper analysis 
detects a number of high molecular weight species in the 100mM, 200mM and 
1,000mM salt fractions with only a small amount of low molecular copper pools 
being present in the 100mM and 1,000mM salt fractions, whereas the rat liver 
mitochondrial extract displayed copper pools that were rather restricted to low 
molecular weight species. In contrast, the zinc pools are remarkably similar to rat 
liver mitochondria zinc pools, however they display reduced amounts of zinc in the 
low molecular weight species and increased amounts of zinc in the high molecular 
weight species with regards to the 300mM and 400mM salt fractions at a size 
exclusion volume of 6-8ml. This indicates that a protein present in both cytoplasm 
and mitochondria might be responsible for these zinc pools or that zinc might have 
been lost during the rat liver mitochondrial extract and relocalised to low molecular 
weight species. Another possibility is that these zinc peaks are caused by proteins 
too large to enter the column, but releasing zinc into the matrix (causing low 
molecular weight metal pools) or that protein-specific properties only allow for a 
slow migration through the column close to the void volume (causing higher 
molecular weight metal pools). A major difference to contour plots shown for 
previous species is observed for manganese pools. Only two manganese pools are 
detected in the 100mM anion exchange fractions, whereas previously manganese 
was detectable throughout the lower molecular weight range in all salt fractions for 
rat liver mitochondrial extracts. These findings suggest the existence of a large 
mitochondria specific manganese pool, which has previously been detected by Luk 
et. al. (Luk et al., 2005) and is thought to be involved in metallation and activation 
of mitochondrial matrix manganese superoxide dismutase SOD2p in yeast. It is 
likely that the same manganese pools exist in HepG2, APPWT and APPswe cells, but 
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remain below the limit of metal detection due to the extracts being composed of 
cytosolic and organelle soluble proteins rather than just mitochondrial proteins. 
Again, the contour plot for iron is very complex with metal  
Figure 3.2: 2D-LC representation of metal pools in rat liver mitochondria 
soluble protein extract 
Rat liver mitochondria were extracted from rat liver by differential centrifugation as 
described in section 2.4.8.2. Soluble protein extract was prepared by freeze grinding 
and sequential centrifugation as described in sections 2.4.3.1. Subsequent to 
sequential centrifugation the protein content was estimated by BSA-calibrated 
Coomassie assay and the extract subjected to 2D-LC (see sections 2.4.3.2 and 
2.4.3.3). First the sample was concentrated on a 1ml HiTrap Q HP anion exchange 
column. Fractions were eluted in extraction buffer (50mM Tris, pH 8.8, 1mM 
PMSF) containing increasing concentrations of NaCl (0mM, 100mM, 200mM, 
300mM, 400mM, 500mM, 1,000mM). Aliquots (0.2ml) of each anion exchange 
fractions was subjected to high performance liquid chromatography on a Tosoh 
TSK SW3000 size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 1mM 
PMSFat a flow rate of 0.5ml min-1. Samples were collected every minute for 30 
minutes and analysed for metals by inductively coupled plasma-mass spectrometry 
standardised to standard metal solutions as described in section 2.4.3.4. Results are 
shown for (a) copper (contours represent 0.03μM increments), (b) zinc (contours 
represent 0.03μM increments), (c) manganese (contours represent 0.02μM 
increments), (d) iron (contours represent 0.03μM increments), (e) cobalt (contours 
represent 0.002μM increments), and (f) copper (blue) and zinc (black) (contours 
represent 0.03μM increments). Fractions containing both copper and zinc pools are 
indicated by the red bar and will be subsequently referred to as p1RLM
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Figure 3.3: 2D-LC representation of metal pools in HepG2 soluble whole cell 
protein extract 
Soluble whole cell protein extract was prepared from 30x150cm2 flasks of 80% 
confluent HepG2 monolayer culture and extracted by freeze grinding and sequential 
centrifugation as described in sections 2.4.3.1. Subsequent to BSA-calibrated 
protein estimation the extract was subjected to 2D-LC (see sections 2.4.3.2 and 
2.4.3.3). First the sample was concentrated on a 1ml HiTrap Q HP anion exchange 
column. Fractions were eluted in extraction buffer (50mM Tris, pH 8.8, 1mM 
PMSF) containing increasing concentrations of NaCl (0mM, 100mM, 200mM, 
300mM, 400mM, 500mM, 1,000mM). Aliquots (0.2ml) of each anion exchange 
fractions was subjected to high performance liquid chromatography on a Tosoh 
TSK SW3000 size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 1mM 
PMSF at a flow rate of 0.5ml min-1
 
. Samples were collected every minute for 30 
minutes and analysed for metals by inductively coupled plasma-mass spectrometry 
standardised to standard metal solutions as described in section 2.4.3.4. Results are 
shown for (a) copper (contours represent 0.03μM increments), (b) zinc (contours 
represent 0.03μM increments), (c) manganese (contours represent 0.02μM 
increments), (d) iron (contours represent 0.03μM increments), (e) cobalt (contours 
represent 0.002μM increments), and (f) copper (blue) and zinc (black) (contours 
represent 0.03μM increments). 
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pools showing throughout both dimensions of the separation with major iron pools 
being present in the high molecular weight samples of the 100mM - 400mM anion 
exchange fractions. As for both previous organisms that were tested for metal 
distribution, HepG2 cells also display a co-migrating copper and zinc pool within 
the 100mM salt fraction. Figure 3.3 (f) displays overlaying copper (blue) and zinc 
(black) metal analyses with a clear overlap of both metals in the region marked by 
the red bar for p1HepG2
3.1.4 2D-LC analysis of SH-SY5Y APP
.  
WT
An experimental model that is often chosen for studies related to neuronal cell 
function is the human neuroblastoma cell line SH-SY5Y. This cell line was 
established in 1970 by subcloning the original cell line SK-N-SH which was created 
by bone marrow biopsy of a female patient. SH-SY5Y readily grows as a monolayer 
culture in DMEM supplemented with foetal calf serum, antibiotic and glutamate 
(see section 2.2.3.1) at 37ºC in a 5% CO
 whole cell soluble protein extract 
2 atmosphere. For crude fractionation of 
major metalloprotein pools cells were grown to 80% confluency and treated as 
described for HepG2 cells. Figure 3.4 shows contour plots for copper (a), zinc (b), 
manganese (c), iron (d), and cobalt (e) distribution throughout the whole cell soluble 
extract. The copper analysis detects several copper pools within the 100mM, 
200mM, 300mM, and 1,000mM salt fractions, however only the 100mM anion 
exchange fraction copper pool at size exclusion volume 11ml is resolved as a 
discrete peak suitable for further analysis of potential metal binding partners. Two 
major zinc pools are observed in the 100mM and 300mM salt fractions. Low 
molecular weight zinc fractions are visible throughout all salt fractions and thus are 
probably consistent of free zinc or zinc inclusions. There are no major detectable 
metal pools for iron. Contours displayed are most likely due to trace contamination. 
Contour plots of copper (blue) and zinc (black) in figure 3.4 (f) indicate the 
presence of the same copper and zinc binding entity in the 100mM salt fraction at 
11ml volume. No other metal pools of copper and zinc overlap, which places 
particular interest on the species that is responsible for binding both metals. 
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3.1.5 2D-LC analysis of SH-SY5Y APPswe
The SH-SY5Y APP
 whole cell soluble protein extract 
swe cell line was previously established by transfection of the 
mammalian transfection vector pcDNA3.1 into the SH-SY5Y APPWT cell line using 
lipofectamine 2000 as transfection reagent. The vector contained a copy of the 695 
amino acid residue version of APP with the familial Swedish mutation comprising 
an amino acid change of lysine and methionine at positions 595 and 596 to 
asparagine and leucine (see figure 1.1). Cells were treated as described before for 
APPWT cells and subjected to 2D-LC with subsequent metal analysis by ICP-MS. 
Results for copper (a), zinc (b), manganese (c), iron (d), and cobalt (e) are shown in 
figure 3.5. A smaller number of copper pools were detectable with the only major 
copper pool present in the 100mM salt fractions with a size exclusion volume of 
10.5ml. A metal pool located at the same position as this copper pool (figure 3.5 (f)) 
indicates the presence of a copper and zinc binding protein in APPswe cells. No 
other copper and zinc pools co-migrate so closely, thus further analysis of this metal 
pool and its binding partner is crucial. It appears that the copper pool in the cell line 
overexpressing the APPswe is smaller than the corresponding copper pool in the 
APPWT cell line. However, this needs to be investigated further since the APPWT 
and APPswe
3.2 Analysis of glutathione content of fractionated Saccharomyces cerevisiae 
extracts 
 metal profiles shown are not average representations of triplicate 
experiments, but replicates that best represent the metal distribution across the 
whole cell extracts.  
Figure 3.1 (f) shows overlaying copper and zinc pools in the 100mM salt fraction. 
To assess the potential of the copper pools for p1yeast being associated with 
glutathione, a cellular antioxidant of low molecular weight, a glutathione assay was 
been performed across all size exclusion fractions of the 100mM salt fraction. 
Figure 3.6 (a) shows a 2-dimensional contour plot representing the relative presence 
of glutathione and copper in the 100mM salt fraction. This result clearly 
demonstrates that the copper pool associated with the zinc pool is not associated 
with glutathione, thus there must be a different binding partner to both metals. 
Protein content across the same fractions that were subjected to the glutathione 
assay was measured in a BSA-calibrated Coomassie assay as described in section 
2.4.2.2 and plotted against copper and glutathione content of the same fractions. 
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Figure 3.6 (b) shows that a protein peak corresponding to the copper pool might be 
responsible for binding the metal. Determining the identity of the metal-binding 
protein is subject of the next section. 
Figure 3.4: 2D-LC representation of metal pools in SH-SY5Y APPWT
Soluble whole cell protein extract was prepared from 30x150cm
 soluble 
whole cell protein extract 
2 flasks of 80% 
confluent APPWT monolayer culture and extracted by freeze grinding and sequential 
centrifugation as described in sections 2.4.3.1. Subsequent to BSA-calibrated 
protein estimation the extract was subjected to 2D-LC (see sections 2.4.3.2 and 
2.4.3.3). First the sample was concentrated on a 1ml HiTrap Q HP anion exchange 
column. Fractions were eluted in extraction buffer (50mM Tris, pH 8.8, 1mM 
PMSF) containing increasing concentrations of NaCl (0mM, 100mM, 200mM, 
300mM, 400mM, 500mM, 1,000mM). Aliquots (0.2ml) of each anion exchange 
fractions was subjected to high performance liquid chromatography on a Tosoh 
TSK SW3000 size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 1mM 
PMSF at a flow rate of 0.5ml min-1. Samples were collected every minute for 30 
minutes and analysed for metals by inductively coupled plasma-mass spectrometry 
standardised to standard metal solutions as described in section 2.4.3.4. Results are 
shown for (a) copper (contours represent 0.03μM increments), (b) zinc (contours 
represent 0.03μM increments), (c) manganese (contours represent 0.02μM 
increments), (d) iron (contours represent 0.03μM increments), (e) cobalt (contours 
represent 0.002μM increments), and (f) copper (blue) and zinc (black) (contours 
represent 0.03μM increments). Fractions containing both copper and zinc pools are 
indicated by the red bar and will subsequently be referred to as p1APPWT
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Figure 3.5: 2D-LC representation of metal pools in SH-SY5Y APPswe
Soluble whole cell protein extract was prepared from 30x150cm
 soluble 
whole cell protein extract 
2 flasks of 80% 
confluent APPswe monolayer culture and extracted by freeze grinding and sequential 
centrifugation as described in sections 2.4.3.1. Subsequent to BSA-calibrated 
protein estimation the extract was subjected to 2D-LC (see sections 2.4.3.2 and 
2.4.3.3). First the sample was concentrated on a 1ml HiTrap Q HP anion exchange 
column. Fractions were eluted in extraction buffer (50mM Tris, pH 8.8, 1mM 
PMSF) containing increasing concentrations of NaCl (0mM, 100mM, 200mM, 
300mM, 400mM, 500mM, 1,000mM). Aliquots (0.2ml) of each anion exchange 
fractions was subjected to high performance liquid chromatography on a Tosoh 
TSK SW3000 size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 1mM 
PMSF at a flow rate of 0.5ml min-1. Samples were collected every minute for 30 
minutes and analysed for metals by inductively coupled plasma-mass spectrometry 
standardised to standard metal solutions as described in section 2.4.3.4. Results are 
shown for (a) copper (contours represent 0.03μM increments), (b) zinc (contours 
represent 0.03μM increments), (c) manganese (contours represent 0.02μM 
increments), (d) iron (contours represent 0.03μM increments), (e) cobalt (contours 
represent 0.002μM increments), and (f) copper (blue) and zinc (black) (contours 
represent 0.03μM increments). Fractions containing both copper and zinc are 
indicated by the red bar and will subsequently be referred to as p1APPswe
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3.3 2D-LC analysis of rat liver mitochondria soluble protein extracts 
To verify the reproducibility of the two dimensional separation for rat liver 
mitochondria protein extracts and later for SH-SY5Y APPWT and APPswe
3.3.1 2D-LC analysis of rat liver mitochondria soluble protein extract 
 cell lines 
(see section 3.5), the experiment was repeated multiple times (n=7). The analyses 
were performed as described for the rat liver mitochondrial protein extract in section 
3.1.2. The resulting contour plots were reproducible with regards to metal 
distribution as shown in figure 3.2 and figure 3.7, however the total metal measured 
differed from experiment to experiment. This might be due to metal loss during the 
experiments at various purification or separation steps, partial sample exposure to 
air with resulting loss of metal from oxidised metal binding sites or simply due to 
variation in the metal detection during mass spectrometry. The ICP-MS was 
calibrated before each experiment. To avoid large errors of standard deviation 
between replicates due to variation in metal detection during metal analysis, the 
replicate most representative of the remaining replicates is displayed. 
A previous replicate of rat liver mitochondrial extract analysed for metal content 
following 2D-LC as seen in figure 3.2 (f) highlights overlaying metal pools of 
copper and zinc in the 100mM anion exchange fraction termed p1RLM. These metal 
pools are reproducible and shown in figure 3.7 (a) for copper and figure 3.7 (b) for 
zinc and comprise of 0.38μM copper and 0.32μM zinc, respectively, in the fraction 
containing the most metal. The metal concentrations thus indicate a possible binding 
stoichiometry of 1:1 copper:zinc, an observation that might aid further identification 
of the putative binding partner for both metals. To assess which protein is 
responsible for the copper and zinc metal pools, fractions across the metal pools 
were resolved on a SDS-PAGE gel, stained with SYPRO Ruby and analysed for 
densitometry of each individual band using BioRad Quantity One software. The 
SDS-PAGE gel is displayed in figure 3.7 (c) with chromatographic representation of 
copper, zinc and protein content across the fractions of interest in figure 3.7 (d). 
 105 
 
 
 
Figure 3.6: Copper and glutathione content in Saccharomyces cerevisiae whole 
cell protein extract 
a) Whole cell protein extract was prepared from a 1L culture grown to an OD600nm 
of 0.4 as described in section 2.4.3.1. The extract was concentrated on a 1ml HiTrap 
Q HP anion exchange column and eluted with increasing concentrations of NaCl 
(100, 200, 300, 400, 500, 1000mM) in 1ml aliquots. Aliquots (0.2ml) of each salt 
fraction was resolved on a Tosoh TSK SW3000 size exclusion chromatography 
column at a flow rate of 0.5ml min-1
b) Aliquots of anion exchange fractions (100mM NaCl) displaying glutathione 
content were subjected to size exclusion chromatography on a Tosoh TSK SW3000 
HPLC column eluted in 10mM Tris pH 7.5, 50mM NaCl, 1mM PMSF at 0.5ml  
min
 and eluted every minute for 30 minutes in 
buffer containing 10mM Tris pH 7.5, 50mM NaCl, 1mM PMSF. Samples were 
analysed for copper content by ICP-MS (blue contours) and for glutathione content 
(orange contours).The 3-D contour plot of whole cell glutathione and copper 
distribution shows that there is a copper pool in the 100mM salt fraction that is not 
glutathione bound. 
-1
 
 with fractions being collected every minute for 30 minutes. Fractions were 
analysed for copper (filled circles), glutathione (open triangles) and protein content 
(open squares) by BSA-calibrated Coomassie assay. 
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3.3.2 Identification of p1RLM
Densitometric data obtained through analysis of bands across copper and zinc 
containing fractions on SDS-PAGE gels (figure 3.7) was applied to Principal 
Component Analysis (PCA), a mathematical tool that combines and correlates metal 
data obtained via ICP-MS analysis and protein data. The statistical analysis is 
explained in section 2.4.10.2. Figure 3.8 shows the correlation analysis (a) for 
proteins (grey) with copper and zinc. Protein p1
 as copper-zinc superoxide dismutase from rat 
mitochondrial extract 
RLM SDS-PAGE correlated best with the 
distribution and intensity of copper and zinc across the analysed fractions, an 
observation, which is confirmed in panels (b), (c), and (d). Comparison of various 
Principal Components generates clustering of p1RLM SDS-PAGE with copper and zinc 
indicating p1RLM SDS-PAGE
The protein band identified as putative metal binding protein was excised from the 
SDS-PAGE gel and analysed by peptide mass fingerprinting. Following zip-tip 
purification the sample was restricted by trypsin and analysed by matrix-assisted 
laser desorption ionisation – time of flight – mass spectrometry (MALDI-TOF-MS). 
The resulting chromatograph of peptide sizes and sequences were compared to the 
MASCOT database resulting in the identification of the metal binding protein  
p1
 as putative binding partner.  
RLM SDS-PAGE as copper – zinc binding superoxide dismutase (hereafter referred to 
as pSOD1RLM). This analysis was performed by The Pinnacle Proteomics and 
Molecular Biology unit, Newcastle University. Figure 3.9 (a) shows the Mowse 
Score analysis which indicates the statistical significance (p<0.05) for any protein 
with a score above 56 as a random event. The chromatograph in figure 3.9 (b) 
reveals several experimental peptide fragments (highlighted in red boxes) that 
match expected MASCOT fragments for rat copper – zinc superoxide dismutase. 
These data strongly suggest that copper – zinc superoxide dismutase is responsible 
for the copper and zinc pool observed in the 100mM anion exchange fraction. The 
protein band corresponding to superoxide dismutase is shown in figure 3.7 (c) 
designated pSOD1RLM with a molecular weight of 20,000Da. An independent 
protein identification (data not shown) using a different extract of rat liver 
mitochondria similarly identified copper – zinc SOD as the prevalent copper and 
zinc pool in the rat liver mitochondrial extract. 
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Figure 3.7: 2D-LC representation of metal pools in rat liver mitochondrial 
extract 
Rat liver mitochondria were extracted from rat liver by differential centrifugation as 
described in section 2.4.8.2. Mitochondria were lysed by freeze grinding in 
extraction buffer (50mM Tris, pH 8.8, 1mM PMSF) and intact organelles removed 
by sequential centrifugation. The protein extract was concentrated on a 1ml HiTrap 
Q HP anion exchange column and eluted in extraction buffer containing increasing 
concentrations of NaCl (0mM, 100mM, 200mM, 300mM, 400mM, 500mM and 
1,000mM). Aliquots (0.2ml) of each anion exchange fraction were subjected to size 
exclusion chromatography on a Tosoh TSK SW3000 column and analysed for metal 
content by inductively coupled plasma-mass spectrometry (ICP-MS). Shown are 3-
dimensional plots for copper (a) and zinc (b) distribution with emphasis on a 
particular copper and zinc peak present in the same fractions (p1) and the presence 
of a putative non-proteinaceous copper binding complex (pCuL) previously 
identified by Cobine et. al. (Cobine et al., 2004). Bars on panels (a) and (b) depict 
samples of eluant that were further analysed by SDS-PAGE in figure 3.7 c) or by 
fluorescent spectroscopy in figure 3.11 b). 
Fractions containing the copper and zinc metal pools (p1RLM) were resolved on a 
15% (w/v) discontinuous SDS-PAGE gel and protein visualised with Sypro Ruby 
(c). Densitometric analysis of protein bands using BioRad quantity one software 
indicates pSOD1RLM as possible binding partner to copper and zinc. Corresponding 
chromatographs (d) of copper (solid line), zinc (long dashed line), and relative 
abundance of protein (short dashed line) across the resolved fractions implies a 
metal binding role for pSOD1RLM
 
. 
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Figure 3.8: Principal component analysis to predict protein binding to copper 
and zinc in rat mitochondrial protein extract 
Aliquots (130μl) of 100mM NaCl size exclusion fractions containing copper and 
zinc (figure 3.7) were resolved on a discontinuous 15% (w/v) SDS-PAGE gel 
(figure 3.7) and analysed for protein distribution in each fraction using BioRad 
quantity one software. Data for copper, zinc and protein chromatographs was used 
to calculate the principal components (see section 2.4.10.2) for this data set. 
Correlation analysis (a) indicates that p1RLM is the closest match to copper and zinc 
with regards to distribution across the resolved fractions and comparison of various 
principal components (b, c and d) shows spatial clustering of copper, zinc and 
p1RLM suggesting a strong indication of p1RLM
 
 being a copper and zinc binding 
protein. 
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Figure 3.9: Identification of a putative copper and zinc binding protein by 
matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry 
(MALDI-TOF-MS) 
Rat liver mitochondria were subjected to 2D-LC as previously described, analysed 
for metal content (figure 3.7) by inductively coupled plasma-mass spectrometry 
(ICP-MS) and resolved on SDS-PAGE for densitometric analysis (figure 3.7). 
Principal component analysis identified p1RLM
 
 as best protein candidate for the 
copper and zinc peaks (figure 3.8), thus the band was excised and analysed by 
MALDI-TOF-MS. The protein analysis involved trypsinisation of the sample for 
peptide mass fingerprinting and comparison of the generated mass-to-charge 
chromatograph to the Mascot database. Mowse Score analysis indicates statistical 
significance (p<0.05) for any protein identified with a score above 56 (a). The 
chromatograph (b) shows fragments that were generated and compared against the 
Mascot database, which revealed that several fragments (red boxes) match expected 
fragments for rat copper/zinc superoxide dismutase. 
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3.4 Purification and partial characterisation of a low molecular weight copper 
complex in rat liver mitochondria 
A second large copper pool was detected in the low molecular weight region of the 
rat liver mitochondrial extract 100mM anion exchange fraction. Previously Cobine 
et. al. discovered a small non-proteinaceous mitochondrial matrix copper complex 
(CuL) in yeast (Cobine et al., 2004) thought to be involved in the metallation of 
cytochrome oxidase and superoxide dismutase (Cobine et al., 2006). Although both 
extraction protocols vary greatly - Cobine et. al. extracted the copper complex using 
anion exchange and reverse phase purification in an acetoniltrile gradient (Cobine et 
al., 2006) - the copper pool observed in rat liver mitochondrial extracts may 
constitute this CuL complex. Figure 3.7 illustrates the intensity and location of the 
copper pool designated pCuL.  
3.4.1 Protein analysis of the low molecular weight copper-binding complex 
To further investigate the existence of the CuL complex in rat liver mitochondria, 
fractions containing the low molecular weight copper pool were resolved 
anaerobically on a Sephadex G-25 size exclusion column to potentially resolve 
binding of metal to protein versus non-protein metal complexes. The column was 
prepared for metal analysis by washing with second dimension elution buffer 
containing 10mM Tris, pH 7.5, 50mM NaCl, 1mM PMSF before residual metal was 
removed through washes in buffer containing 10mM Tris, pH 7.5, 1M NaCl and 
10mM EDTA. Subsequently the column was washed with three column volumes of 
elution buffer and sample fractions containing the CuL complex applied. Fractions 
were eluted with second dimension elution buffer in 0.5ml aliquots and analysed for 
protein content by BSA-calibrated Coomassie assay and metal content by ICP-MS. 
Chromatographs shown in figure 3.10 (a) indicate that protein (filled squares) and 
copper (open triangles) do not co-migrate, thus, in accordance with the findings of 
Cobine et. al. (Cobine et al., 2004), the entity responsible for the low molecular 
copper pool (CuL) is not of proteinaceous nature. Metal analyses for manganese and 
zinc across the copper containing fractions (shown in figure 3.10 b), reveal that both 
metals are also not protein-bound. However, they do co-migrate with copper, which 
is an indication for three possible conclusions: 
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Figure 3.10: Protein analysis of the pCuL copper pool in rat liver mitochondria 
Rat liver mitochondria were lysed by freeze grinding, analysed for protein content 
by BSA-calibrated Coomassie assay, subjected to 2D-LC as previously described 
and analysed for metal content (figure 3.7) by inductively coupled plasma-mass 
spectrometry (ICP-MS). The large low molecular weight copper pool designated 
pCuL (figure 3.7 a) was analysed for protein content and co-migration of protein 
with copper by chromatographic separation on a sepharose PD-10 size exclusion 
column with subsequent analysis for metals  and protein by ICP-MS and BSA-
calibrated Coomassie assay, respectively. Chromatographic separation (a) of copper 
(open triangles) and protein (filled squares) indicates that copper constituting the 
low molecular copper peak is not protein-bound. Analysis of metals other than 
copper (b) shows that neither zinc (open squares), nor manganese (filled circles) 
binds to protein. 
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Firstly, it is possible that during the experimental procedure copper, zinc and 
manganese were released from their protein binding sites with consequent binding 
to EDTA resulting in a low molecular metal – chelate complex. Secondly, the 
possibility exists that the CuL complex not only binds copper, but can also 
accommodate other metal ions. This would, however, pose the problem of providing 
binding sites to metals with different affinities to different metal sites, different 
conformations and different valencies. The third conclusion is that the CuL complex 
binds only copper with the elution of a manganese – EDTA - complex and a zinc - 
EDTA – complex at the same volume being coincidental and involving different co-
migrating complexes. Besides EDTA, other organic or inorganic compounds may 
contribute to binding of free metal ions. Culotta et. al. (2005) report that in the yeast 
vacuole toxic levels of manganese are possibly chelated by phosphate groups. Thus, 
although copper might be bound to the CuL complex, zinc and manganese might be 
complexed to other low molecular weight compounds. 
3.4.2 Analysis of metal binding to the copper - ligand 
Cobine et. al. (Cobine et al., 2004) report fluorescence emission of yeast fractions 
containing the low molecular weight copper pool at 360nm upon sample excitation 
at 220nm. The rat liver mitochondrial fractions containing low molecular weight 
copper were pooled and anaerobically transferred to an acid washed Quartz cuvette 
fitted with a double septum anaerobic seal. Fluorescence spectra were taken on a 
Cary Eclipse Fluorescence Spectrometer between wavelengths 200nm-800nm. 
Sample measurements were controlled for by using second dimension elution buffer 
as blank. Figure 3.12 (a) shows sample fluorescence at 360nm (see inset for more 
detail) when corrected against the blank. 
The metallation status (the extent of metal – saturation) of the CuL complex is 
unknown. It is anticipated that the low molecular weight copper pool is composed 
of apo- and holo – ligand and binds Cu(I) rather than Cu(II) as result of the reducing 
environment present in the cell. PCuL was titrated with Cu(I) using a gas – tight 
Hamilton syringe fitted with an automated dispenser. Refer to section 2.4.9.1 for 
Cu(I) stock preparation from cuprous chloride. Due to rapid disproportionation of 
Cu(I) to Cu(II) stocks were prepared under anaerobic conditions and all solutions 
purged with nitrogen before the experiment. Scans were taken after each titration, 
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graphs of which are shown in figure 3.12 (a). As expected, at 360nm spectra 
decreased in fluorescence with increasing concentrations of Cu(I). Spectral 
quenching was also observed by Cobine et. al. (Cobine et al., 2004) and indicates 
that this copper binding ligand might be the same species that was previously 
detected in yeast and also that it is not fully metallated. Whether this is the 
physiological status quo or the result of experimental displacement of metal from 
the ligand cannot be determined at this point. However, only small changes in 
fluorescence intensity were detectable, suggesting that the majority of the CuL 
might be metallated. 
3.4.2.1 Cu(I) competition with BCS 
To investigate the cause of the spectral feature at 400nm a second dimension elution 
buffer sample (previously representing the blank) was subjected to anaerobic 
titration with BCS in 2μM increments. The results are shown in figure 3.11 (a). As 
expected, increasing concentrations of BCS cause the increase in fluorescence 
intensity. It should be noted that the BCS spectra are at their maximum intensity at a 
wavelength of 420nm. The spectral feature observed at 400nm in the sample 
containing biological CuL extract, Cu(I) and BCS suggests that the shift of the 
420nm BCS spectrum to the lower wavelength is possibly due to BCS interaction 
with Cu(I), rather than the CuL sample. To investigate the possibility of Cu(I) and 
BCS interacting without the involvement of the CuL complex, a titration of 
equimolar concentrations of BCS:Cu(I) in a stoichiometry of 2:1 was performed to 
an aliquot of second dimension elution buffer. These concentrations were chosen on 
the basis that BCS binds monovalent copper in a ratio of 2 molecules to 1 atom. 
Titrations were made simultaneously and spectra taken after thorough mixing by 
inversion. Spectra are shown in figure 3.11 (b). Data clearly suggest that the spectral 
feature observed at a wavelength of 400nm is an effect of a BCS - Cu(I) complex as 
opposed to solely BCS, indicating that free Cu(I) is neutralised by BCS prior to 
incorporation into the apo-ligand. Even at high μM concentrations of BCS the signal 
at 400nm would overcome the signal released from the CuL complex and thus 
render it undetectable. No further analysis was performed on this copper-binding 
ligand. 
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Figure 3.11: Characterisation of putative BCS-related spectral features 
Rat liver mitochondrial fractions containing low molecular copper were subjected to 
fluorescence spectroscopy and CuL complex-like features were observed at 360nm 
(figure 3.12). To investigate the fluorescence shift from 360nm to 400nm as a BCS-
related spectral feature, increasing concentrations of BCS were titrated to sample 
buffer without sample present (a). Absorbance at 420nm is detected when excited at 
220nm indicating that the shift in absorbance is caused by BCS titrations. Copper 
titrations coupled with BCS titrations to sample buffer without sample present (b) at 
a stoichiometry of 1:2 shifts the absorbance to 400nm, but does not abolish any 
features emitted by BCS, but does quench the absorbance intensity slightly. 
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Figure 3.12: Copper binding properties of the putative low molecular copper 
compound pCuL 
Rat liver mitochondrial protein extract was subjected to 2D-LC with subsequent 
analysis for copper content by ICP-MS (figure 3.7). Size exclusion fractions 
containing low molecular weight copper, but not protein, in the 100mM NaCl anion 
exchange fraction were pooled and fluorescence spectra obtained between 
wavelengths λ200nm-800nm
 
. The copper binding complex emits at 360nm when excited 
at 220nm (a). Addition of Cu(I) under anaerobic conditions quenches the spectral 
features (see inset for clearer representation) as previously observed by Cobine et. 
al. (Cobine et al., 2004). The same fractions of a duplicate mitochondrial protein 
extract were pooled and Cu(I) and BCS were titrated to the sample (b) resulting in a 
spectral shift from 360nm to 400nm. With increasing Cu(I) titrations slight 
quenching is visible until BCS concentrations exceed those of Cu(I).  
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3.4.2.2 Copper depletion of low molecular weight copper complex using the 
monovalent copper specific chelator BCS 
To determine whether minor changes in fluorescence quenching at 360nm are a 
result of a high metallation status of the copper-binding ligand or rather due to the 
low abundance of CuL in the sample, the Cu(I) specific chelator BCS was titrated to 
a fresh sample of pooled CuL. As previously the sample was first titrated with 
increasing concentrations of Cu(I) as shown in figure 3.12 (b) at 360nm. However, 
when titrated with increasing concentrations of Cu(I) the sample shows hardly any 
quenching in fluorescence intensity. This leads to the conclusion that the ligand 
might be fully saturated with copper. To counteract saturation, μM concentrations of 
BCS were titrated to the sample. Contrary to the expected increase in fluorescence 
absorbance with increasing concentrations of BCS, the spectra remained unchanged 
at 360nm. However, a significant spectral feature appeared at 400nm which 
increased in fluorescence intensity upon continued titration with BCS. The 
appearance of this feature interfered with signal detection at 360nm rendering 
further analysis of the CuL copper status impossible.  
3.5 Low resolution 2D-LC analysis of metal distribution in SH-SY5Y APPWT 
and APPswe
It was reported by Arciello et. al. (Arciello et al., 2005), that SH-SY5Y cells cultured 
in increasing concentrations of CuSO
 whole cell extracts 
4
Previous analysis of rat liver mitochondrial soluble protein fraction by 2D-LC 
detected at least the predominant metal pools for copper, zinc, iron and manganese 
(see figure 3.2). Although, apart from the higher molecular weight copper 
association to SOD1, none of these metal pools could be attributed to a specific 
binding partner, the data clearly indicate the possibility of protein identification 
from mitochondrial fractions rather than whole cell extracts. Subsequent efforts 
were concentrated on mitochondrial soluble protein two dimensional separation of 
SH-SY5Y extracts of APP
 exhibit phenotypes of copper toxicity. 
Effects of high cellular copper concentrations included functional impairment and 
decreased protein levels of several mitochondrial dehydrogenases. It was 
hypothesised that toxic levels of copper mediate oxidative stress and trigger 
mitochondrial damage, which could possibly lead to neurodegenerative diseases 
(Arciello et al., 2005). 
WT and APPswe cell lines to investigate changes in metal 
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distribution and/or binding to proteins as a result of normal cellular copper status 
(APPWT cell line) and depleted cellular copper status (APPswe
3.5.1 2D-LC metal analysis of SH-SY5Y APP
 cell line). 
WT
Mitochondrial fractionation was performed on 30x150cm
 mitochondrial soluble protein 
fraction 
2 flasks of 80% confluent 
monolayer cultures of the SH-SY5Y APPWT
When compared to the metal analysis for the whole cell soluble protein extract 
shown in figure 3.4, it becomes apparent, that most of the higher molecular weight 
metal pools disappeared, while the low molecular weight metal pools remain nearly 
unchanged (figure 3.14). This can be best observed for copper with the 
disappearance of the metal pools previously present in the 100mM and 200mM 
anion exchange fractions and for zinc in the 100mM, 300mM and 400mM anion 
exchange fractions. It must be noted, however, that the previously observed trace 
contamination in the iron analysis has diminished and instead a very abundant iron 
pool can be detected in the 200mM anion exchange fraction. 
 cell line as described in section 2.4.8.2. 
Small changes to the cell lysis method were applied to compensate for the small 
volume of cells compared with rat liver mitochondrial extracts. Pellets were 
resuspended in 5ml MSE buffer supplemented with 1% (w/v) BSA and lysed by 30 
strokes in a glass Elvejhem homogeniser. The homogenate was differentially 
centrifuged as described before for rat liver mitochondrial extracts in section 
2.4.8.2. Pelleted mitochondria were resuspended in MSE buffer without BSA before 
centrifugation and final aspiration. Mitochondrial extracts were subjected to 2D-LC 
under anaerobic conditions as described previously in sections 2.4.3.2 and 2.4.3. 
Subsequent multi-elemental analysis by ICP-MS is shown in figure 3.14. displayed 
as 2-dimensional contour plots for copper (a), zinc (b), manganese (c), iron (d), and 
cobalt (e). 
The most remarkable change in metal distribution between APPWT whole cell and 
APPWT mitochondrial soluble protein extracts is the elimination of the co-migrating 
copper and zinc pools in the 100mM exchange fraction which was previously 
identified as SOD1 from rat liver mitochondrial extracts. This change in copper and 
zinc pools might be attributed to localisation differences of SOD1 to the 
mitochondria in rat liver or the cytoplasm in SH-SY5Y cells due species variation. 
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Figure 3.13: Comparison of metal elution upon loading of different protein 
concentrations on an anion exchange column performed on rat liver 
mitochondrial protein extracts 
Rat liver mitochondria were extracted as described in section 2.4.8.2. Aliquots 
containing 4mg (open squares) and 40mg (filled circles) of mitochondrial protein 
extract were loaded onto HiTrap Q HP anion exchange columns at 0.3ml min-1 and 
eluted in 1ml of 50mM Tris, pH 8.8, 1mM PMSF buffer containing 100mM NaCl. 
Aliquots (0.2ml) of each eluant were resolved by size exclusion chromatography on 
a Tosoh TSK SW3000 HPLC column and eluted in 10mM Tris pH 7.5, 50mM 
NaCl, 1mM PMSF at 0.5ml min-1
 
. Fractions were collected every minute for 30 
minutes and analysed for copper by ICP-MS. 
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Figure 3.14: 2D-LC fractionation of metal pools in SH-SY5Y APPWT
Soluble mitochondrial protein extract was prepared from 30x150cm
 soluble 
mitochondrial protein extract 
2 flasks of 80% 
confluent APPWT monolayer culture using an adjusted extraction method described 
in section 2.4.8.2. The soluble protein fraction was extracted by freeze grinding and 
sequential centrifugation as described in sections 2.4.3.1 and after BSA-calibrated 
protein estimation subjected to 2D-LC (see sections 2.4.3.2 and 2.4.3.3). First the 
sample was concentrated on a 1ml HiTrap Q HP anion exchange column. Fractions 
were eluted in extraction buffer (50mM Tris, pH 8.8, 1mM PMSF) containing 
increasing concentrations of NaCl (0mM, 100mM, 200mM, 300mM, 400mM, 
500mM, 1,000mM). Aliquots (0.2ml) of each anion exchange fractions was 
subjected to high performance liquid chromatography on a Tosoh TSK SW3000 
size exclusion column in 10mM Tris, pH 7.5, 50mM NaCl, 1mM PMSF at a flow 
rate of 0.5ml min-1
 
. Samples were collected every minute for 30 minutes and 
analysed for metals by inductively coupled plasma-mass spectrometry standardised 
to standard metal solutions as described in section 2.4.3.4. Results are shown for (a) 
copper (contours represent 0.03μM increments), (b) zinc (contours represent 
0.03μM increments), (c) manganese (contours represent 0.02μM increments), (d) 
iron (contours represent 0.03μM increments), (e) cobalt (contours represent 
0.002μM increments), and (f) copper (blue) and zinc (black) (contours represent 
0.03μM increments). 
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However, it is very likely to be an artefact of experimental variation between the 
two dimensional separations. It has to be noted that 70mg of rat liver mitochondrial 
and whole cell SH-SY5Y soluble protein were concentrated onto the first dimension 
anion exchange column, whereas the accessible soluble protein content of SH-SY5Y 
mitochondria was merely 4mg. The relevance of the amount of protein subjected to 
the 2D-LC procedure is measured by comparing metal analyses of a protein 
separation using 4mg and 40mg of the exact same rat liver mitochondrial extract. 
Figure 3.13 shows the results of copper analysis of the size exclusion fractions 
obtained from the 100mM anion exchange fraction. The metal pool for SOD1 
previously resolved at a volume of 10ml, which coincides with a 0.1μM copper 
peak at 10ml for the 40mg protein separation (filled circles) and 10.5ml for the 4mg 
protein separation (open squares). Discrepancies in co-localisation of both copper 
peaks are a result of the second dimension chromatography. Although, the 
abundance of copper is nearly identical in the fractions containing SOD1 for both 
extracts, later experiments were performed with whole cell soluble protein extracts 
for SH-SY5Y cell lines to guarantee meaningful metal analysis across all anion 
exchange fractions. 
Comparison of zinc and copper abundance in the individual metal pools identified 
to bind SOD1 and shown in figure 3.2 and figure 3.4 indicates that upon resolution 
of the same amount of protein on the first dimension column the abundances of 
copper and zinc between the two species vary by more than two-fold. The 
abundance of metal in the putative SH-SY5Y SOD1 pool is higher than those in rat 
liver mitochondria for both metals. 
3.5.2 2D-LC metal analysis of SH-SY5Y APPWT and APPswe
Previous studies (Treiber et al., 2004) imply that APP might be involved in cellular 
copper homeostasis by supporting copper efflux from the cell. However, the role of 
APP in copper transport and direction of transport or in fact its influence on efflux 
or influx due to it binding copper in the extracellular domain is still unknown and 
further studies are necessary to assess APP-dependent cellular copper status. To 
assess the role of APP in copper homeostasis SH-SY5Y APP
 soluble whole cell 
protein 
WT and APPswe cell 
lines were compared to detect any changes in copper abundance in whole cell 
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extracts that were subjected to 2D-LC and possible changes in copper distribution 
due to increased or decreased copper availability to protein species. It is noted that 
the APPWT cell line has endogenous APP levels, whereas the APPswe cell line 
overexpresses the Swedish mutation in the APPWT cell line. Thus any contribution 
of APP to, for example, copper efflux could be altered in the APPswe
APP
 cells due to 
enhanced production of Aβ due to increased cleavage and APP expression (Citron et 
al., 1992). 
WT and APPswe cell lines were subjected to 2D-LC in triplicate experiments. 
Both cell lines were grown simultaneously and growth conditions monitored to 
enable direct comparison between extracts. Due to the large number of cells used 
for the extraction process (30x150cm2 flasks per extract) cell culture medium from 
different bottles, but the same production batch were used. Supplementation was 
performed with standard volumes of foetal calf serum, antibiotics and glutamate. 
However, the possibility of slight substrate variation from bottle to bottle remains. 
Cultures were harvested and washed several times in D-PBS to remove residual 
metals from the cell surface. Cell lysis was performed and protein extracts prepared 
as described in section 2.4.3.1. Following BSA-calibrated protein content analysis 
of each extract, 70mg of protein were resolved on a HiTrap Q HP anion exchange 
column under anaerobic conditions and eluted in buffer containing 50mM Tris, pH 
8.8, 1mM PMSF and increasing concentrations of NaCl. The effectiveness of first 
dimension separation of protein is portrayed in figure 3.15, showing different 
amounts of protein being eluted in different salt concentrations. An aliquot (0.2ml) 
of each anion exchange eluant was transferred to a high pressure liquid 
chromatography column further separating proteins on the basis of their molecular 
weight with high molecular weight species being eluted after the column void 
volume and low molecular weight species before total column volume. Samples 
were eluted in 10mM Tris, pH 7.5, 50mM NaCl and 1mM PMSF for 30 minutes at 
a flow rate of 0.5ml min-1. Samples were analysed for copper and zinc by ICP-MS. 
Metal content of fractions post gel filtration chromatography of anion exchange 
fractions is shown in figure 3.16; only the most representative replicate for each cell 
line is shown. Copper and zinc pools are observed in the 100mM anion exchange 
fractions in APPWT and APPswe cell lines which have similar chromatographic 
properties to SOD1 in rat liver mitochondria, volume 9-12ml (see figure 3.7). 
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Figure 3.15: Protein content of SH-SY5Y APPWT
Whole cell extracts of SH-SY5Y APP
 whole cell extract after first 
dimension liquid chromatography 
WT (30x150cm2 flasks of 80% confluent 
monolayer culture) were prepared for 2D-LC as described in section 2.3.4.1 and 
concentrated on a 1ml HiTrap Q HP anion exchange column. Samples were eluted 
with 1ml buffer (50mM Tris, pH 8.8, 1mM PMSF) containing increasing 
concentrations of NaCl (0mM, 100mM, 200mM, 300mM, 400mM, 500mM, 
1,000mM). Protein content of each sample (a) was determined by BSA-calibrated 
Coomassie assay. Error bars represent standard deviation from triplicate 
measurements. Aliquots (50μl) of the anion exchange samples were resolved on a 
15% (w/v) SDS-PAGE gel (b) and stained with Sypro Ruby. Individual pools of 
protein are detectable in the various salt concentrations suggesting that anion 
exchange is representative for a first dimensional separation step. 
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Figure 3.16: Comparison of copper and zinc pools in whole cell extracts of SH-
SY5Y APPWT and APP
Whole cell protein extracts were prepared from 30x150cm
swe 
2 flasks of 80% confluent 
monolayer cultures as described in section 2.4.3.1. After BSA-calibrated protein 
estimation of each extract equal amount of protein were concentrated on a 1ml 
HiTrap Q HP anion exchange column and eluted with 1ml buffer (50mM Tris, pH 
8.8, 1mM PMSF) containing increasing concentrations of NaCl (100, 200, 300, 400, 
500 and 1,000mM). Aliquots (0.2ml) of each salt fraction were resolved on a Tosoh 
TSK SW3000 high performance size exclusion chromatography column at 0.5ml 
min-1. Samples were collected every minute for 30 minutes and analysed for copper 
and zinc content by inductively coupled plasma-mass spectrometry (ICP-MS). 2D-
LC was performed in independent triplicate for both APPWT and APPswe and the 
most representative replicate shown. Whole cell metal pools are visualised on 3-
dimensional plots representing the relative metal content for (a) APPWT copper, (b) 
APPswe copper, (c) APPWT zinc and (d) APPswe zinc. All plots are on the same scale 
(z-axis showing metal concentration) for one particular metal to allow for direct 
comparison. pSOD1SY5Y is presumed to be SOD1. Bars on panels (a) and (b) depict 
sample eluants that were further analysed by SDS-PAGE in figure 3.17. Metal 
content analysis indicates that there is less copper and zinc in the putative SOD1 
peak in the SH-SY5Y APPswe
e) Copper and zinc peaks represented in a) and c) and presumed to contribute to 
SOD1 activity were compared for metal concentration. Total metal content for zinc 
and copper was determined by integration of all values under the peak labelled 
pSOD1
 cell line. 
SY5Y. SH-SY5Y APPWT (black) and SH-SY5Y APPswe
f) Aliquots (100μl) of 100mM NaCl anion exchange eluant were resolved on a 15% 
(w/v) SDS-PAGE gel and stained with Sypro Ruby. Anion exchange 
chromatography was performed with the same amount of protein (70mg) for both 
cell lines. An equal amount of pure SOD1 was loaded as control. 
 (grey) are shown. Error 
bars represent standard deviations from triplicate measurements of three 
independent whole cell protein extracts. 
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This metal pool, designated pSOD1SY5Y was further analysed to identify the binding 
partner for both metals. Metal concentrations are displayed on the same scale to 
allow for direct comparison for each individual metal. Phenotypic differences in 
metal content in the pSOD1SY5Y peak for copper and zinc are detectable. The 
APPswe cell line contains half the amount of copper compared to the APPWT cell 
line and roughly a third less zinc in this particular replicate. Figure 3.16 (e) shows 
data for metal analysis of both cell lines across the pSOD1SY5Y peak produced by 
integrating the concentrations of copper and zinc for all three replicates and 
calculating the average. Results indicate that the protein species responsible for the 
pSOD1SY5Y peak is less metallated with copper (50%) and zinc (30%) in the APPswe 
cell line. Copper – zinc superoxide dismutase aquires a zinc ion before accepting 
copper metallation by its metallochaperone CCS (Field et al., 2003), thus in 
accordance with the data the reduced copper status in APPswe cells follows a 
reduced level of metallation with zinc. To further test the possibility of differences 
in metallation, an aliquot (100μl) of 100mM anion exchange fraction of APPWT and 
APPswe
3.5.3 Identification of SOD1 in SH-SY5Y APP
 was resolved on an SDS-PAGE gel. Bands co-migrating with the control of 
pure SOD1 at a molecular weight of 20kDa show the same intensity after staining 
with SYPRO Ruby, indicating that following initial protein estimation of whole cell 
soluble extracts the same amount of protein was subjected to resolution on anion 
exchange column. However, the identity of the ligand binding copper and zinc in 
fractions across 9-12ml of size exclusion elution remains to be established.  
To identify the protein species binding copper and zinc in the pSOD1
WT 
SY5Y peak, 
fractions spanning these metal pools were resolved on SDS-PAGE and band 
intensity determined by densitometric analysis using BioRad Quantity One 
software. The SDS-PAGE gel for samples being subjected to one size exclusion 
column is shown in figure 3.17 (a). The corresponding chromatograph (figure 3.17 
b) suggests that the relative intensity of one particular protein species correlates 
with the distribution of copper and zinc across the analysed fractions. Principal 
Component Analysis reveals pSOD1SY5Y as potential copper and zinc ligand, which 
is indicated by clustering of the protein with copper and zinc (figure 3.18 a and b). 
To increase sample resolution in the second dimension size exclusion 
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chromatography was repeated with two size exclusion columns fitted in sequence 
generating a larger number of eluted fractions. However, sequential resolution on 
two size exclusion column decreases copper, zinc and protein concentrations in each 
individual sample. This might cause protein levels to fall below the detection limit 
of the SYPRO Ruby gel stain on subsequent SDS-PAGE. Samples subjected to 
resolution on two size exclusion columns fitted in sequence were analysed for 
copper and zinc by ICP-MS and SDS-PAGE gel for protein. The gel and 
chromatograph are shown in figure 3.17 (c) and (d) and again indicate one protein 
species correlating with the metal peaks. Principal Component Analysis identifies 
one protein as best candidate to match the distribution and intensity of copper and 
zinc across the analysed fractions. The relevant protein band was excised and 
analysed by MALDI - TOF - MS as was previously done with the band identified as 
best candidate to bind copper and zinc in rat liver mitochondria. However, after 
several attempts no identification could be achieved due to low abundance of the 
protein. Comparing the rat liver mitochondrial SDS-PAGE gel (figure 3.7) showing 
a protein band which was clearly identified as SOD1 at a molecular weight of 
20kDa with the gels generated from APPWT samples that were resolved on single - 
and double size exclusion columns, it is highly likely that the copper and zinc pools 
in APPWT are also generated by SOD1. Both protein species migrate at the same 
molecular weight, both co-migrate with copper and zinc and there is the indication 
of diminished metallation in the same metal pools in APPswe
 
 cells. 
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Figure 3.17: SDS-PAGE analysis of SH-SY5Y APPWT
Whole cell protein extracts were subjected to 2D-LC and analysed for metals by 
ICP-MS (figure 3.16). Aliquots (130μl) of 100mM NaCl size exclusion fractions 
containing copper and zinc (figure 3.16) were resolved on a discontinuous 15% 
(w/v) SDS-PAGE gel (a and c) and analysed for protein distribution in each fraction 
using BioRad quantity one software. Due to high gel complexity size exclusion of 
the 100mM NaCl anion exchange fraction was performed using one HPLC Tosoh 
TSK SW3000 size exclusion column (a) and two SW3000 columns (c) in sequence 
to allow for better protein resolution. The corresponding chromatographs of copper 
(solid line), zinc (long dashed line) and relative protein density (short dashed line) 
obtained from densitometric analysis of protein staining are shown for single 
column size exclusion (b) and sequential column size exclusion (d). The protein 
referred to as pSOD1 was identified from the SDS-PAGE gel as best possible match 
for the copper and zinc pools obtained through ICP-MS by using PCA to correlate 
the distribution and concentration of zinc and copper to the proteins resolved on the 
gel. 
 2D-LC fractions 
 134 
-0.8 -0.4 0 0.4 0.8 -0.8 -0.4 0 0.4 0.8
PC3
P
C
4
P
C
3
PC2
a c
Cu
Zn
pSOD1SY5Y
Cu
Zn
b d
pSOD1SY5Y
 
 
Figure 3.18: Principal component analysis to predict protein binding to copper 
and zinc 
Aliquots (130μl) of 100mM NaCl size exclusion fractions containing copper and 
zinc (figure 3.16) were resolved on a discontinuous 15% (w/v) SDS-PAGE gel (a 
and c) and analysed for protein distribution in each fraction using BioRad quantity 
one software. SDS-PAGE gels were prepared for samples subjected to single and 
sequential size exclusion columns (figure 3.17). Data for copper, zinc and protein 
chromatographs was used to calculate the principal components (see section 
2.4.10.2) for this data set. Correlation analysis for single column (a) and double 
column (c) indicate protein pSOD1SY5Y
 
 as best match with regards to copper, zinc 
and protein distribution across the size exclusion fractions analysed by SDS-PAGE. 
Comparing various principal components (b and d) the putative SOD1 protein 
clusters closely with copper and zinc indicating that this protein is likely to bind 
both metals. 
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3.6 Comparative analysis of enzymatic activity of copper binding enzymes in 
SH-SY5Y APPWT and APP
Several studies have shown that the Swedish mutation of APP is processed more 
readily by BACE1 rather than α – secretase (Citron et al., 1992, Scheuner et al., 
1996), thus not only generating increased levels of extracellular plaques due to 
increased release of Aβ, but also an intracellular copper deficiency which has been 
correlated with aiding the efflux of copper out of the cell (Maynard et al., 2002, 
Bush et al., 2003). To clarify whether limitations in intracellular copper availability 
affect enzymatic activity of copper – dependent enzymes, activity assays were 
performed for the major cytosolic antioxidant enzyme SOD1 and cytochrome c 
oxidase. Both are crucial to cell survival with regards to defence against oxidative 
stress inducing oxygen species and provision of energy as well as generation of 
mitochondrial membrane gradients involved in energy production. It was reasoned 
that results of activity assays would provide an insight to the differences in enzyme 
activity between APP
swe 
WT and APPswe cell lines under normal culture conditions. 
Additional experiments also investigated the effect of surplus extracellular copper 
and intracellular copper limitation by addition of increasing concentrations of 
copper to the cell culture medium of both strains or by chelation of copper from the 
medium using the copper specific chelator BCS, respectively. Again it must be 
noted that data for the APPswe cell line might in part reflect the effects of basic 
endogenous levels of APPWT
3.6.1 In-gel SOD activity assay 
. 
To test the prediction that the copper and zinc pools in the APPWT 100mM anion 
exchange fraction are ligands to SOD1, an in-gel SOD1 activity assay was 
performed. Equal volumes of duplicate samples of the 100mM anion exchange 
fraction of both APPWT and APPswe cell lines were resolved on a discontinuous 15% 
(v/v) native PAGE gel under omission of SDS from the gel and the running buffer. 
In contrast with the method described by Beauchamps and Fridovich (Beauchamp 
and Fridovich, 1971) riboflavin was omitted from the gel and only introduced 
during the process of soaking the gel with the substrates required for the activity 
assay. Including riboflavin in the native gel previously resulted in a colour change 
from light yellow to purple, too vivid to detect any SOD1 related features. 
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Figure 3.19: Comparison of whole cell SOD1 activity in SH-SY5Y APPWT and 
APPswe
Whole cell protein extracts for SH-SY5Y APP
 using an in-gel activity assay 
WT and APPswe were prepared as 
described in section 2.4.3.1 and concentrated on a HiTrap Q HP anion exchange 
column at 0.3ml, min-1. Samples were eluted in 1ml of 50mM Tris, pH 8.8, 1mM 
PMSF buffer containing 100mM NaCl. Aliquots (0.2ml) of each 100mM fraction 
were further resolved on a Tosoh TSK SW3000 size exclusion chromatography 
column at 0.5ml min-1
a)  Equal aliquots of the 100mM NaCl anion exchange fractions and 2x native 
loading dye (50μl) were loaded onto a discontinuous 15% (w/v) native 
polyacrylamide gel and resolved for 2 hours at 100V. Subsequently the gel was 
prepared for the activity assay as described in section 2.4.7.2.2. SH-SY5Y APP
. Samples were collected every minute for 30 minutes and 
analysed for copper and zinc by ICP-MS. 
WT 
and APPswe were analysed for SOD1 activity in duplicate. The comparison of APWT 
and APPswe
b) Aliquots of SH-SY5Y APP
 samples does not indicate any difference in SOD1 activity between the 
cell lines. 
WT
c) Aliquots (50μl) of SH-SY5Y APP
 samples obtained through 2D-LC as described in 
sections 2.4.3.2 and 2.4.3.3 were analysed for copper and zinc by ICP-MS. The 
graph shows matching distributions of copper and zinc across sample fractions and 
with the relative SOD1 activity, which was analysed by densitometric 
measurements and is displayed as arbitrary units of SOD1 activity. 
WT
d) ICP-MS analysis of SH-SY5Y APP
 samples obtained through anion exchange 
chromatography followed by size exclusion chromatography were resolved on a 
discontinuous 15% (w/v) native polyacryamide gel and treated as described above. 
Pure SOD1 (20μl) and a sample the 100mM anion exchange fraction were used as a 
loading control. 
swe
e) The same procedure as described above was applied to SH-SY5Y APP
 for copper and zinc indicates that both 
metals match the distribution of SOD1 activity across protein fractions. 
swe. The 
activity gel shows SOD1 activity across fractions obtained through 2D-LC. 
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Following electrophoresis the gel was soaked in 2.45mM NBT and a solution 
containing 28mM TEMED, 28μM riboflavin and 36mM potassium phosphate. The 
exact procedure is described in section 2.4.7.2.2 and a schematic representation of 
chemical processes is shown in figure 2.3. The two – step chemical reaction was 
initiated by illumination of the gel and SOD1 activity was observed as white bands 
on a purple background. SOD1 activity in APPWT and APPswe cell lines is depicted 
in figure 3.19 (a) suggesting that SOD1 is present in the 100mM salt fraction of 
both cell lines. Due to signal saturation it is not possible to determine any 
differences in enzyme activity. The assay was repeated with the second dimension 
size exclusion fractions which contained the copper and zinc pools proposed to bind 
SOD1, at volume 9-12ml. Figure 3.19 (c) and (e) illustrate activity gels for APPWT 
and APPswe, respectively. Data obtained by densitometric analysis of relative band 
intensity across the resolved fractions was compared to copper and zinc 
chromatographs and indicates a strong co-migration pattern. The data clearly 
suggest that the metal pool is generated by SOD1. Densitometric data for SOD1 
activity suggests that there is slightly more activity in the APPWT
3.6.2 Spectrophotometric analysis of SOD1 activity 
 cell, line although 
the chromatograph shows signs of saturation. 
In order to obtain absolute rather than relative data for SOD1 activity, liquid assays 
using the xanthine/xanthine oxidase system were performed. The assay works on 
the basis of xanthine being oxidised to uric acid by xanthine oxidase under aerobic 
conditions resulting in the release of anionic superoxide. Superoxide in turn reduces 
oxidised cytochrome c triggering an increase in absorbance intensity when 
measured at a wavelength of 550nm in a spectrophotometer. Superoxide dismutase 
prevents this cytochrome c reduction by sequestration of superoxide radicals and 
dismutation to hydrogen peroxide. Thus enzyme activity is measured as the lack of 
increasing absorbance intensity. 
Whole cell soluble protein extracts of APPWT and APPswe were prepared using a 
modified extraction method as specified in section 2.4.7.2.3. Cultures were 
supplemented with increasing concentrations of copper and grown for another 24 
hours before being harvested at 80% confluency. BCS supplemented cells were 
grown at respective BCS concentrations of 5μM, 10μM, 20μM, 25μM, 50μM and 
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100μM for four generations to limit intracellular copper. All solutions used to 
passage BCS supplemented cultures were supplemented with BCS at the 
appropriate concentrations to prevent introduction of copper throughout the 
passaging procedure. Attempts were made to culture copper supplemented cells for 
four generations as was done with BCS supplemented cultures to control for the 
unequal number of passages, which might result in increased antioxidant status due 
to stress during the passaging process. All cell culture solutions were supplemented 
with copper. However, during the first passage it was observed that cells and copper 
peletted during centrifugation, thus increasing the copper concentrations from 
generation to generation until toxic levels of copper were achieved. No direct 
comparison of SOD1 activity in control cultures (not supplemented with either 
copper or BCS) of APPWT and APPswe
Cell pellets were obtained from one 150cm
 cell lines is possible. Therefore data are 
shown as individual replicates and not as the average of triplicate experiments. 
Further replicates are shown in appendix1 figures 5.1 and 5.3 for copper 
supplemented cultures and appendix 1 figures 5.2 and 5.4 for BCS supplemented 
cultures.  
2 flask per sample and resuspended in 
420μl of 50mM phosphate buffer, pH 7.8 and 120μl of 10% (w/v) SDS. Following 
incubation at 37ºC for 30 minutes the sample was cooled and 60μl of 3M KCl 
added. After further incubation intact cells were pelleted and the supernatant 
analysed for protein content by BSA – calibrated Coomassie assay. A fresh SOD1 
standard curve was prepared on the day of the experiment to control for differences 
in absorbance readings that arise from mechanical variation and prolonged use of 
the spectrophotometer. Pure SOD1 extracted from human erythrocytes was added to 
the working solution in 0.5 unit increments up to 3 units SOD activity. Reactions for 
the standard curve were also supplemented with 60μl of the 300mM KCl, 2% (w/v) 
SDS,  35mM phosphate buffer mixture, which was used for sample extraction, to 
control for any differences in absorbance arising from reaction components other 
than cytochrome c. Spectra for both cell lines, whether supplemented with copper or 
BCS, were taken for half an hour using 100μg of protein per measurement and the 
reaction initiated by addition of 50μM xanthine. Data displayed in figure 3.20 
shows SOD1 activity in copper supplemented APPWT (a) and APPswe (b) cell lines. 
Direct comparison of control samples is not possible due to different standard 
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Figure 3.20: SOD1 activity in SH-SY5Y APPWT and APPswe
Whole cell protein extracts were prepared from 1x150cm
 under copper 
supplementation 
2 flask per sample of 80% 
confluent monolayer culture as described in section 2.4.7.2.3. Three independent 
extracts were produced (see appendix 1 figures 5.1 and 5.3 for two further 
replicates). The protein content was estimated by BSA-calibrated Coomassie assay 
and all three extracts diluted to the same protein concentration to minimise 
experimental variation. On the day of the experiment a fresh standard curve using 
pure SOD1 was prepared. Samples could not be analysed in triplicate due to the 
duration of individual measurements. SOD1 activity was measured 
spectrophotometrically at a wavelength of 550nm as described in section 2.4.7.2.4. 
Histograms represent enzyme activity in units SOD for APPWT (a) and APPswe
 
 (b). 
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Figure 3.21: SOD1 activity in SH-SY5Y APPWT and APPswe
APP
 under copper 
depletion 
WT and APPswe cells were cultured in increasing concentrations of BCS for four 
generations and seeded for the final analysis. Cultures were harvested when 80% 
confluent and cell numbers determined as described in section 2.4.6.1 using a 
Coulter Cell Counter system. Whole cell protein extracts were prepared from 
1x150cm2 flask per sample of monolayer culture as described in section 2.4.7.2.3. 
Three independent extracts were produced (see appendix 1 figures 5.2 and 5.4 for 
further two replicates). The protein content was estimated by BSA-calibrated 
Coomassie assay and all three extracts diluted to the same protein concentration to 
minimise experimental variation. On the day of experiment a fresh standard curve 
using pure SOD1 was prepared. Samples could not be analysed in triplicate due to 
the duration of individual analyses. SOD1 activity was measured 
spectrophotometrically at a wavelength of 550nm as described in section 2.4.8.2.4. 
Histograms represent enzyme activity in units SOD for APPWT (a) and APPswe
 
 (b). 
The copper(I) specific chelator BCS was used to culture SH-SY5Y for 4 generations 
to remove all copper. 
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curves for each replicate. However, the control samples suggest the base levels of 
SOD activity to be the same in both cell lines. In APPWT cells increasing copper 
concentration triggers a slight increase in SOD1 activity, although the data are 
inconclusive with regards to major differences between lower copper concentrations 
at 50μM and 500μM copper. High copper concentrations do not result in an 
elevation of SOD1 activity, thus it is expected that cell cultures do not experience 
oxidative insult. Contrary, in APPswe cells supplemented with increasing 
concentrations of copper a clear increase in SOD1 activity is detectable. This leads 
to the conclusion that more copper is available to activate SOD despite the 
continued increased secretion of Aβ. These data may reflect a mechanism for the 
APPswe
Cell cultures supplemented with BCS and thus deprived of copper for several 
generations show a drastic decrease in SOD1 activity (see figure 3.21). Both APP
 cell line to detoxify excess levels of copper by increased binding, thus 
enhancing the reduction of copper-mediated ROS generation. 
WT 
and APPswe cell lines display decreases in SOD1 activity which seem to be greater 
in the earlier stages of copper limitation (at 5μM BCS to 20μM BCS) and then trail 
off, suggesting possible adaptation of the cellular machinery to low level 
antioxidant defense. Although both cell lines show diminished SOD1 activity with 
increasing BCS concentrations, the APPWT cell line seems more susceptible to low 
levels of copper showing a greater decrease in activity than the APPswe cell line. In 
fact, although levels of activity are lower in the APPswe control sample, activity 
remains higher in the high BCS concentrations as compared to APPWT
3.6.3 Analysis of cytochrome c oxidase activity 
. Whether 
this is due to experimental conditions such as the use of the spectrometer and 
preparation of standard curves on different days or actual events can not be 
concluded from this data set.  
Cytochrome c oxidase activity was measured spectrophotometrically at a 
wavelength of 550nm.The assay is based on the same principles as the liquid SOD1 
activity assay. The rate of oxidation of reduced cytochrome c by cytochrome c 
oxidase is measured by observing the level of quenching of absorbance intensity at 
this particular wavelength. It is necessary for this activity assay that prior to the 
experiment cytochrome c is fully reduced. Maximum reduction of cytochrome c 
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was achieved by supplementation of the stock solution with ascorbic acid. Excess 
reducing agent was subsequently removed by dialysis in 20mM phosphate buffer, 
pH 7.8 using dialysis membrane with a molecular weight cut - off of 3,500 Daltons. 
Multiple additions of ascorbic acid stock to a diluted sample of cytochrome c stock 
determined the minimum concentrations required to fully reduce cytochrome c. The 
chromatograph of this experiment is shown in appendix 2 figure 5.5.  
Whole cell membraneous protein extract was prepared from one 150cm2 flask per 
sample for both cell lines and pellets resuspended in 1ml of 20mM phosphate 
buffer, pH 7.8 before lysis in a waterbath. Intact cells were removed by low speed 
centrifugation and the supernatant subjected to ultracentrifugation. Resulting pellets 
were resuspended in 0.5ml of phosphate buffer and protein content determined by 
BCA protein assay. Samples for both cell lines and all copper depletion or 
supplementation conditions were adjusted to the same protein concentration to 
minimise errors in absorbance measurements due to variations in protein content or 
sample volume. To control for full cytochrome c reduction before each individual 
measurement, aliquots (0.9ml) of fully reduced 3μM working solution were scanned 
between wavelengths 200 and 800nm to compare absorbance at 550nm and 
reactions initiated by addition of 8μg of sample protein. The rate of cytochrome c 
oxidation was determined by using ε550nm = 29,500M-1 cm-1. Triplicate 
measurements were taken of each sample. Three individual extracts of APPWT and 
APPswe cell lines were subjected to analysis of cytochrome c oxidase activity. 
Further replicates are shown in appendix 2 figures 5.6 and 5.8 for copper 
supplemented cultures and appendix 2 figures 5.7 and 5.9 for BCS supplemented 
cultures. Direct comparison of base levels of APPWT and APPswe (figure 3.22) 
shows that under physiological conditions the cell line overexpressing the Swedish 
mutation exhibits 50% less enzyme activity. This finding has potential implications 
for patients carrying the Swedish mutation who are more prone to 
neurodegeneration than patients carrying the wild type allele of APP. Even small 
changes in cytochrome c oxidase activity and thus energy production within the 
brain can cause a multitude of biochemical alterations which can lead to loss of 
mitochondrial gradients resulting in initiation of the ischaemic cascade and loss of 
active import of nutrients into the brain. 
 145 
 
nm
ol
es
of
 o
xi
di
se
d 
cy
to
ch
ro
m
e 
c 
μg
 p
ro
te
in
-1
, m
in
-1
*
0
200
400
600
800
1000
1200
1400
AP
P W
T
AP
P sw
e
 
 
Figure 3.22: Comparison of cytochrome c oxidase activity in SH-SY5Y APPWT 
and APPswe
Membraneous protein extracts were prepared from 1x150cm
 cell lines 
2 flask per sample of 
80% confluent monolayer culture for each cell line as described in section 2.4.7.3.1. 
Cells pellets were lysed in 1ml of 20mM KPO4 buffer (pH 7.8) by sonication in a 
water bath followed by centrifugation to remove intact cells. The protein content 
was estimated using the BCA assay for membraneous protein and both extracts 
adjusted to the same protein concentration to minimise experimental variation.  
Prior to the activity assay cytochrome c was fully reduced with molar excess of 
ascorbic acid, which was subsequently removed by dialysis. Cytochrome oxidase 
activity was measured spectrophotometrically at a wavelength of 550nm as 
described in section 2.4.8.3.6. Histograms show enzyme activity as calculated using 
the extinction coefficient, ε550nm = 29,500 M-1 cm-1 for APPWT (black bar) and 
APPswe (grey bar). Error bars represent standard deviation for triplicate 
measurements. Results indicate a higher level of endogenous cytochrome c oxidase 
activity in the APPWT cell line, compared to the APPswe cell line. Error bars 
represent standard deviation for triplicate measurements. Symbols represent 
statistical significance as follows: *: p<0.05 compared to the control, #: p<0.01 
compared to the control, **: p<0.05 compared to previous treatment, ##: p< 0.01 
compared to previous treatment. 
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Figure 3.23: Cytochrome c oxidase activity in SH-SY5Y APPWT and APPswe
Membraneous protein extracts were prepared from 1x150cm
 
under copper supplementation 
2 flask per sample of 
80% confluent monolayer culture as described in section 2.4.7.3.1. Three 
independent extracts were produced (see appendix 2 figures 5.6 and 5.8 for 2 further 
replicates). The protein content was estimated using the BCA assay for 
membraneous protein and all three extracts diluted to the same protein concentration 
to minimise experimental variation.  Prior to the activity assay cytochrome c was 
fully reduced with molar excess of ascorbic acid, which was subsequently removed 
by dialysis. Cytochrome oxidase activity was measured spectrophotometrically at a 
wavelength of 550nm as described in section 2.4.7.3.6. Histograms show enzyme 
activity as calculated using ε550nm = 29,500 M-1cm-1 for APPWT (a) and APPswe (b). 
Error bars represent standard deviation for triplicate measurements. Results indicate 
no changes in cytochrome oxidase activity in APPWT and increased cytochrome 
oxidase activity in APPswe
 
 cell lines. Error bars represent standard deviation for 
triplicate measurements. Symbols represent statistical significance as follows: *: 
p<0.05 compared to the control, #: p<0.01 compared to the control, **: p<0.05 
compared to previous treatment, ##: p< 0.01 compared to previous treatment. 
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Figure 3.24: Cytochrome c oxidase activity in SH-SY5Y APPWT and APPswe
APP
 
under copper depletion 
WT and APPswe cells were cultured in increasing concentrations of BCS for four 
generations and seeded for the final analysis. Cultures were harvested when 80% 
confluent and cell numbers determined as described in section 2.4.6.1 using a 
Coulter Cell Counter system. Membraneous protein extracts were prepared from 
one 150cm2 flask per sample of monolayer culture as described in section 2.4.7.3.1. 
Three independent extracts were produced (see appendix 2 figures 5.7 and 5.9 for 
further two replicates). The protein content was estimated using the BCA assay for 
membraneous protein and all three extracts diluted to the same protein concentration 
to minimise experimental variation.  Prior to the activity assay cytochrome c was 
fully reduced with molar excess of ascorbic acid, which was subsequently removed 
by dialysis. Cytochrome oxidase activity was measured spectrophotometrically at a 
wavelength of 550nm as described in section 2.4.7.3.6. Histograms show enzyme 
activity as calculated using ε550nm = 29,500 M-1cm-1 for APPWT (a) and APPswe
 
 (b). 
Error bars represent standard deviation for triplicate measurements. Results indicate 
a decrease in cytochrome oxidase activity in both cell lines. Error bars represent 
standard deviation for triplicate measurements. Symbols represent statistical 
significance as follows: *: p<0.05 compared to the control, #: p<0.01 compared to 
the control, **: p<0.05 compared to previous treatment, ##: p< 0.01 compared to 
previous treatment. 
 
 
 
 
 
 
 
 149 
 
 
nm
ol
es
of
 o
xi
di
se
d 
cy
to
ch
ro
m
e 
c 
μg
 p
ro
te
in
-1
, m
in
-1
nm
ol
es
of
 o
xi
di
se
d 
cy
to
ch
ro
m
e 
c 
μg
 p
ro
te
in
-1
, m
in
-1
a
b
##
##
##
#
#
# #
#
#
#
##
#
#
#
**
0
500
1000
1500
2500
2000
3000
3500
0
500
1000
1500
2500
2000
3000
5μ
M 
BC
S
10
μM
 B
CS
50
μM
 B
CS
10
0μ
M 
BC
S
20
μM
 B
CS
25
μM
 B
CS
0μ
M 
BC
S
0μ
M 
BC
S
5μ
M 
BC
S
10
μM
 B
CS
50
μM
 B
CS
10
0μ
M 
BC
S
20
μM
 B
CS
25
μM
 B
CS
 
 
 
 
 
 
 150 
Increases in extracellular copper concentrations did not have any effect on the 
APPWT cell line (figure 3.23), whereas cytochrome c oxidase activity seems to be 
restored to a certain extend in the APPswe cell line. These data are consistent with a 
decreased base level of enzyme activity under normal physiological conditions and 
suggest that cytochrome c oxidase activity is at its maximum in APPWT cells. In cell 
lines depleted of copper for four generations sharp decreases in cytochrome c 
oxidase activity were observed (figure 3.24). There is no apparent difference 
between the two cell lines with regards to intensity of activity reduction upon 
increasing BCS concentrations or the level to which enzymatic activity is reduced. 
This observation implies that the naturally increased cleavage of APP in the APPswe 
cell line does not affect intracellular copper content to a level that prevents or 
favours cytochrome c oxidase metallation compared to the APPWT
3.7 Phenotypic analysis and comparison of SH-SY5Y APP
 cell line. 
WT and APP
3.7.1 Survival studies under copper supplementation 
swe 
Since differences with respect to copper sensitivity and activity of copper - binding 
enzymeshad been rescued, survival was monitored for APPWT and APPswe cell lines 
under increasing copper concentrations. Cultures were supplemented with the 
appropriate concentration of copper and grown for a further 24 hours. Ratios of live 
to dead cells were established by counting cells in a hemocytometer following 
trypan blue staining with cells excluding the stain being counted as live and cells 
penetrated by the stain as dead. Figure 3.25 shows data represented as % survival. It 
is clear that toxic levels of copper drastically decrease the survival of APPWT cells, 
whereas the same concentration of copper rescues survival in APPswe cultures. 
Findings suggest that APPswe cultures under normal conditions experience 
intracellular copper deficiency, which results in the loss of vital functions for cell 
survival. These data are consistent with decreased cytochrome c oxidase activity 
shown under normal conditions in APPswe cultures. Survival studies could not be 
performed on cultures supplemented with BCS, due to consecutive passaging to 
eliminate intracellular copper resulting in dead cells being lost in the process. 
However, further replicates of survival studies in copper supplemented cultures are 
shown in appendix 3 figures 5.10 and 5.11 for APPWT and APPswe, respectively. 
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Figure 3.25: Survival of SH-SY5Y APPWT and APPswe
Cell cultures of 1x10
 under increasing copper 
concentrations 
6 cells were prepared for both cell lines and grown for several 
days before being supplemented with the appropriate concentration of copper and 
grown for another 24 hours. Cultures were harvested as described in section 2.2.3.2 
and analysed for life and dead cells by the trypan blue exclusion method using a 
hemocytometer. Survival rates are shown for APPWT (a) and for APPswe
 
 (b). Error 
bars represent standard deviation of triplicate measurements. Symbols represent 
statistical significance as follows: *: p<0.05 compared to the control, #: p<0.01 
compared to the control, **: p<0.05 compared to previous treatment, ##: p< 0.01 
compared to previous treatment. 
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Figure 3.26: Growth of SH-SY5Y APPWT and APPswe
APP
 under increasing copper 
concentrations 
WT (a) and APPswe (b) cells were seeded at 1x106
 
 cells per flask, cultured in 
increasing concentrations of copper for 10 days and harvested at appropriate time 
intervals.  Cell numbers were determined as described in section 2.4.6.1 using a 
Coulter Cell Counter system. Copper concentrations were as follows: 0μM copper 
(filled circles), 50μM (open squares), 150μM (open triangles), 300μM (filled 
triangles) and 500μM (open circles). Error bars represent standard deviation in 
triplicate measurements. 
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Figure 3.27: Growth of SH-SY5Y APPWT and APPswe
APP
 under copper depletion 
WT (a) and APPswe (b) cells were cultured in increasing concentrations of BCS 
for four generations and seeded at 1x106
 
 cells per flask for the final analysis. 
Cultures were harvested at appropriate time intervals and cell numbers determined 
as described in section 2.4.6.1 using a Coulter Cell Counter system. BCS 
concentrations were as follows: 0μM BCS (filled circles), 5μM BCS (open squares), 
10μM BCS (open triangles up), 20μM BCS (filled triangles), 25μM BCS (open 
circles), 50μM BCS (open triangles down) and 100μM BCS (filled square). Error 
bars represent standard deviation in triplicate measurements. 
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3.7.2 Growth analysis under copper depletion and supplementation 
To examine growth characteristics of both cell lines under high copper conditions, 
cells were seeded at 1x106 cells per flask and instantly supplemented with copper. 
Culture medium was exchanged every two days and cells harvested at various time 
intervals. Cell numbers were determined using a Coulter Counter. Data shown in 
figure 3.26 show continued but somewhat decreased growth of APPWT cells in low 
copper concentrations (50μM). However, toxic concentrations of copper ranging 
from 150μM to 500μM copper result in complete loss of growth. In contrast, 
APPswe cells exhibit increased growth in high copper concentrations starting at day 
5. At lower copper concentrations of 50μM APPswe cells show slightly decreased 
growth, however, they are more resistant against copper related insults than APPWT 
cells. The data imply that the APPswe
Cells supplemented with BCS were again cultured for four consecutive passages to 
deplete intracellular copper levels and seeded at 1x10
 cell line is more resistant to high copper 
concentrations on a short term and long term basis. 
6 cells per flask. Culture 
medium was exchanged every two days and cells harvested at various time 
intervals. It was observed that in cultures supplemented with higher BCS 
concentrations longer time intervals were needed between measurements implying 
reduced growth in both cell lines. Cell numbers were determined using a Coulter 
Counter. Data shown in figure 3.27 show continued growth for both cell lines. It is 
noticible that APPswe cultures supplemented with 20μM and 25μM BCS reach the 
same levels of growth as APPWT cultures supplemented with the same amount of 
BCS. However, growth delay results in the APPswe cell line taking nearly twice as 
much time as APPWT cells to grow to the same level. Further APPswe cultures 
containing 50μM BCS do not exhibit any signs of growth, whereas APPWT cultures 
display growth after 7 days of culture in 50μM BCS. Growth of both cell lines is 
almost abolished at a concentration of 100μM BCS. Special attention needs to be 
paid to growth behaviour at low BCS concentrations. Although, in comparison with 
control cultures both cell lines display the same amount of growth for cells 
supplemented with 5μM BCS, growth delay in the APPswe cell line seems to be 
initiated at a BCS concentration of 10μM. Data suggests that APPWT cultures may 
be able to compensate for higher BCS concentration by mobilising intracellular  
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Figure 3.28: Total copper content of whole cell SH-SY5Y APPWT and APPswe
Copper supplemented cultures were prepared as described previously (section 
2.4.1), harvested and repeatedly washed in D-PBS. Aliquots of 1.5x10
 
under copper supplementation 
6 cells for 
each cell line and copper concentration were resuspended in 1ml of ultrapure 65% 
(v/v) HNO3. Samples were incubated at room temperature for at least one week and 
repeatedly centrifuged to remove cells and cell debris, before being analysed by 
inductively coupled plasma-mass spectrometry for copper content. Whole cell 
copper content is shown for APPWT (a) and APPswe (b). Error bars represent 
standard deviation for triplicate measurements. Symbols represent statistical 
significance as follows: *: p<0.05 compared to the control, #: p<0.01 compared to 
the control, **: p<0.05 compared to previous treatment, ##: p< 0.01 compared to 
previous treatment. Panel c represents a direct comparison of whole cell copper 
content of untreated APPWT and APPswe
 
. 
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Figure 3.29: Total iron and zinc content of whole cell SH-SY5Y APPWT and 
APPswe
Copper supplemented culture were prepared as described previously (section 2.4.1), 
harvested and repeatedly washed in D-PBS. Aliquots of 1.5x10
 under copper supplementation 
6 cells for each cell 
line and copper concentration were resuspended in 1ml of ultrapure 65% (v/v) 
HNO3. Samples were incubated at room temperature for at least one week and 
repeatedly centrifuged to remove cells and cell debris, before being analysed by 
inductively coupled plasma-mass spectrometry for iron and zinc content. Whole cell 
zinc content is shown for APPWT (a), APPswe (c), iron for APPWT (b) and APPswe
 
 
(d). 
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copper stores, which are depleted in APPswe cells. This might be due to the total 
amount of copper being higher in APPWT cells, thus more time is needed relative to 
the APPswe cell line to fully deplete the culture of copper. Further a metabolic 
switch might be responsible for the sudden delay in growth in APPswe
3.7.3 Metal accumulation under copper depletion and supplementation 
 cells once 
copper levels fall below a certain level (equivalent to 10μM BCS supplementation). 
A simple method of testing for differences in copper efflux between APPWT and 
APPswe cell lines is to quantify total cellular metal content. Cultures of APPWT and 
APPswe cell lines were grown in triplicate in high copper concentration or copper 
depleted conditions, washed thoroughly in D-PBS and after centrifugation 
resuspended in concentrated nitric acid. Following repeated centrifugation to 
remove cell debris samples were analysed for metal content by ICP-MS. Results in 
figure 3.28 for total copper analysis of APPWT and APPswe in increasing copper 
concentrations show increased intracellular copper content for both cell lines. 
However, the copper content of APPWT cells is nearly two fold higher than the 
copper content of APPswe cells, indicating that the latter is more effective in 
exporting toxic quantities of the metal. This observation is consistent with increased 
survival of APPswe cells under increasing copper conditions. Metal analyses for zinc 
and iron are displayed in figure 3.29. The chromatographs for both metals are 
inconclusive due to large errors and low μmolar abundance. Metal content of acid 
digests performed on BCS supplemented APPWT and APPswe
 
 cell lines are shown in 
appendix 3 figure 5.12 for copper, zinc and iron. 
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4.1 Analysis of metal content and distribution in mammalian cells  
Chapter 4: Discussion 
The development of the 2D-LC method to establish major metal pools in whole cell 
extracts allows for the analysis, identification and subsequent characterisation of 
specific and abundant metal-binding proteins without the need for extensive 
purification steps which might result in the loss of the metal co-factor. This method 
was previously applied to prokaryotic systems (Waldron et al., 2007, Tottey et al., 
2008). 
Part of this project was the application and if required further development of the 
2D-LC method to eukaryotic organisms. Climbing the evolutionary tree to gain data 
from increasingly complex organisms analyses were performed on Saccharomyces 
cerevisiae, rat liver mitochondria, HepG2 and SH-SY5Y human cell lines. Rat liver 
mitochondria were chosen on the basis that the organ contains vast amounts of 
heme and thus should present major metal pools for iron and be suitable as indicator 
for the success of the experiment. However, the high abundance of metals in the 
organ might also lead to saturation of metal detection by ICP-MS resulting in 
profiles where large amounts of metal, but no individual metal pools are visible. 
Cell fractionation was performed to obtain liver mitochondria. These organelles are 
very abundant in the liver and provide solutions to two problems of 2D-LC. The 
protocol requires large amounts of protein to be present for anion exchange 
chromatography with the column being able to separate 70mg of protein. This first 
experimental step also benefits from a large dilution factor of solid protein in buffer. 
Thus it is important that the starting material for the whole cell protein extracts 
contains high amounts of protein and is also very easy to grow in high numbers. 
Saccharomyces cerevisae as well as rat liver mitochondria possess these 
characteristics and are ideal for first trials. 
Shown in figures 3.1 and 3.2 are metal profiles obtained from both organisms, 
respectively, using the standard 2D-LC protocol as used for Syneccocystis and 
outlined in section 2.4.3. Metal content was analysed for copper, zinc, manganese, 
iron and cobalt by multi-elemental analysis using ICP-MS. The iron profile for 
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yeast (figure 3.1 d) shows a variety of individual iron pools mainly in the 100mM, 
400mM and 1000mM anion exchange fractions and a wide spread of molecular 
sizes of individual metal pools indicating successful separation of proteins in the 
first and also second dimension. It was therefore concluded that protein separation 
was also successful for protein bound to copper, zinc, manganese and cobalt. 
Copper and zinc profiles of yeast show major metal pools in the 100mM, 200mM, 
and 400mM and 100mM, 300mM and 1000mM NaCl fractions, respectively. 
However, most of the binding partners for both metals are of smaller molecular 
weight and are eluted towards the total column volume of the HPLC. 
Rat liver mitochondria metal profiles (figure 3.2) also show successful separation of 
metal pools through the first and second dimension and major pools of copper, zinc, 
manganese and iron can be detected indicating that not only is the 2D-LC protocol 
suitable for eukaryotic systems, but cell fractionation can be used to determine 
differences in intracellular metal trafficking between different cell types, 
environmental stimuli or genetic background of the same organism. Although not 
tested as part of this project, various organelles such as ER, Golgi, vesicular 
fractions and nuclei – all known to have some role in metal trafficking or storage - 
could be subjected to 2D-LC. 
Although a slight internal variation between metal profiles of yeast replicates and 
replicates of all other organisms tested were observed, the major metal pools which 
were subjected to analysis by SDS-PAGE and subsequent identification by MALDI-
TOF-MS were reproducible (data not shown). Slight variations in metal pool 
concentration or resolution by anion exchange and HPLC column and therefore 
distribution in the final profile, can be attributed to variations in manual extraction 
from each column, precision of protein estimations throughout the experiment, 
slight variation in amounts pipetted for metal content analysis of individual samples 
and sensitivity of ICP-MS detection. 
HepG2 cultured cells – a human liver carcinoma cell line - were the first human cell 
line to be subjected to 2D-LC in the hope that some resemblance to the metal 
profiles obtained for rat liver mitochondria would become apparent. The results 
shown in figure 3.3 indicate the same distribution of several metal pools between 
HepG2 and rat liver mitochondria extracts. Low molecular weight zinc pools in the 
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100mM and 200mM fractions, low molecular weight copper pools in the 100mM 
fraction, as well as high molecular iron pools in the 200mM and 1000mM fractions 
with the same distribution are visible in both profiles and are again replicable within 
different metal profiles of the same cell line. 
One final proof of the successful application of the 2D-LC protocol to eukaryotic 
organisms was the identification of an abundant copper and zinc containing metal 
pool as SOD1 in rat liver mitochondria which became of particular interest at later 
stages of the project. All three organisms tested - Saccharomyces cerevisiae, rat 
liver mitochondria and HepG2 - displayed this replicable co-migrating pool 
indicated by the red bar in figures 3.1 f, 3.2 f and 3.3 f. Metal concentrations and 
ratios of 1:1 between copper and zinc remained constant and thus were not an 
artefact of the experimental procedure. Supported by these findings the 2D-LC 
protocol was applied to SH-SY5Y APPWT and APPswe 
One caviat of 2D-LC is the elimination of the membraneous cell fraction prior to 
anion exchange chromatography. It is therefore not possible to detect membrane-
bound or transmembrane metalloproteins using this method. Western Blot analysis 
would be required to establish the presence of proteins such as CCO and APP. 
Metal content analysis of such membraneous proteins is complicated by the fact that 
membraneous fractions resist resolution on HPLC columns and result in the metal 
content analysis of all membraneous proteins in one sample without the possibility 
to differenciate between individual proteins. As a result the 2D-LC profiles obtained 
from whole cell SH-SY5Y cell lines do not contain a metal pool representative for 
APP and the effect of APP
cell lines to compare copper 
content and possible differences in copper distribution within both cell lines. 
WT or APPswe
4.2 Comparison of functional copper content and distribution in SH-SY5Y 
APP
 is purely measuring the balance of copper 
import and export, the availability of functional copper to soluble copper-binding 
proteins and the absolute cellular copper content. Additional analyses were 
performed to verify the data obtained through 2D-LC.     
WT and APPswe
Several lines of evidence suggest linkage between APP and copper homeostasis and 
a possible link between APP
 cell lines 
swe and cellular copper deficiency. These include a 
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significant decrease in survival of APPWT cells cultured in high concentrations of 
copper, whereas APPswe cultures display significant increase in survival under the 
same conditions. Copper is readily accumulated in both cell lines at high exogenous 
copper supplementation, however APPWT cultures show a higher degree of 
intracellular copper accumulation than APPswe cells and SOD1 metallation with 
copper is higher than that detected in APPswe cells. Further copper-dependent 
enzyme activity assays of cultures grown in high copper concentrations show 
unchanged and increased SOD1 activity in APPWT and APPswe, respectively and 
significant decreases and increases in CCO activity in APPWT and APPswe cultures, 
respectively. SOD1 and CCO enzyme activities were significantly reduced in 
cultures grown in copper deplete media for both cell lines and a significant 
difference between APPWT and APPswe basal levels of CCO activity were observed 
with activity in APPWT being around 50% higher than CCO activity in APPswe. Cell 
growth is diminished by high levels of copper, whereas slight increases in copper 
concentration (50μM) result in 25% reduction in growth in APPswe and 50% 
APPWT. Copper deplete media allows growth of both cell cultures to the same level, 
although APPswe cultures require twice the amount of time than APPWT cultures and 
growth of APPswe containing cells is more affected in high BCS concentrations than 
in APPWT. It needs to be mentioned that the SH-SY5Y APPswe cell line contains base 
levels of endogenous APP as well as an unspecified overexpression of APPswe, 
whereas the SH-SY5Y APPWT cell line contains base levels of endogenous APP 
only. As part of this project no experiments were performed to estimate the amount 
of overexpression or expression differences of endogenous APP and APPswe
Previously APP was identified to have a role in maintaining cellular copper 
homeostasis (Strausak et al., 2001) and mutations in APP recognised as major 
contributors in the development of early onset AD (Citron et al., 1992). In an effort 
to elucidate the influence of APP on intracellular copper levels the neuroblastoma 
cell line SH-SY5Y was used as a model to compare copper-related phenotypes in an 
APP
 
between both cell lines by Western Blot or RT-PCR. Thus the interpretation of all 
data involving comparisons of both cell lines is limited and effects that could be 
attributed to the mutation are potentially a consequence of the level of APP 
expression. 
WT and APPswe cell line. It was suggested that increased APP cleavage due to 
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the Swedish mutation might result in detectable differences in copper-dependent 
phenotypes between the two cell lines, which provide an indication of the possible 
role of APP in cellular copper homeostasis. 
Survival studies (figure 3.25) indicate that even small amounts of exogenous copper 
(50μM) have detrimental effects on APPWT cultures, a feature that is enhanced in 
cultures that are supplemented with even higher concentrations of copper. This 
indicates that under normal culture conditions APPWT displays copper sensitivity 
that can not be rescued by adjustments of cellular mechanisms that prevent toxic 
copper accumulation and resulting in large scale cell death. It must be noted that 
cultures were exposed to copper for only 24 hours thus there might be a possibility 
that gene expression did not adjust according to changes in extracellular conditions. 
This point raises the question of whether efficient adaptation of the cell’s 
metabolism to excess copper is time-dependent and did not occur within the 24 hour 
experimental period resulting in induction of apoptosis. It might also be that cellular 
adjustments were not effective for the chosen copper concentrations, and so cell 
death was inevitable. Analysis of culture growth in increasing copper concentrations 
(figure 3.26) supports the view that cell death was not time, but rather 
concentration-dependent. Cell growth was inhibited upon exposure to copper 
concentrations including and exceeding 150μM and diminished by 50% when 
supplemented with low amounts of copper. Similar findings were reported in SH-
SY5Y cells by Arciello et. al. (Arciello et al., 2005), indicating that cellular 
mechanisms that facilitate excretion of excess copper are either defective or 
overwhelmed depending on metal concentration. Intracellular copper accumulation 
(figure 3.28) in APPWT cells further suggests that the equilibrium between copper 
import and copper efflux is imbalanced resulting in either decreased copper efflux 
or increased copper import. Cellular defence mechanisms against excess amounts of 
copper also include metallothioneins, which sequester and store physiological metal 
ions, thus the increase in intracellular copper levels might represent copper species 
bound to metallothionein or represent a switch in gene expression to proteins that 
require copper as co-factor for their physiological function. Copper could also be 
compartmentalised in the TGN or mitochondrial matrix. Increased exposure to 
copper potentially causes increased risk of cellular damage due to ROS production 
in all of these compartments. 
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To test cellular copper distribution in excess exogenous metal and possible 
buffering mechanisms, activity assays were performed on the most prevalent 
copper-dependent enzymes that are vital for cellular energy production (CCO) and 
antioxidant defence (SOD1). CCO is a mitochondrial membrane bound protein 
complex that requires a number of accessory proteins for full maturation; in 
particular the insertion of metal co-factors is a highly co-ordinated process (see 
section 1.5.4). Total membrane preparations of APPWT were analysed for CCO 
activity and spectrophotometric analysis showed significant changes in enzyme 
activity upon copper supplementation. Despite the level of significance in CCO 
activity, the results for replicates were conflicting with regards to observations of 
increased and decreased enzyme activity, thus no clear statement can be made 
whether excess copper is directed towards CCO. The second enzyme tested for 
copper-dependent changes in activity was the ubiquitously expressed cytoplasmic 
SOD1 antioxidant protein. In APPWT
There is evidence (Schmidt et al., 2000) that a reservoir of unmetallated apo-SOD1 
exists in the cytosol in yeast, which upon copper availability becomes metallated 
and activated. However, such an increase was not observed in cultures 
supplemented with high amounts of copper, suggesting that either copper is directed 
to cellular copper stores rather than being available for SOD1 incorporation or the 
cytoplasmic pool of SOD1 was fully metallated, thus only increased protein 
production could lead to increased enzyme activity. Elevated cellular copper may 
ultimately lead to the production of ROS, indicating that the decrease in survival in 
APP
 cultures upon copper addition no changes 
were observed in SOD1 activity. Thus it can be concluded that increased cellular 
copper accumulation does not result in increased metallation of either CCO or 
SOD1. 
WT cultures might be due to increased oxidative insult that is not matched with 
an adequate response in oxidative stress defence. Determination of cellular 
adjustments to excess copper by increasing the abundance of transcripts encoding 
copper-binding proteins using the RT-PCR approach was unsuccessful. No clear 
conclusions can be drawn from the gene expression data for SOD1 and its copper 
chaperone CCS (figures 5.14 and 5.15). If SOD1 was one of the major targets of 
copper distribution and detoxification in excess copper conditions, an increase in 
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gene expression of both SOD1 and CCS might be expected to protect the cell from 
oxidative stress and possibly provide a transient buffering mechanism. 
Additionally monitoring metallothionein gene expression and protein abundance 
would elucidate the localisation of intracellular excess copper. To conclusively 
establish whether increased protein production of SOD1, CCS or metallothionein is 
a governing factor in copper buffering, Western blot analysis and monitoring of 
RNA accumulation in conjunction with the use of ribosomal translation inhibitors in 
both APPWT and APPswe
Contrary to phenotypes observed in APP
 cell lines in deplete and high copper concentrations could 
be used. 
WT cells, the APPswe cell line displayed 
many characteristics of intracellular copper deficiency. Enzyme activities for both 
CCO and SOD1 were increased by and directly linked to increases in copper 
concentrations (figure 3.23 and 3.20, respectively). These data indicate that under 
normal culture conditions there may be a deficit in mitochondrial respiration and 
production of ATP required for cell survival. If the cell’s requirements for ATP and 
thus copper are not met, vital functions such as energy dependent molecular 
transport and gene expression are impeded resulting in delay or abortion in the 
cell’s response to extracellular and intracellular stimuli and likely cell death. It has 
not been established through experimental procedures whether this phenotype was 
the effect of the APPswe
The copper-deficient phenotypes of APP
 mutation or simply its overexpression in this cell line. 
swe cultures are rescued by supplementation 
with high concentrations of copper (300-500μM), as demonstrated in figure 3.25, to 
the point at which cell survival is restored to almost APPWT survival rates. Further it 
was observed that under normal culture conditions the APPswe cell line displays 
50% less CCO activity than APPWT (figure 3.22), which explains the decreased 
survival of control cultures relative to the wild type cell line. The apparent copper 
resistant phenotype of APPswe cells is supported by increased activity in SOD1 in 
high copper. Although cellular copper accumulation (figure 3.28) similar to that in 
APPWT is detected the oxidative stress posed on the cell is likely to be at lower 
levels than that in APPWT due to copper incorporation into CCO and SOD1, thus 
lower levels of intracellularly available copper remains to facilitate oxidative 
damage. Further oxidative stress is opposed by increased levels of SOD1 
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contributing to enhanced cell survival. Although APPswe cultures grow more readily 
in low copper concentrations compared with APPWT culture (figure 3.26), copper 
supplemented cultures do not attain the same growth rate as control cultures 
indicating that there is a slight copper sensitivity at concentrations including and 
exceeding 50μM. These data are contradictory to the high copper concentrations 
required to initiate increases in CCO and SOD1 enzyme activity indicating that 
although exposure to high copper concentrations can restore cellular survival for a 
short period, copper exposure over a longer time period might still lead to 
detrimental effects on cell survival. APPswe is cleaved to form Aβ more readily than 
APPWT and produces around 2-8 fold more of this soluble copper-binding amyloid 
species (Citron et al., 1992), thus one could conclude that cell lines carrying the 
APPswe mutation are less succeptible to copper toxicity due to an enhanced export 
function, which is supported by data from figure 3.28 showing reduced intracellular 
copper content compared to APPWT cell lines. Although APPswe cultures 
demonstrate increased copper resistance in a 24 hour period, the increased cleavage 
of APPswe might result in increased extracellular Aβ that binds to secreted copper 
and accumulates locally thus increasing the potential of localised oxidative damage 
that can not be counteracted by the cell over a longer period of time. The failure of 
APPswe
2D-LC was applied to whole cell protein extracts of both APP
 growth recovery in low copper concentrations to the levels of the control 
culture (figure 3.26) might be representative of this scenario with Aβ fibrilisation 
being mediated by the 50μM copper supplement.  
WT and APPswe cell 
lines. This method was developed to study differences in major cellular metal pools 
and their associated proteins in response to extracellular stimuli or cellular metal 
responses to genetic mutation. Thus 2D-LC provides an ideal tool to determine 
which possible role APP holds with regards to cellular copper homeostasis by 
comparing changes in copper distribution throughout the cell or alterations in 
copper concentrations within particular copper pools. Further identification of 
proteins associated with specific metal pools can be achieved by resolution of 
fractions containing the metal on SDS-PAGE and subsequent analysis using 
Principal Component Analysis. 
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Soluble extracts of APPWT and APPswe were separated by anion exchange and size 
exclusion chromatography and fractions analysed for manganese, iron, zinc, cobalt 
and copper content simultaneously (figures 3.4 and 3.5). One particular copper pool 
in the 100mM NaCl fraction at a size exclusion volume of 11ml displayed co-
migration with a zinc pool in the same fractions in both cell lines indicating the 
presence of a putative copper and zinc binding species. Glutathione activity assays 
across the same copper and zinc containing fractions in a whole cell extract obtained 
from Saccharomyces cerevisiae show co-migration of the copper peak with a 
protein peak (figure 3.6). Copper did not co-migrate with glutathione, thus it is not 
the copper-binding species in yeast and unlikely to represent the copper binding 
species in APPWT and APPswe extracts. To identify the proteinaceous ligand 
associated with copper and zinc, fractions containing the metals were resolved on 
SDS-PAGE and subjected to PCA analysis (figures 3.17 and 3.18). Although one 
particular protein, designated pSOD1SY5Y (figure 3.16), displayed strong correlation 
patterns to the metal distribution and metal concentration across the analysed 
fractions final identification of the protein by MALDI-TOF mass spectrometry was 
unsuccessful. However, previous experiments on soluble rat liver mitochondria 
extracts using the same method displayed the same copper and zinc pools (figure 
3.7). SDS-PAGE (figure 3.7), PCA (figure 3.8) and MALDI-TOF-MS analysis 
(figure 3.9) identified the copper and zinc binding species as SOD1, thus it was 
assumed that the same metal pools in APPWT and APPswe were associated with the 
same protein, SOD1. This assumption was confirmed by in-gel SOD1 activity 
assays performed on the copper and zinc containing fractions (figure 3.19). Direct 
comparison of triplicate metal analysis experiments confirmed SOD1 copper:zinc 
stoichiometry of 1:1 (Tainer et al., 1982) in APPWT, however the copper and 
partially zinc content in the APPswe SOD1 pool was decreased (figure 3.16) 
suggesting that the Swedish mutation or in APP or its overexpression modifies 
cellular copper content to the degree of functional copper deficiency. To assess 
whether decreased copper and zinc levels might be due to variation in the amounts 
of protein extract used for 2D-LC, aliquots of the 100mM NaCl fractions of post 
anion exchange separation were resolved on SDS-PAGE with a control of pure 
SOD1. No difference in protein abundance for SOD1 was observed in the two 
extracts (figure 3.16), thus the alteration in SOD1 metallation is most likely due to 
effects of the Swedish mutation. 
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Metallation status of CCO could not be assessed in this way due to CCO 
localisation to the membrane and its elimination from the protein extract early in the 
extraction process. Anion exchange and size exclusion chromatography were 
performed using an adjusted extraction protocol containing the non-ionic zwitter-
detergent Chaps to generate a membraneous extract of APPWT
To test the effects of, and cellular responses to, copper deficiency both the APP
. However, metal 
content analysis of CCO by ICP-MS was not possible due to large amounts of 
suspended solids in the samples that interfere with ICP-MS. Additional difficulties 
arose with the resolution of Chaps-containing membraneous extract on HPLC 
columns, thus singular fractions usually subjected to ICP-MS for their metal-content 
characteristics could not be obtained. Analysis of membraneous samples by ICP-
MS without resolution on the HPLC columns would result in metal content analysis 
of all membraneous proteins and not be specific for CCO. Further resolution of 
membraneous samples on Chaps containing SDS-PAGE was also unsuccessful 
(data not shown) and resulted in smeared gels that were inadequate for further 
analysis.  
WT 
and APPswe cell lines were treated with the copper chelator BCS. Since previous 
results indicate a copper-deficient phenotype in APPswe cultures, treatment with 
BCS is expected to affect this cell line more severely than the APPWT cell line. CCO 
and SOD1 activity assays demonstrate significant decreases in enzyme activities 
(figures 3.21 and 3.24) most likely due to inadequate metallation of both enzymes. 
This view is supported by analysis of cellular metal content (figure 5.12) which 
represents intracellular iron, copper and zinc concentrations after four generations of 
cell culture grown in BCS at levels that are in the low μM range and hardly 
detectable by ICP-MS. Especially high concentrations of BCS seem to affect growth 
of APPswe cells more than the growth of APPWT cells (figure 3.27). No growth was 
recorded for APPswe cultures in BCS concentrations of 50-100μM, whereas APPWT 
cultures recovered from treatment with 50μM BCS. At 5μM BCS concentration 
both cell lines display 60% growth, however the discrepancy in the cell’s ability to 
adjust to low intracellular copper becomes apparent at 10μM BCS. At this 
concentration APPWT growth remains at a level of 60%, whereas APPswe growth 
drops to 25%. This trend continues with increasing BCS concentrations. It must be 
noted that at concentrations of 10-2 5 μM BCS the APPswe cell line recovers from 
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impaired growth and reaches cell numbers comparable to those of APPWT in a time-
dependent manner (after 20 day rather than 9 days), which suggests rescue 
mechanisms that could potentially alter CCO and SOD1 enzyme activities and 
increase cell survival. Survival studies could not be performed on BCS treated cell 
lines to test for cell line-specific and BCS-mediated rates in survival due to the loss 
of cells and thus the means of standardisation between treatments during the cell 
culture process. As previously observed in copper-supplemented cultures, in which 
exposure to high copper concentrations initially increases CCO and SOD1 activity, 
but when monitored for a longer period results in cell death, the treatment with BCS 
might result in an initial decrease in CCO and SOD1 activity, which might be 
reversed after a certain time due to the cell adjusting to the environmental changes 
by mechanisms such as increased gene expression of copper importers, re-routing of 
copper chaperones or copper release from dispensable places namely the 
mitochondrial matrix or metallothioneins. However, due to a lack of extracellular 
copper and no indication of intracellular copper accumulation in metallothioneins or 
alternative storage it is not clear in what way the APPswe
The maintenance of cellular copper levels and correct distribution to target proteins 
in accordance with cellular requirements is one of the main focuses in finding new 
therapeutics for neurodegenerative diseases, many of which show symptoms of 
metal deregulation and imbalance. However, before chelation or supplementation 
therapies can be devised a clear understanding of cellular pathways and their 
alterations due to changes in copper availability is paramount. Two of the most 
prevalent copper-enzymes in the cell are mitochondrial CCO and cytosolic SOD1. 
However, recently SOD1 localisation to the mitochondrial intermembrane space in 
Saccharomyces cerevisiae (Sturtz et al., 2001) and SOD1 accumulation in the 
mitochondrial matrix in the human brain (Vijayvergiya et al., 2005) has been 
detected. It was shown that translocation of SOD1 was dependent on a high intra-
mitochondrial concentration of CCS (Sturtz et al., 2001) and also the non-metallated 
immature state of SOD1 (Field et al., 2003). Active mitochondrial SOD1 has further 
been detected in mammalian neuronal tissue (Stadtman and Levine, 2000), 
indicating that activation occurs within the mitochondria. It has further been 
demonstrated that the SOD1 pool in the cytosol and the mitochondria are freely 
 cell line could adjust to 
severe copper deficiency and restore growth. 
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interchangeable when SOD1 is not metallated or the disulfide bond established, thus 
changes in exogenous copper could alter the SOD1 distribution equilibrium to the 
cytosol since CCS is present in the cytosol in large quantities and contributes to 
extra-mitochondrial maturation of the protein. It was suggested that SOD1 as well 
as CCO might obtain their copper co-factor from the mitochondrial matrix low 
molecular weight copper pool, which was reported by Cobine et. al. in yeast 
(Cobine et al., 2004). Studies showed that this CuL complex is present in the 
cytoplasm in an unmetallated state and translocates to the mitochondrial matrix 
upon Cu(I) binding (Cobine et al., 2006). Exogenous copper supplementation in 
yeast increased the mitochondrial CuL pool giving rise to the hypothesis that with 
regards to increased CCO activity in copper supplemented cultures, the CuL 
complex might be involved in the provision of copper to CCO in SH-SY5Y cells 
also. In this thesis a putative CuL complex was identified in rat liver mitochondria, 
however, it was not possible to perform comparative studies of CuL concentrations 
between APPWT and APPswe by 2D-LC and ICP-MS metal analysis. Metal analysis 
of 2D-LC samples in APPWT whole cell extracts revealed very low amounts of 
putative CuL (figure 3.16) with the result that analysis was not further pursued, 
whereas mitochondrial extracts of APPWT
For SOD1 activity assays whole cell extracts were prepared, thus it is impossible to 
determine the contribution of mitochondrial SOD1 or cytosolic SOD1 to the overall 
activity measured. Copper supplementation of APP
 (figure 3.14) yielded amounts of protein 
too low for 2D-LC analysis. 
swe cultures resulted in increased 
enzyme activity indicating that SOD1 is partially unmetallated under normal culture 
conditions, which provides the conditions required for mitochondrial import of the 
enzyme. Upon increasing copper concentrations it is possible that not only the 
metallated state of cytosolic SOD1 increased, but also that of mitochondrial SOD1, 
thus preventing oxidative stress produced by increased copper concentrations in the 
cytosol and increased ROS being produced by newly metallated CCO. The 
increased survival and growth rate of APPswe cells in high copper compared to the 
APPswe control may be a direct result of activating both enzymes and increased 
copper efflux via Aβ. This finding is supported by studies in SH-SY5Y cells lacking 
both alleles for SOD1, which identified that although the decrease in SOD1 was less 
in mitochondria with respect to its cytosolic counterpart, the effects of SOD1 
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deficiency were highly noticible in mitochondria rather than cytosolic proteins 
(Aquilano et al., 2006). It needs to be mentioned that liquid analysis of SOD1 
activity by spectrophotometry represents all SOD activity and is not soecific for 
SOD1. Although SOD1 activity can be inactivated by the addition of KCN with 
residual activity originating from alternative SOD proteins, the decision was made 
not to use the chemical to perform these controls due to concerns for Health and 
Safety. Since SOD1 is the most abundant SOD isoform in mammalian cells activity 
was recorded as originating from SOD1. This might attribute to the variation in 
SOD1 activity measured between various experiments. 
The increase in CCO activity in copper supplemented APPswe cultures indicates a 
further symptom of early neurodegeneration in FAD patients carrying this mutation. 
Permanent reduction in oxidative phosphorylation creates cellular ATP deficits and 
dissipation in mitochondrial transmembrane potentials which result in release of 
cytochrome c and initiation of the apoptotic cascade (Krysko et al., 2001). The 
reduced level of CCO activity in APPswe compared to APPWT
However, mitochondrial dysfunction is not only caused by reduced levels of CCO 
and SOD1 following copper depletion. Copper supplementation of APP
 might be caused by a 
number of factors since the maturation of this protein complex requires a multitude 
of accessory proteins. Studies show that in copper-deficient SH-SY5Y cultures the 
CCO subunit COX2, which contains copper as a co-factor, is present at much lower 
levels (Rossi et al., 2001). This observation is not likely due to deficient copper-
dependent mitochondrial import mechanisms, since this subunit is expressed within 
the mitochondrion. Furthermore, in copper-deficient cells the CuL complex 
suggested to metallate CCO, would remain in the cytoplasm, thus the mitochondrial 
matrix copper pool is reduced in its ability to mediate CCO assembly. 
WT cultures 
resulted in decreased survival depending on copper concentration (figure 3.25) and 
attenuation of growth in high copper (figure 3.26). Although APPswe cells show 
copper resistance and recovery of copper-dependent enzyme activity, growth is 
attenuated in high concentrations of copper (figure 3.26) indicating that copper-
deficient phenotypes can not be rescued by metal supplementation alone. 
Anandatheerthavarada et. al. (Anandatheerthavarada et al., 2003) previously 
demonstrated full length APP insertion into the outer mitochondrial membrane in 
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cortical neurons of transgenic AD mice, and Aβ co-localisation with mitochondria 
has been reported in human AD affected brains (Lustbader et al., 2004) and Tg2576 
mouse brain carrying the Swedish mutation of APP (Crouch et al., 2005). One 
important observation was that the decrease in CCO activity, which is thought to be 
caused by the presence of Aβ in the mitochondrion, is specific to brain regions 
normally affected by neurodegeneration in AD (Anandatheerthavarada et al., 2003). 
It was reported by Casley et. al. (Casley et al., 2002) that Aβ1-42 mediates the 
reduction in CCO activity directly and not through oxidative changes of the 
surrounding membrane environment. It is suggested that Aβ1-42 directly interacts 
with CCO and possibly through structural rearrangement upon binding prevents the 
association of reduced cytochrome c with CCO. Inhibition of CCO is thought to 
increase the production of ROS by the previous complexes of the electron transport 
chain (Casley et al., 2002). Aβ-mediated inhibition of CCO was dependent on the 
presence of Cu(II) and chelation of the metal reduced CCO inhibition (Crouch et al., 
2005), therefore it was suggested that copper might aid the process either by Aβ 
oligomerisation, formation of dityrosine crosslinks (as described in section 1.6.1) or 
directly in Aβ-CCO interaction. An additional factor contributing to increased ROS 
production in mitochondria is the ability of Aβ to facilitate the reduction of Cu(II) to 
Cu(I). This in turn could result in the oxidation and carbonylation of membrane and 
proteins and ultimately the activation of apoptosis via cytochrome c release. These 
findings support the observation that in high copper concentrations cell growth is 
drastically alleviated in both APPWT and APPswe
Recent research has established links between the oxidative stress response and 
APP processing. Angeletti et. al. (Angeletti et al., 2005) demonstrated that the APP 
cleavage enzyme BACE1 and CCS stably interact via their C-terminal cytoplasmic 
 cell cultures. The mechanisms 
behind Aβ import into the mitochondrion are still unknown. It is possible that 
during increased APP cleavage and Aβ generation, which was observed in many 
FAD patients, combined with axonal transport inhibition through 
hyperphosphorylated tau protein the secretory pathway becomes congested and 
vesicles are redirected to organelles not normally targetted. This might account for 
the accumulation of intracellular copper which was not mirrored in increased CCO 
and SOD1 activity, but being bound to vesicular and mitochondrial Aβ. However, 
further studies need to be performed to validate this hypothesis. 
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domain and domain I, respectively, and it was shown that overexpression of BACE1 
directly competes for CCS with SOD1 resulting in decreased enzyme activity. This 
phenotype was rescued by CCS overexpression. The neuronal adaptor protein X11α 
was shown to have a similar effect on SOD1 activity due to it binding to CCS 
domain III (McLoughlin et al., 2001). Despite the co-localisation of BACE1 and 
APP via X11α, the adaptor protein inhibits the production of Aβ from APP in the 
presence of CCS, a process that is interrupted and results in increased Aβ generation 
in SH-SY5Y deletion mutants of CCS (Gray et al., 2010). Thus these data suggests 
that X11α-mediated CCS interaction with BACE1 and Cu(I) transfer may contribute 
to cellular copper homeostasis by altering APP metabolism and thus preventing 
APP participation in copper homeostasis. Moreover, the interaction of APP, 
BACE1, CCS and X11α could determine BACE1 activity or BACE1 association 
with APP in a copper-regulated manner. 
The localisation of CCS also needs further consideration. CCS localisation in the 
mitochondrion additionally decreases the amount of CCS available to cytosolic 
SOD1 and BACE1, thus increased cellular copper might cause increased CCS 
concentrations in the mitochondrion due to increased oxidative stress as mentioned 
previously. This would ultimately result in increased APP cleavage, since less CCS 
is available to bind BACE1, and possible export of copper due to extracellular Aβ 
release. The fact that the APP gene contains a copper responsive element in its 
promoter region emphasises the role of APP in copper homeostasis (Bellingham et 
al., 2004b). It was shown that upon copper depletion in fibroblasts APP gene 
expression was down-regulated suggesting a role in copper export for APP. This 
view is supported by findings of this project that in APPswe cultures copper-
dependent enzyme activities are decreased compared to APPWT. APP expression 
analysis in APPWT and APPswe neurons from AD patients needs to be performed to 
confirm that the down-regulation of APP is not cell-type specific or an artefact of 
experimental prcedures. APP quantification could not be performed in APPWT and 
APPswe cell lines, since the APPswe cell line was designed to overexpress the mutant 
APP gene. However, there is a line of evidence that APP might not be involved in 
copper efflux, but rather copper import. The ability of APP and Aβ to bind copper 
has led to the hypothesis that APP might be involved in plasmamembrane reduction 
of Cu(II) to Cu(I) prior to Ctr1-mediated import analogous to the role Fre1 plays in 
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copper import in yeast (Hassett and Kosman, 1995). The increase in intracellular 
copper monitored in both APPWT and APPswe cell lines (figure 3.28) supports this 
assumption. Although APPswe cells produce up to eight times more Aβ (Citron et 
al., 1992) than APPWT
One factor of APP metabolism that has not been studied in very much detail is the 
APP AICD. AICD is produced by intramembraneous γ-secretase cleavage in both 
non-amyloidogenic and amyloidigenic pathways (figure 1.2). AICD is either 
restricted to cytosolic membranes by the adaptor protein X11α or interacts with the 
adaptor proteins Jip1b and Fe65, which aid AICD transport into the nucleus and 
subsequent interaction with the nuclear histone acetylase Tip60 (von Rotz et al., 
2004), where it indirectly regulates the gene expression of APP, BACE1 and Tip60 
among others (Cao and Sudhof, 2001). The AICD-mediated gene expression for 
both APP and BACE1 ensures that full-length APP levels are at a constant steady-
state. However, during increased APP metabolism as was detected for most FAD 
mutations, this feedback mechanism becomes imbalanced. Although gene 
expression of APP and BACE1 are linked and constant, additional cellular changes 
such as increased or decreased copper levels can influence APP processing and/or 
trafficking and possibly BACE1 activity, thus shifting the delicate balance towards 
pathways that could accelerate symptoms observed in AD patients. 
 cells, both cell lines displayed increased concentrations of 
intracellular copper when treated with high exogenous concentrations of copper. If 
APP was involved in the cell’s protection against excess copper, elevated 
intracellular copper levels would have been counteracted. 
The importance of oxidative stress in the progression of AD pathology is 
compelling. Due to its high metabolic rate, the brain is an organ rich in molecular 
oxygen and consumes large amounts of glucose. Energy production depends on the 
electron transport chain, which is renowned for its production of oxidative stress 
inducing by-products. Mitochondrial oxidative stress was shown to be involved in 
hyperphosphorylation of cytoplamsic tau (Melov et al., 2007), thus deregulating 
axonal transport of mitochondria and exocytic vesicles destined to participate in 
neuronal transmission. Two independent research groups (Tong et al., 2005, Borghi 
et al., 2007) identified oxidative stress as a factor contributing to increased BACE1 
activity, but not gene expression or protein translation. This increased activity 
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facilitates the accumulation of extracellular Aβ and amyloid which exerts copper-
catalysed oxidative insults to the surrounding membranes and proteins. In FAD 
mutations, such as the Swedish mutation of the APP gene, which already display 
symptoms of cellular oxidative stress either through reduced activity of cellular 
antioxidant defence or increased production of mitochondrial ROS, oxidative insult 
is likely to exacerbate disease progression. Studies in a PC12 APPswe
In the past decade particular emphasis has been placed on neurodegenerative 
diseases as pathologies involving alterations in metal homeostasis, oxidative stress 
and mitochondrial dysfunction. Special attention has been paid to the possible role 
of mitochondria in the early stages of disease development. However, there are no 
conclusions with regards to mitochondrial dysfunction being a consequence or the 
cause of neurodegeneration. 
 cell line 
demonstrated elevated activity of caspase 3 after treatment with hydrogen peroxide 
indicating that early onset AD in this particular FAD mutation might result from 
increased neuronal vulnerability to extracellular oxidative stress (Marques et al., 
2003). 
One hallmark to characterise the degree of AD progression in patients is the amount 
of deposited Aβ. Soluble Aβ is produced at low levels under physiological 
conditions and present in all biological fluids implying that under pathological 
conditions either the natural balance of Aβ metabolism is perturbed or a rogue form 
of the peptide exists in AD individuals (Bush, 2002). Association of Aβ with 
aberrant metal homeostasis was inferred from distribution patterns of amyloid 
deposits in the brain, which occurred particularly localised to synapses thus there is 
a possibility that reagents participant in synaptic transmission might contribute to 
amyloid pathology. Aβ was localised intra-mitochondrially and extracellularly, 
destinations characteristic for generation of ROS and high content of metal ions, in 
particular zinc and copper. Synaptic elevation of ROS production is correlated with 
the ability of Aβ to bind copper and participate in redox-cycling mediated reactions. 
Direct neuronal damage and a contribution of ROS to AD pathology was 
demonstrated by the reversal of age-related learning deficits and brain oxidative 
stress in mice during chronic systemic administration of synthetic catalytic 
scavengers of ROS (Liu et al., 2003). Although it is not yet established whether 
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ROS generation is a cause or consequence of neurodegeneration and Aβ toxicity it 
is likely that intracellular ROS production is an event early in disease progression. 
Studies have shown that intraneuronal Aβ accumulation precedes plaque formation 
in APP and PS double transgenic mice (Wirths et al., 2001) and that hippocampal 
neuron loss exceeds amyloid plaque load in a transgenic mouse model of AD 
(Schmitz et al., 2004). These findings emphasise the importance of elucidating early 
cellular events in order to develop therapeutic agents for the prevention of the 
disease and to slow or abolish disease progression. 
It was demonstrated that under physiological concentrations of copper and zinc 
synthetic Aβ added to CSF was readily degraded by metal requiring IDE and MMP 
(Saido and Iwata, 2006). Increased concentrations of copper and zinc seem to 
increase Aβ accumulation and oxidative stress suggesting that not only Aβ 
generation, but also metal availability, is increased in AD. The normal ageing brain 
displays increased copper concentrations, a feature which might lead to altered 
metal homeostasis and the onset of AD. However, to detect changes between 
normal and AD brains, it is insufficient to assess whole brain copper. Detailed post-
mortem analyses are necessary to test the copper concentrations in different brain 
regions and also distinguish between extracellular and intracellular copper 
concentrations. General statements about brain copper concentrations with regards 
to AD do not hold true since specific regions in the brain are affected and although 
overall copper concentrations might be increased, local or indeed intracellular 
copper concentration might be reduced. It is therefore important to assess copper 
homeostasis in both a physiological model such as transgenic mice and cell culture. 
Only in a combined study, can the flux of copper be assessed and a thorough 
understanding of the interplay between organellar, cellular and systemic copper 
concentrations be gained. 
Before discussing the effect of APP on cellular copper homeostasis, a critical 
appraisal of current models in the study of copper homeostasis in AD provides a 
useful context. There are several cell culture models using fibroblasts, HEK296, 
PC12, SH-SY5Y cells and many more harbouring APP mutations relevant to the 
respective studies. However, these models can only assess intracellular copper 
distribution, influx and efflux. The interplay between extracellular amyloid beta 
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deposits and their possible effect on cell survival through ROS production is not 
readily performed due to cell culture procedure and constant change of culture 
media resulting in the removal of extracellular factors contributing to the pathology. 
Additionally it is a challenge to recreate physiological concentrations of metals, 
serum constituents and nutrients in cell culture medium in a consistently stable and 
reliable manner, since physiological CSF represents an ultrafiltrate of blood 
(Saunders et al., 1999) supplemented with components that are actively transported 
into the CSF depending on cellular demands. Thus the results obtained in this study 
reflect rather the effect of exogenous copper and the APPswe mutation on 
intracellular copper distribution and neuronal damage that is potentially caused by 
mitochondrial Aβ. Another model for the determination of the role of APP in copper 
homeostasis are transgenic mouse models harbouring relevant APP mutations, such 
as the Tg2976 mouse model overexpressing the human version of APPswe
The APP protein plays a central role in the brain and might have functions beyond 
the participation in metal homeostasis. It was established that its AICD is involved 
in transcriptional activation (Cao and Sudhof, 2001) and the sAPPα domain in 
neurite outgrowth (Mattson et al., 1993) and it was speculated that APP participates 
in G-coupled protein signalling (Nishimoto et al., 1993) or even act as a 
metallochaperone. Despite the possibility of APP possessing diverse biological 
functions the presence of two copper-binding sites is prevalent and strongly 
. Mice 
possess a version of the APP protein in which a three amino acid change compared 
to the human protein results in reduced aggregation of Aβ and a higher affinity to 
Cu(II) with less observable ROS production. Deploying transgenic mice carrying 
the human APP additionally to the mouse counterpart in metal homeostasis studies 
carries the risk of data being obscured by the impact native APP has on the 
biochemical behaviour of human APP. The copper scavenging ability of mouse Aβ 
prevents human Aβ, at least in part, in participating in Cu(II) binding events and the 
reduction of Cu(II) to Cu(I), thus impairing analysis of ROS generation and the 
degree of amyloid deposition. However, both model systems in conjunction with in 
vitro studies to understand the biochemical dynamics of copper-binding to proteins 
allow an insight into cellular mechanisms contributing to neurodegeneration in the 
context of AD. 
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suggests a role in metal homeostasis. However, the exact role of APP has not been 
determined.  
In the scope of this project the results obtained by biochemical analysis of cellular 
metal distribution, copper-dependent enzymatic activity assays and phenotypic 
analysis of cell growth and survival suggest that APP presents a means to facilitate 
copper efflux from the cell. Previously reported elevation of APPswe
Mitochondrial ROS production which is implicated in cytosolic tau 
hyperphosphorylation (Melov et al., 2007) might prevent the release of vesicular Aβ 
due to inhibition of APP-mediated axonal trafficking. The increase observed in 
intracellular copper concentration in APP
 cleavage by 
BACE1 results in increased production of Aβ species (Citron et al., 1992). At the 
same time cellular copper deficiency was demonstrated via increased copper-
dependent enzyme activity upon copper supplementation. The relationship between 
Aβ production and copper efflux is partly assessed within this thesis. Whether these 
Aβ species are secreted or remain intracellular in mitochondria or microtubule 
associated secretory vesicles remains unknown and further research employing 
cellular fractionation techniques coupled with immunohistochemistry and ICP-MS 
analysis would aid in the identification of Aβ localisation. 
WT
Deficiencies in axonal transport affect mitochondrial transport to the synapse, where 
large amounts of ATP are needed for active transport of extracellular zinc into 
vesicles following neurotransmission. Failure of zinc endocytosis results in 
constitutive neurotransmission and excitotoxicity. Further free synaptic zinc is 
scavenged by Aβ to form extracellular plaques (Lovell et al., 1999). These plaques 
constitute β-sheet fibrils inaccessible to IDE and MMP, thus a reduction of Aβ 
levels by its natural clearance mechanism is prevented. With zinc acting as catalytic 
co-factor of IDE and MMP, both enzyme activities are depleted when zinc that is 
readily avaialbale under normal physiological conditions is scavenged by Aβ 
 cultures might be a direct result of 
mitochondrial induced inhibition of vesicular transport, since copper-dependent 
enzyme activity did not change upon copper supplementation in this cell line. 
Accumulation of intracellular Aβ contributing to intracellular oxidative stress due to 
redox-cycling of bound copper contributes to the degeneration of neurons as well as 
vesicular lesions during Aβ membrane pore formation. 
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plaques. Since Aβ is produced under physiological conditions (Bush, 2003) 
potential treatments of AD need to be assessed carefully. Simple inhibition of 
BACE1 is impossible with regards to other physiological functions both BACE1 
and Aβ may hold. BACE1 may be important in copper homeostasis, not just by 
processing APP, but the high affinity Cu(I) binding site in  BACE1 might be 
directly involved in copper export, import or shuttling. BACE1 involvement in 
APP-mediated metal homeostasis suggests that treatment of AD with BACE1 
inhibitors in the early stages might result in disruption of the physiological role that 
BACE1 plays and contribute to rather than prevent pathology. It was shown that 
copper binding to APP greatly reduces APP processing in vitro (Barnham et al., 
2003b) via structural changes in the APP dimer, thus BACE1 together with CCS 
might be involved in regulating APP processing via metallation or dematallation of 
the protein.  
The role of CCS in cellular copper distribution and possible implications in 
neuronal pathology also need to be clarified. Cellular CCS expression and 
localisation patterns in conditions of copper deficiency and copper surplus need to 
be established to determine the impact of CCS on copper trafficking and mediation 
of copper transport. Specifically the interactions of CCS with BACE1 and APP via 
X11α hold potential explanations with regards to CCS-dependent copper-mediated 
BACE1 processing of APP. Although many of the aspects of copper transport 
remain to be identified results in this study suggest a contribution of APP to copper 
efflux. Whether this is due to APP regulation of efflux or direct involvement of APP 
in copper excretion remains unknown. The evidence supporting this hypothesis is 
briefly recapitulated below and summarised in figures 4.1 and 4.2. 
The increased CCO and SOD1 activity in copper-supplemented APPswe cultures is 
indicative of a copper deficient phenotype contributing to early onset neuronal 
degradation and reduction in survival compared to APPWT cultures due to reduced 
CCO and SOD1 activity under normal culture conditions. Survival was restored 
almost to APPWT levels upon copper supplementation, however, the growth of 
APPswe cultures was inhibited in high copper indicating toxicity of prolonged 
copper exposure even at low dosage. Intracellular copper accumulation in both cell 
lines is most likely due to increased copper trafficking to CCO and SOD1 in APPswe 
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and increased vesicular efflux of copper in APPWT which was potentially prevented 
by failure of vesicular axonal trafficking. APPWT displayed a high degree of 
vulnerability towards high and low copper concentrations suggesting deficiencies in 
detoxification of surplus copper. Additionally exogenous copper probably exerted a 
greater detrimental effect on APPWT culture than APPswe, since APPswe
The evidence for APP contribution in copper homeostasis obtained during this 
project highlights that especially in FAD early stages of AD might be caused by 
alterations in cellular metal homeostasis, however, advanced neurodegeneration is 
potentiated by both metal-dependent and metal-independent processes that 
fundamentally alter cellular metabolism and the cell’s ability to tolerate a whole 
host of different stress insults. 
 provided 
more intracellular ligands for excess copper, thus shifting the equilibrium towards 
increasing copper import and in the process reducing the concentrations of 
extracellular copper. 
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Figure 4.1: Summary of processes involved in copper homeostasis in SH-SY5Y 
APPWT
Copper is imported into the cell by Ctr1 and distributed to three distinct pathways. 
Copper is bound by the copper chaperone for superoxide dismutase (CCS) for metal 
delivery to SOD1, to Cox17 for insertion into mitochondrial cytochrome c oxidase 
and to Hah1 for incorporation into proteins in the Golgi and exocytosis. Upon 
trafficking to the cell surface APP is cleaved either by α-secretase (APP
 cell lines supplemented with copper 
WT) or β-
secretase (APPswe). It was shown by McLoughlin et. al. (McLoughlin et al., 2001) 
that CCS binds BACE1 through the adapter protein X11-α. It was demonstrated that 
SH-SY5Y APPWT
 
 cell lines supplemented with copper do not display increased 
SOD1 and CCO enzyme activity, thus it is hypothesised that the increased cellular 
copper content is likely to be distributed to the secretory pathway for excretion. 
However, this process might be affected by hyperphosphorylated tau-mediated 
retention of APP-containing vesicles. This could impact not only on the 
physiological functions of soluble APP fragments, but also interfere with secretion 
of other extracellular proteins and alter cellular copper homeostasis. 
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Figure 4.2: Evidence for alteration in cellular copper homeostasis by the 
Swedish mutation in SH-SY5Y cells and the implications for copper-dependent 
enzymes 
Copper is imported into the cell by Ctr1 and distributed to three distinct pathways. 
Copper is bound by the copper chaperone for superoxide dismutase (CCS) for metal 
delivery to SOD1, to Cox17 for insertion into mitochondrial cytochrome c oxidase 
and to Hah1 for incorporation into proteins in the Golgi and exocytosis. Upon 
trafficking to the cell surface APP is cleaved either by α-secretase (APPWT) or β-
secretase (APPswe). It was shown by McLoughlin et. al. (McLoughlin et al., 2001) 
that CCS binds BACE1 through the adapter protein X11-α. Citron et. al. (Citron et 
al., 1992) demonstrated that the Swedish mutation causes a 6-8 fold increase in APP 
cleavage by BACE1. It is thus hypothesised that the ability of CCS to deliver 
copper to SOD1 and BACE1, or at least interact with both proteins, might lead to 
aberrant copper homeostasis in cells containing the Swedish mutation. It was 
observed that in physiological copper concentrations APPswe
 
 cell cultures displayed 
a copper-deficient phenotype, which could be rescued by copper supplementation. 
SOD1 and CCO enzyme activities increased in copper supplemented cells and 
survival rates were increased compared to the control. It is hypothesised that the 
copper deficit was reversed through increased copper transport by enhanced 
chaperone delivery of copper to respective target proteins, possibly resulting in 
reduced interactions between BACE1 and CCS. Whether this interaction is of a 
physiologically relevant or pathological nature remains to be determined. 
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4.3 Future work 
The data presented in this thesis raised several issues regarding copper distribution 
and cellular responses to metal stimulation or depletion. Specifically copper-
dependent enzymatic activity contributed to the understanding of alterations in 
copper homeostasis with regards to the Swedish mutation and changes in copper 
levels. 
As a start to future work it might be worth increasing the number of replicates for 
SOD1 activity assays, whole cell metal content analysis and also survival studies to 
achieve greater insight about significance of the data (some replicates hardly 
displayed any significant changes). Attempts to compare the metal content for 
APPWT and APPswe in the SOD1 protein pool after 2D-LC and ICP-MS analysis 
have been made and data suggest decreased copper levels in APPswe compared to 
APPWT
The Cu(I) specific chelator BCS, used for copper depletion in both cell cultures, 
could potentially be substituted or combined with additional copper chelators, such 
as EDTA. In biological fluids as well as cell culture medium there is a constant 
equilibrium between the two oxidation states of copper. BCS chelation of Cu(I) 
shifts this equilibrium resulting in increased presence of Cu(II). BCS combined with 
a non-specific copper chelator might result in greater copper chelation, thus reduce 
the amount of cell passaging needed to completely devoid the cell of copper. A 
reduction in passaging would reduce the stress cells endure during the culturing 
process, which might lead to increased basal SOD1 activity and as a result might 
flaw data. 
 bound to this particular copper pool. However, data only represents a non-
statistically significant trend, which needs to be pursued further in order to draw 
conclusions concerning the SOD1 metallation status. 
With regards to differences in copper trafficking between the two cell lines, it is of 
interest to establish the presence of the CuL complex in SH-SY5Y cells and 
subsequently compare its copper content in physiological and pathological copper 
concentrations.  
One question that remains is the role of APP in copper homeostasis. Although 
results from this thesis point to APP mediating copper efflux, intense analysis of 
 186 
APP cleavage fragments needs to be performed. Western blot analysis of secreted 
fragments and organellar fragments might identify further contributions of Aβ to 
neuronal degeneration or a possible physiological role during copper trafficking or 
detoxification. Analysis of the vesicular fraction for Aβ and APP content is of 
particular interest since data from intracellular copper content determination 
indicates that in copper supplemented APPWT
Another question to be answered is the effect copper binding exerts on APP. It was 
reported that copper-binding to APP prevents APP processing by BACE1 due to 
inducing conformational changes in the APP dimer. A logical consequence would 
be that copper normally bound to Aβ resides in full-length APP and undergoes 
reinternalisation, rather than excretion. This changes not only physiological copper 
distribution, but also increases intracellular copper concentrations. However, 
increased APP cleavage in APP
 cells copper might accumulate in 
vesicles destined for synaptic excretion. Intracellular accumulation of such vesicles 
probably by hyperphosphorylated tau-mediated inhibition of axonal transport could 
contribute to cerebral metal imbalance. 
swe indicates decreased basal levels of copper 
binding to APP, an effect which might be potentiated by increased Aβ generation. 
Western blot analysis of soluble Aβ and sAPPβ in conjunction with full-length APP 
would identify cleavage preferences of BACE1 in APPWT and APPswe
The creation of an APP knock-out mutant in SH-SY5Y cultures and subsequent 
phenotypic analysis as performed in this work might provide further insight into the 
relevance of APP in copper homeostasis. However, it is possible that these mutants 
are not viable due to loss of neurite outgrowth and metal imbalance. 
 cultures in 
high and deplete copper concentrations depending on APP copper binding state. 
A bioinformatic based approach to elucidating the roles of BACE1 and APP copper-
binding is the comparison of their copper-binding sites to copper-binding sites in 
other metalloproteins. APP is an evolutionarily conserved protein and comparison 
of its metal-binding site might be of use in the deduction of a function as chaperone, 
importer, exporter or even regulator of the above.   
To determine which role CCS plays in copper distribution in elevated or depleted 
copper conditions, it is important to establish organellar CCS location. CCS-
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mediated copper delivery can affect SOD1 activity, SOD1 import into mitochondria 
and function in an unknown capacity during BACE1 binding. It is not yet 
understood how copper depletion or supplementation influences CCS trafficking 
and variation in copper delivery to target proteins in either APPWT and APPswe
Additionally to CCS gene expression analysis, studies of MT-3, CTR1, HAH1, 
ATP7A, COX17, BACE1, SOD1 and APP gene expression could be useful to 
assess the routes of distribution of excess exogenous copper throughout the cell. 
Admittedly, the gene expression analysis for APP might prove difficult in these two 
cell lines, since the APP
 
culture, thus comparative studies of CCS localisation can be achieved by cell 
fractionation techniques coupled with copper content analysis by ICP-MS of 
respective cellular fractions and possible quantitative Western blot analysis to 
confirm protein presence. Results would further need to be verified by comparative 
analysis of CCS gene expression to establish whether changes in CCS localisation 
under varying copper concentration or genetic background is due to gene expression 
or variation in protein translation patterns. Studies employing ribosomal inhibitory 
agents would clarify the degree of translation-dependent changes in CCS activity. 
Another possibility is the expression of GFP-CCS in both cell lines to observe CCS 
trafficking and localisation under the microscope. However, this could potentially 
flaw results of cellular metal distribution and CCS localisation, since GFP may 
prevent trafficking of CCS into the mitochondrion or interfere with copper binding 
to the protein. Further, overexpressing CCS impedes direct comparison of cell lines 
carrying the modified gene and the amount of copper delivered to target proteins 
might vary due to varying expression levels. 
swe
 
 cell line was designed to overexpress the protein. Thus 
methods of standardisation need to be identified first. 
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5.1 Spectrophotometric analysis of SOD1 activity 
Chapter 5: Appendix 
Liquid SOD1 activity assays were performed to obtain absolute data for comparison 
of SOD1 activity between APPWT and APPswe
Whole cell soluble protein extracts of APP
 cell lines in copper supplemented or 
depleted conditions. The assay was performed using the xanthine/xanthine oxidase 
system which is outlined in section 2.4.7.2.4. Oxidation of xanthine to uric acid by 
xanthine oxidase under aerobic conditions releases anionic superoxide, which 
reduces oxidised cytochrome c triggering an increase in absorbance intensity when 
measured at a wavelength of 550nm. SOD1 prevents the reduction of cytochrome c 
by sequestration and dismutation of the superoxide to hydrogen peroxide. The 
measured increase in absorbance intensity due to free superoxide is quenched and 
directly relates to SOD1 activity. 
WT and APPswe
Cell pellets were obtained from one 150cm
 were prepared as outlined 
in section 2.4.7.2.3. Cultures were supplemented with increasing concentrations of 
copper and grown to 80% confluence for another 24 hours or supplemented with 
BCS and grown for four generations before being subjected to further analysis. 
Supplement concentrations are specified in figures 5.1 through 5.4. 
2 flask per sample and resuspended in 
420μl of 50mM phosphate buffer, pH 7.8 and 120μl of 10% (w/v) SDS. Following 
incubation at 37ºC for 30 minutes the sample was cooled and 60μl of 3M KCl 
added. After further incubation intact cells were pelleted and the supernatant 
analysed for protein content by BSA-calibrated Coomassie assay. A fresh SOD1 
standard curve was prepared on the day of experiment to control for mechanical or 
experimental variation. Pure SOD1 extracted from human erythrocytes was titrated 
to the working solution in 0.5 unit increments up to 3 units of SOD1 activity. 
Reactions for the standard curve were supplemented with 60μl of the 300mM KCl, 
2% (w/v) SDS, 35mM phosphate buffer mixture which was used for sample 
extraction to control for differences in absorbance arising from reaction components 
other than cytochrome c. Spectra for both cell lines in either supplementation 
conditions were taken for 30 minutes using 100μg of protein per measurement with 
the reaction being initiated by titration of 50μM xanthine to the cuvette. 
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Figure 5.1: SOD1 activity in SH-SY5Y APPWT
Whole cell protein extracts were prepared from 1x150cm
 under copper supplementation 
2 flask per sample of 80% 
confluent monolayer culture as described in section 2.4.7.2.3. Three independent 
extracts were produced. The protein content was estimated by BSA-calibrated 
Coomassie assay and all three extracts diluted to the same protein concentration to 
minimise experimental variation. On the day of experiment a fresh standard curve 
using pure SOD1 was prepared. Samples could not be analysed in triplicate due to 
the duration of individual analyses. SOD1 activity was measured 
spectrophotometrically at a wavelength of 550nm as described in section 2.4.7.2.4. 
Histograms represent enzyme activity in units SOD for APPWT
 
 replicate 2 (a) and 
replicate 3 (b). The first replicate is shown in figure 3.20. 
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Data displayed in figure 5.1 shows two independent replicates of SOD1 activity 
measurements in APPWT
SOD1 activity of copper supplemented APP
 whole cell protein extracts. Due to the long time period 
each of each of the experiments triplicate measurements could not be obtained, thus 
it is difficult to determine, whether changes in enzyme activity are statistically 
significant. Direct comparison between both replicates is not possible due to the use 
of different SOD1 standard curves. This results in different SOD1 activity values 
for the controls. Although there seems to be a threefold difference between the two 
replicates, it must be noted, that there is no major change in enzyme activity across 
increasing copper treatments. This data is consistent with the replicate shown in 
figure 3.20. The results of measuring SOD1 activity in cells grown under copper 
deplete conditions indicate a decrease in enzyme activity with increasing BCS 
concentration, although a decrease in activity reduction can be observed in higher 
BCS concentrations in both replicates shown in figure 5.2 and in figure 3.21. This 
might be caused by the cell adjusting to low copper levels redirecting endogenous 
copper from copper stores to essential copper-binding enzymes such as SOD1 or 
alterations in protein expression as the cell prepares for apoptosis. Another option 
for base level SOD1 activity in high BCS concentrations is the exhaustion of 
enzyme assay sensitivity, thus the plateau might represent zero base levels of SOD1 
activity. 
swe cells is shown in figure 5.3. It must 
be noted that, although there is no increasing or decreasing trend in SOD1 activity, 
enzyme activity is increased at 50μM copper in each replicate. This data is 
consistent with data shown in figure 3.20 where a general increase in SOD1 activity 
is observed. Although no definite statements about copper-dependent alterations in 
enzyme activity can be made, the increase of enzyme activity at 50μM copper 
seems to be cell line specific. This feature was not observed in APPWT 
supplemented with copper, thus a copper-dependent mechanism for increased SOD1 
metallation or altered metabolism might be responsible for this observation. As 
previously observed for BCS-supplemented APPWT cultures, SOD1 enzyme activity 
decreased in BCS-supplemented APPswe
   
 cells with even small amounts of BCS 
accounting for most of the decrease in enzyme activity. 
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Figure 5.2: SOD1 activity in SH-SY5Y APPWT
Whole cell protein extracts were prepared and the SOD activity assay performed as 
previously described. Histograms represent replicate 2 (a) and replicate 3 (b) of 
three independent replicates. Replicate 1 is shown in figure 3.21. 
 under copper depletion 
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Figure 5.3: SOD1 activity in SH-SY5Y APPswe
Whole cell protein extracts were prepared and the SOD1 activity assay performed as 
previously described. Histograms show replicate 2 (a) and replicate 3 (b) of three 
independent experiments. Replicate 1 is shown in figure 3.20. 
 under copper supplementation 
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Figure 5.4: SOD1 activity in SH-SY5Y APPswe
Whole cell protein extracts were prepared and SOD1 activity assay performed as 
previously described. Histograms depict replicate 2 (a) and replicate 3 (b) from 
three independent experiments. Replicate 1 is shown in figure 3.21. 
 under copper depletion 
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5.2 Analysis of CCO activity 
The CCO activity assay is based on the same principles as the SOD1 activity assay. 
The rate of oxidation of reduced cytochrome c is measured spectrophotometrically 
at a wavelength of 550nm. Upon oxidation of cytochrome c quenching of the 
absorbance spectrum is expected which relates directly to enzyme activity. Full 
reduction of cytochrome c is essential prior to the experiment, thus titration of the 
reducing agent ascorbic acid to the final working solution was performed to 
determine the concentration of reducing agent needed to fully reduce cytochrome c. 
Figure 5.5 shows spectra obtained during titration of 50μM increments of ascorbic 
acid to the assay working solution and increased absorbance of cytochrome c at 
550nm was observed. Absorbance plateaus at concentrations of 350-400μM of 
ascorbic acid indicating that cytochrome c reduction is complete. It was calculated 
that a minimum of 64mM ascorbic acid were required to fully reduce the 50μM 
cytochrome c stock solution. Addition of 100mM ascorbic acid to the stock solution 
resulted in a colour change from red to pink indicating reduction of cytochrome c. 
Excess reducing agent was removed by dialysis in 20mM phosphate buffer, pH 7.8 
using dialysis membrane with a molecular weight cut-off of 3,500 Da. 
Whole cell membrane extracts were prepared from one 150cm2 flask per sample for 
both cell lines and pellets resuspended in 1ml of 20mM phosphate buffer, pH 7.8. 
Lysis was performed in a sonication waterbath in three intervals of three minutes 
with five minute intervals on ice. Intact cells were removed by low spin and the 
supernatant subjected to ultracentrifugation to collect the membraneous fraction of 
the extract. The pellet was resuspended in 0.5ml of 20mM phosphate buffer and 
protein content determined by BSA-calibrated BCA protein assay. Samples for both 
cell lines and various copper or BCS treatments were adjusted to the same protein 
concentration to control for sample variation. To control for full cytochrome c 
reduction for each individual measurement, aliquots (0.9ml) of fully reduced 3μM 
working solution were scanned between wavelengths 200nm and 800nm to compare 
absorbance at 550nm. The CCO assay reaction was initiated by addition of 8μg 
protein extract and the rate of cytochrome c oxidation determined using ε550nm = 
29,500 M-1 cm-1. 
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Figure 5.5: Reduction assay of cytochrome c for cytochrome oxidase activity 
assay 
The CCO activity assay measures the oxidation of cytochrome c by CCO. Thus, it is 
required for the cytochrome c to be fully reduced before the activity assay to detect 
the best possible absorbance signal. An aliquot (0.9ml) of 3μM cytochrome c in 
20mM KPO4
 
 buffer has been treated with increasing concentrations (50μM 
increments) of 2.5M ascorbic acid and absorbance spectra were taken at a 
wavelength of 550nm. Saturation was observed at 350μM with an arbitrary 
absorbance of 0.04. It was calculated that 64.8mM ascorbic acid were needed to 
fully reduce the 50μM cytochrome c stock, however an excess of this concentration 
was used and the surplus reductant removed by dialysis. 
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Triplicate measurements of three individual replicates for both cell lines and all 
copper or BCS treatments were taken. Figure 5.6 shows two additional replicates of 
copper supplemented APPWT to that shown in figure 3.23. Whereas no significant 
changes in enzyme activity were observed in the latter replicate, the replicates 
shown here contradict with statistically significant increases and decreases in CCO 
activity. Therefore no definite statement about copper-dependent changes of CCO 
activity in APPWT cultures can be made. BCS treated APPWT
CCO activity assayed in copper supplemented APP
 cells as shown in 
figure 5.7 display a clear and significant reduction in CCO activity, a feature which 
is highly replicable. 
swe cultures as shown in figure 
5.8 indicates significant increases in CCO activity in higher concentrations of 
copper. Although one replicate does not show any significance (figure 5.8 panel a) 
the additional replicate in figure 3.23 clearly indicates increased enzyme activity. As 
for APPWT, the APPswe
 
 cell line displays significant decreases in enzyme activity 
due to BCS treatment as shown in figure 5.9 and 3.24. 
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Figure 5.6: Cytochrome c oxidase activity in SH-SY5Y APPWT
Whole cell protein extracts were prepared from 1x150cm
 under copper 
supplementation 
2 flask per sample of 80% 
confluent monolayer culture as described in section 2.4.7.3.1. The protein content of 
three independent extracts was estimated using the BCA assay for membraneous 
protein and all three extracts diluted to the same protein concentration to minimise 
experimental variation.  Prior to the activity assay cytochrome c was fully reduced 
with molar excess of ascorbic acid, which was subsequently removed by dialysis. 
Cytochrome oxidase activity was measured spectrophotometrically at a wavelength 
of 550nm as described in section 2.4.7.3.6. Histograms show enzyme activity as 
calculated using ε550nm = 29,500 M-1cm-1 for APPWT replicate 2 (a) and replicate 3 
(b). Replicate 1 is shown in figure 3.28. Error bars represent standard deviation for 
triplicate measurements. Symbols represent statistical significance as follows: *: 
p<0.05 compared to the control, #: p<0.01 compared to the control, **: p<0.05 
compared to previous treatment, ##: p< 0.01 compared to previous treatment.  
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Figure 5.7: Cytochrome c oxidase activity in SH-SY5Y APPWT and APPswe
Whole cell protein extracts of three independent experiments were prepared and the 
cytochrome c oxidase assay performed as described previously. Cytochrome 
oxidase activity was measured spectrophotometrically at a wavelength of 550nm as 
described in section 2.4.7.3.6. Histograms show enzyme activity as calculated using 
ε
 
under copper depletion 
550nm = 29,500 M-1cm-1 for APPWT
 
 replicate 2 (a) and replicate 3 (b). Replicate 1 is 
shown in figure 3.29. Error bars represent standard deviation for triplicate 
measurements. Results indicate a decrease in cytochrome oxidase activity. Symbols 
represent statistical significance as follows: *: p<0.05 compared to the control, #: 
p<0.01 compared to the control, **: p<0.05 compared to previous treatment, ##: p< 
0.01 compared to previous treatment. 
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Figure 5.8: Cytochrome c oxidase activity in SH-SY5Y APPswe
Whole cell protein extracts of three independent experiments were prepared and 
cytochrome oxidease activity assay performed as previously described. Cytochrome 
oxidase activity was measured spectrophotometrically at a wavelength of 550nm as 
described in section 2.4.7.3.6. Histograms show enzyme activity as calculated using 
ε
 under copper 
supplementation 
550nm = 29,500 M-1cm-1 for APPswe replicate 2 (a) and replicate 3 (b). Replicate 1 is 
shown in figure 3.28. Error bars represent standard deviation for triplicate 
measurements. Results indicate increased cytochrome oxidase activity in the APPswe
 
 
cell line. Symbols represent statistical significance as follows: *: p<0.05 compared 
to the control, #: p<0.01 compared to the control, **: p<0.05 compared to previous 
treatment, ##: p< 0.01 compared to previous treatment. 
 232 
0
0
200
400
600
800
1000
1200
1400
500
1000
1500
2000
2500
0μ
M 
BC
S
5μ
M 
BC
S
10
μM
 B
CS
20
μM
 B
CS
25
μM
 B
CS
50
μM
 B
CS
0μ
M 
BC
S
5μ
M 
BC
S
10
μM
 B
CS
20
μM
 B
CS
25
μM
 B
CS
50
μM
 B
CS
nm
ol
es
of
 o
xi
di
se
d 
cy
to
ch
ro
m
e 
c 
μg
 p
ro
te
in
-1
, m
in
-1
nm
ol
es
of
 o
xi
di
se
d 
cy
to
ch
ro
m
e 
c 
μg
 p
ro
te
in
-1
, m
in
-1
a
b
##
#
#
#
#
 
 
Figure 5.9: Cytochrome c oxidase activity in SH-SY5Y APPswe
Whole cell protein extracts of three independent experiments were prepared and 
cytochrome oxidase activity assay performed as described previously. Cytochrome 
oxidase activity was measured spectrophotometrically at a wavelength of 550nm as 
described in section 2.4.7.3.6. Histograms show enzyme activity as calculated using 
ε
 under copper 
depletion 
550nm = 29,500 M-1cm-1 for APPswe
 
 replicate 2 (a) and replicate 3 (b). Replicate 1 is 
shown in figure 3.29. Error bars represent standard deviation for triplicate 
measurements. Results indicate a decrease in cytochrome oxidase activity in this 
cell line. Symbols represent statistical significance as follows: *: p<0.05 compared 
to the control, #: p<0.01 compared to the control, **: p<0.05 compared to previous 
treatment, ##: p< 0.01 compared to previous treatment. 
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5.3 Survival studies under copper supplementation 
Survival rates were monitored in copper supplemented APPWT and APPswe cell 
lines. Appropriate concentrations of copper were added to cultures and grown to 
80% confluence for another 24 hours. Ratios of life to dead cells were established 
by manually counting cells in a hemocytometer following trypan blue staining with 
cells excluding the stain counted as life and those penetrated by the stain counted as 
dead. Figures 5.10 and 5.11 show survival data for APPWT and APPswe, 
respectively. As previously observed in figure 3.25 panel a, a significant decrease in 
survival was detected in APPWT
APP
 cultures directly linked to the amount of copper 
added to the culture. Although the replicate shown in figure 5.10 panel b does not 
display significant changes, a slight reduction is observed which follows the trend 
of the more prominent phenotypes in replicates shown in figures 5.10 and 3.25 
panels a. 
swe cultures supplemented with copper as shown in figure 5.11 do not display 
any significant change in survival. The survival between control groups is 
comparable between the two cell lines, indicating that the overexpression of APPswe 
does not affect survival under culture conditions. However, the replicates presented 
in figure 5.10 differ from the replicate shown in figure 3.25, where a statistically 
significant increase in survival was detected in high copper concentrations. The 
APPswe control culture shows reduced survival rates compared with the APPWT 
control culture, suggesting that there might be a survival difference in both cell lines 
under culture conditions with APPswe displaying resistance to high copper that is 
higher compared to that of APPWT
 
.  
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Figure 5.10: Survival of SH-SY5Y APPWT
Cell cultures of 1x10
 under increasing copper 
concentrations 
6 cells were prepared for the SH-SY5Y APPWT cell line and 
grown for several days before being supplemented with the appropriate 
concentration of copper and grown for another 24 hours. Cultures were harvested as 
described in section 2.2.3.2 and analysed for life and dead cells by the trypan blue 
exclusion method using a hemocytometer. Survival rates are shown for APPWT 
replicate 2 (a) and replicate 3 (b). Replicate 1 is shown in figure 3.25. Error bars 
represent standard deviation of triplicate measurements. Results indicate a slight but 
statistically significant decrease in survival when extracellular copper levels are 
increased. Symbols represent statistical significance as follows: *: p<0.05 compared 
to the control, #: p<0.01 compared to the control, **: p<0.05 compared to previous 
treatment, ##: p< 0.01 compared to previous treatment. 
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Figure 5.11: Survival of SH-SY5Y APPswe
Cell cultures of 1x10
 under increasing copper 
concentrations 
6 cells were prepared for the SH-SY5Y APPswe cell line and 
grown for several days before being supplemented with the appropriate 
concentration of copper and grown for another 24 hours. Cultures were harvested as 
described in section 2.2.3.2 and analysed for life and dead cells by the trypan blue 
exclusion method using a hemocytometer. Survival rates are shown for APPswe 
replicate 2 (a) and replicate 3 (b). Replicate 1 is shown in figure 3.25. Error bars 
represent standard deviation of triplicate measurements. Symbols represent 
statistical significance as follows: *: p<0.05 compared to the control, #: p<0.01 
compared to the control, **: p<0.05 compared to previous treatment, ##: p< 0.01 
compared to previous treatment. 
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5.4 Metal content of APPWT and APPswe
Cellular metal content was previously determined in copper supplemented cultures 
of APP
 under copper depletion 
WT and APPswe as shown in figures 3.28 and 3.29 detecting significant 
increases in copper but not zinc and iron content in both cell lines. Whole cell metal 
content was determined in both cell lines that were treated with increasing 
concentrations of BCS. Cultures were grown in independent triplicates for four 
generations in the appropriate concentrations of BCS and following harvest were 
resuspended in 65% ultrapure (v/v) HNO3 at a cell count of 1.5x106 per sample. 
Cells were left to lyse for at least one week at room temperature and samples 
analysed for metal content by ICP-MS subsequent to two high spin centrifugation 
steps to remove unlysed cells and cell debris. ICP-MS measurements were 
performed in triplicate and data is shown in figure 5.12. There is no evidence of 
significant changes in metal content for copper, zinc and iron in BCS treated 
cultures in both cell lines. This might be due to complete cellular metal depletion 
during the four generations of cell culture with metal trafficking processes 
continuously transporting metals to the cell surface and ultimately shifting the 
cellular metal equilibrium to the cell surface where metals were sequestered from 
the culture system by BCS. Changes in cellular metal content at this stage could be 
minimal and below detection levels of the ICP-MS or influenced by external 
contaminations which would hardly influence data with high metal content, but may 
interfere with data showing minimal amounts of metal. Another complication in 
determining exact changes in metal content in BCS treated cells is that BCS could 
be occupied by metal originating from lysed cells in culture, which would be more 
prevalent in higher BCS concentrations compared to lower BCS concentrations 
which a cell could survive. With several changes of BCS containing growth 
medium between cell culture generations it is possible that more metal was 
extracted from culture subjected to higher BCS concentrations and that data 
obtained would be flawed as a result. This issue is not prevalent in copper 
supplemented cultures as they are only grown for another 24 hours and do not 
require growth medium change. Thus, if supplementations are performed carefully 
the same amount of copper is added to all cells, which renders the data more 
comparable between triplicate measurements and samples within one replicate. 
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Figure 5.12: Total metal analysis in whole cell SH-SY5Y APPWT and APPswe
APP
 
under copper depletion 
WT and APPswe cells were cultured in increasing concentrations of BCS for four 
generations and seeded for the final analysis. Cultures were harvested at 80% 
confluency and cell numbers determined as described in section 2.4.6.1 using a 
Coulter Cell Counter system. Aliquots of 1.5x106 cells for each cell line and copper 
depletion status were resuspended in 1ml of ultrapure 65% (v/v) HNO3. Samples 
were incubated at room temperature for at least one week and repeatedly 
centrifuged to remove cells and cell debris, before being analysed by ICP-MS for 
copper, zinc and iron content. Whole cell metal content is shown for APPWT copper 
(a), zinc (b) and iron (c) concentrations and for APPswe
 
 copper (d), zinc (e) and iron 
(f) concentrations. Error bars represent standard deviation of triplicate 
measurements. 
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5.5 Comparison of expression levels of hsod1 and hccs genes in SH-SY5Y 
APPWT and APPswe
The copper chaperone CCS and its target protein SOD1 are both soluble proteins 
and closely linked to cellular copper status and homeostasis, thus should provide 
ideal candidate genes to monitor changes in one particular cellular copper 
trafficking pathway. Cell line specific patterns of gene expression of both hsod1 and 
hccs could give an indication about differences in copper handling between APP
 under copper supplementation and depletion 
WT 
and APPswe
APP
 and possible provide and insight in copper-dependent alterations in 
gene expression. Although a multitude of genes coding for copper-binding proteins 
or copper transporting/trafficking proteins could be studied in this manner, the focus 
was based on these two genes, especially since there was evidence of CCS and 
BACE1 interactions and possible redirection of copper away from SOD1 (Angeletti 
et al., 2005). It has previously been shown that in yeast high copper concentrations 
lead to an increase in sod1 gene expression as one of the cellular copper buffering 
mechanisms (Culotta et al., 1995). Gene expression was tested on the 
neuroblastoma cell lines in high copper concentrations and copper deplete 
conditions. 
WT and APPswe cells were cultured in increasing BCS concentrations for four 
generations before being seeded for the final analysis. Copper supplementations 
were performed 24 hours before cells were harvested Whole cell RNA extracts were 
prepared from one 150cm2
Cell pellets were resuspended in 10 volumes of pre-warmed RNA lysis buffer 
(50mM Tris-Cl, pH 8.0, 100mM NaCl, 20mM EDTA, pH 8.0, 2% (w/v) SDS, 
60mM β-mercaptoethanol, 10µg/ml proteinase K) and incubated at 37°C for 30 
minutes. A 5x phenol extraction was performed by adding an equal volume of 5:1 
phenol:lysis buffer to the sample, which was centrifuged at 4,000rpm for 10 minutes 
and the aqueous top layer collected into a new tube. An equal volume of 1:1:1 
phenol:chloroform:lysis buffer added and the centrifugation step repeated. The 
aqueous top layer was collected into corex ultracentrifuge tubes and adjusted to 
0.5M ammonium acetate using a 10M stock. RNA was subsequently precipitated by 
 flask per sample of 80% confluent monolayer culture 
using the phenol extraction protocol adapted from Sambrook and Russell 
(Sambrook and Russell, 2001) and described in section 2.3.1.1.  
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adding 2.5 volumes of 100% ethanol (-20°C) and sample incubation at -20°C for 2 
hours. Following the incubation the nucleic acid was pelleted by ultracentrifugation 
at 12,000 rpm for 30 minutes at 4°C. The supernatant was discarded, the pellet 
resuspended in a small volume (2ml) of 70% (v/v) ethanol and the centrifugation 
step repeated. The pellet was then allowed to air-dry over night, resuspended in 
50µl DEPC-treated water and the amount of RNA per sample was estimated. 
Following DNaseI treatment reverse transcription was performed using the Im-
PromII reverse transcription kit and 1µg of RNA per sample. Preliminary studies 
shown in figure 5.13 show that the reverse transcription step was more successful 
using oligo(dT)15 primers rather than gene specific primers. For all steps in the RT-
PCR reaction a master-mix solution was prepared and aliquots added to each sample 
RNA to control for experimental variation. Reverse transcription was performed as 
specified in section 2.3.1.2.3 with reaction components and volumes as shown in 
table 2.2. The PCR reaction step was performed as outlined in section 2.3.1.3 and 
1.5μl of cDNA were used per sample. The PCR reaction was run for 30 cycles and 
gene products visualised on a 2% (w/v) agarose gel using 100kb ladder as size 
marker. To test whether the hccs and hsod1 primers generated the expected product, 
preliminary studies were performed as shown in figure 5.13. RT-PCR products 
obtained from whole cell APPWT
 
 RNA extracts were run on a 2% (w/v) agarose gel 
and single products visualised at 210bp and 230bp for hsod1 and hccs, respectively. 
The observed products were of the same length as was expected. In the following 
RT-PCR reactions the house keeping gene β-actin was used as loading control. 
Standardisation of hβ-actin between samples was achieved by adjusting loading 
volumes until a homogenous signal intensity from all samples was detected. PCR 
products of hccs and hsod1 were loaded onto the gel as multiple volumes of the 
volumes determined for hβ-actin as their expression was less prominent. Due to loss 
of RNA during sample preparation or RNA estimation errors due to low 
concentration in the sample, certain individual copper or BCS treatments did not 
show any PCR products and were thus excluded from the analysis. 
 
 
 240 
m m
S
O
D
1,
 s
pe
ci
fic
 p
rim
er
S
O
D
1,
 o
lig
o
(d
T)
15
 
C
C
S
, o
lig
o
(d
T)
15
 
200
100
300
400
500
 
Figure 5.13: Verification of primers for RT-PCR 
Whole cell RNA extracts of SH-SY5Y APPWT have been subjected to reverse 
transcriptase polymerase chain reaction to test primer for generation of correct 
product size. Expected product sizes for human sod1 and human ccs are 210 and 
230 bp, respectively. The gel shows products of RT-PCR reactions using sod1 
specific primers and oligo(dT)15 primers being use for the reverse transcription step. 
Single products at 210 and 230 bp can be detected for hsod1 and hccs, whereas the 
use of specific primers during the reverse transcription step results in multiple 
products of varying sizes. For all RT reactions oligo(dT)15
 
 primers will be used with 
gene specific primer being used in the PCR reaction. 
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Results of RT-PCR experiments are shown in figures 5.14 and in duplicate 
experiments in figure 5.15. All gene products were subjected to the same gel to 
prevent false data due to minimal differences in gel composition such as ethidium 
bromide or agarose content and to control for differences in UV exposure and 
photography. However, most of the hccs and hsod1 gene products do not show any 
trend in gene expression depending on cellular copper status. This might in part be 
due to signal saturation of the house keeping gene. Although sometimes fractions of 
a μl were loaded onto the gel to prevent signal saturation due to large amounts of 
PCR product, the signal might still be saturated which prevents the accurate 
evaluation of correct sample volumes to be loaded onto the gel. Further it must be 
noted that when working with such small volumes, pipetting errors or slight volume 
changes are clearly visible and might be mistaken as a genuine result. Experiments 
with varying amounts of cDNA and RNA were performed (data not shown), but 
yielded no improvement to the gel loading optimisation process. 
Although most of the data does not reveal copper-dependent alterations in gene 
expression, two interesting observations need to be mentioned. Firstly, in both 
replicates the BCS supplemented APPWT cell line displays a decrease in hsod1 
expression which is accompanied by a slight increase in hccs gene expression. This 
has physiological implications since it is detrimental for the cell to use energy on 
the production of proteins that can not be metallated due to co-factor deprivation. At 
the same time gene expression switches to cellular mechanisms that could rescue 
this deficient phenotype by providing more copies of copper-trafficking proteins. It 
would be interesting to perform gene expression studies on copper importers such as 
Ctr1 and Dmt1 to test whether the compensatory mechanisms for copper deficiency 
include increased gene expression of copper importers or copper exporters. With a 
presumed role of APP in copper export it might be worth testing APP gene 
expression in copper depleted cell lines. Secondly, figure 3.14 panel b shows an 
interesting expression pattern of hccs and hsod1 whose PCR products signals seem 
to be inversed. No copper-dependent trend of increased or decreased gene 
expression can be observed, however in 50μM copper hsod1 expression is high, 
whereas it is low in hccs at 50μM of copper. At a copper concentration of 150μM, 
however, hsod1 gene expression signals are low as compared with hccs which 
shows a large amount of PCR product. This is an unusual scenario, one which is 
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unlikely to be due to experimental error. Results suggest that there is an intricate 
interplay between the expression levels of hccs and hsod1, with the reduction in one 
causing an increase in the other. From a homeostatic point of view, in high copper 
the cell needs to adjust to either excrete excess copper or generate more ligands for 
the excess metal. Thus an increase in gene expression of copper exporters and 
certain copper chaperones such as HAH1 and a decrease in gene expression of 
copper importers would be expected. Increases in extracellular and intracellular 
copper increases the risk of ROS generation, thus one would expect the gene 
expression of the antioxidant SOD1 and its chaperone to increase. However, copper 
might be directed to other compartments for excretion rather than storage in 
intracellular ligands, thus there is no need for increased expression of SOD1. 
Further, one would expect that CCS and SOD1 are co-expressed since their 
physiological roles are co-dependent. However, with the suggestion that CCS also 
binds to other cellular targets, its expression might be governed by additional 
factors depending on its role in other pathways and the expression of the proteins 
CCS interacts with.  
 
 
 
 
 
 
 
 
 
 
 
 
 
` 
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Figure 5.14: Comparison of expression levels of hsod1 and hccs in SH-SY5Y 
APPWT and APPswe
APP
 under copper supplementation and depletion 
WT and APPswe cells were cultured in increasing concentrations of BCS (0μM, 
5μM, 10μM, 20μM, 25μM, 50μM and 100μM) for four generations before being 
seeded for the final analysis. Copper supplementations were performed 24 hours 
before cells were harvested for RNA extraction. Whole cell RNA extracts were 
prepared from 1x150cm2 flask per sample of 80% confluent monolayer culture 
using the phenol extraction protocol as described in section 2.3.1.1. Briefly, cell 
pellets were lysed in lysis buffer (50mM Tris-Cl, pH 8.0, 100mM NaCl, 20mM 
EDTA, pH 8.0, 2% (w/v) SDS, 60mM β-Mercaptoethanol, 10μg/ml proteinase K) 
and incubated at 37ºC for 30 minutes. Subsequent extractions using a 5:1 
phenol:lysis buffer and 1:1:1 phenol:lysis buffer:chloroform were performed and 
protein and RNA precipitated by the addition of 0.5M ammonium acetate and 100% 
ethanol. RNA was peletted , resuspended in 50μl DEPC-treated water and analysed 
for RNA content using a NanoDrop ND-1000 Spectrophotometer. Aliquots of each 
sample (5μg of RNA) were subjected to DNAseI treatment before reverse 
transcription was performed with 1μg RNA of each sample (see sections 2.3.1.2.1 
and 2.3.1.2.2). Reverse transcription using oligo(dT)15 primers for hsod1, hccs and 
hβ-actin was followed by polymerase chain reaction (1.5μl of cDNA per 100μl 
reaction volume) using gene specific primers with product sizes of 210bp, 230bp 
and 612bp, respectively. Hβ-actin was used as control and standardised by adjusting 
the volume loaded onto a 2% (w/v) agarose gel across the samples. Multiple 
volumes of hsod1 and hccs were loaded in comparison to hβ-actin. Gels show 
expression of hβ-actin hsod1and hccs for APPWT in increasing copper (a), APPWT 
in increasing BCS (b), APPswe in increasing copper (c) and APPswe
 
 in increasing 
BCS (d). Depending on the success of the RNA extract only a few copper and BCS 
concentrations are shown on the gels. 
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Figure 5.15: Comparison of expression levels of hsod1 and hccs in SH-SY5Y 
APPWT and APPswe
RNA extraction and RT-PCR were performed as previously described for copper 
supplemented and depleted APP
 under copper supplementation and depletion duplicate 
WT and APPswe cell lines. The same concentrations 
of reagents and volumes of RNA/cDNA were used in this RT-PCR. Hβ-actin was 
used as control and standardised by adjusting the volume loaded onto a 2% (w/v) 
agarose gel across the samples. Multiple volumes of hsod1 and hccs were loaded in 
comparison to hβ-actin. Gels show expression of hβ-actin hsod1and hccs for 
APPWT in increasing copper (a), APPWT in increasing BCS (b), APPswe in 
increasing copper (c) and APPswe
 
 in increasing BCS (d). Depending on the success 
of the RNA extract only a few copper and BCS concentrations are shown on the 
gels. 
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